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It has been exciting and at the same time intimidating to be the first doctoral student who 
works on this topic in the group. Reflecting on my decision of choosing the project at the start 
of the PhD, I realised that being the first or only one doing something has intrigued and 
motivated me. Like every self-congratulatory graduate student who just received an o!er from 
Cambridge, I had a peacockish ambition that I would be changing the world with my great 
scientific discovery during my PhD – curing cancer, solving global warming and such. Now 
that I am writing up what I have done for the past three years, only do I hope that I could have 
contributed to a tiny little barely-to-be-seen push at the boundary of human knowledge, as 
depicted by Matt Might in his Illustrated guide to a PhD.1 
However, even this tiny little barely-to-be-seen push would not be made possible without all 
the support I received. I would like to thank Professor Christopher A. Hunter, the best 
supervisor that I could wish for, for his British humour (essential talent), for his guidance and 
mentorship both in science and personal development, as well as his full understanding and 
support. I remembered well that there was a time when, after several months of synthesis, I 
became very discouraged about my research because a key experiment did not work as designed. 
I presented Prof. Hunter the data with a sad face and, out of my surprise, he showed no 
disappointment at all. “"ere must be something much more interesting going on”, he said, 
“and we will figure that out”. He was right. Walking back to the lab I saw the sun shined 
through heavy clouds and it cheered me up, just like his encouragements that made I felt I was 
still doing a good job. 
Before I joined the group, Dr Maria Ciaccia, Dr Flore Keymeulen and Dr Matthew J. 
Langton have done an enormous work in the project and provided the foundation of this thesis. 
I especially thank Dr Langton for his day-to-day hands-on supervision in the laboratory during 
my first year. Apart from technical skills and scientific knowledge, his calmness and the ability 
to stay composed in all situations are what I found most valuable to learn. Except for one time 
when Dr Langton went furious as Yorkshire tea, i.e. proper British tea, got mixed up in the 
kitchen and I quote that he has “now discovered that lemon, ginger and milk is not a popular 
combination for a good reason, and for an English person this is as high on the disaster scale 
as pineapple on pizza and chorizo in paella!” 
Gossip tends to get more pervasive when people work in an open-plan o#ce and up to 90% 
of conversations could qualify as gossip.2 "is is especially the case in our o#ce as for example, 
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almost everyone was asked by Mr Peter Bolgar about Dr Istvan Kocsis’ dating preferences after 
his interview with the group, and even with Dr Francesco Fasano’s excellent online stalking 
skills we could not figure it out. Only once I started working with him did I clear up the 
mystery. Dr Kocsis is an extraordinary colleague and an awesome friend to spend time with. 
He is also a keen advocate for collaboration and a potent idea generator who makes the 
Transduction team strong and productive. I also thank Ms Lucia Trevisan for her contribution 
to the team. For details of our collaboration, please see Chapter 5. 
!ree years of research would have been monotonous without Professor Steven V. Ley being 
my mentor, whose guidance and encouragement led my way to business schools (both HBS 
and Judge). !e economic knowledge I gained completely changed my perspective of this 
constantly evolving world, and suddenly current political a"airs that used to puzzle me started 
to make sense. Until then, I realised how Xu Zhimo, the eminent poet from King’s College 
whose name brings Chinese tourists flooding into Cambridge throughout the year, felt when 
one century ago he wrote the following sentences in a prose3: 
“ 
… I dare not say how knowledgeable I have become through my education in Cambridge, 
I dare not say one can be regenerated and deified through the baptism of Cambridge. What 
I dare say is that it was Cambridge that opened my eyes, it was Cambridge that aroused my 
curiosity in knowledge, it was Cambridge that generated the awareness of ‘I’ in me.” 
I am not at King’s. I chose Queens’ College because of its colour – a lush, emerald green. It 
seems random to most, but this was probably one of the best decisions I have made. I was lucky 
enough to have been involved in the college Governing Body and which allowed me to peer 
into the eight-hundred-year formality of this University from a unique angle. It was fun.  
  And time flies. 
One take-home message for those who cannot be bothered to read the rest of the thesis: bring 
flowers next time when you meet Her Majesty the Queen, she will come and say hi.4  
 




(1)  Might, M. !e Illustrated Guide to a Ph.D. 
http://matt.might.net/articles/phd-school-in-
pictures/ (accessed Oct 14, 2019). 
(2)  Bassuk, A.; Lew, C. !e Antidote to O#ce 
Gossip. Harvard Business Review. November 11, 
2016. 
 
(3)  Xu Z. On Smoking and Culture; 1915. 
(4)  !e Patroness returns to Queens’ 
https://www.queens.cam.ac.uk/life-at-
queens/news-and-events/the-patroness-returns-to-
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Cell membranes coordinate a large variety of biological processes by selectively recognising and 
responding to di!erent external stimuli, and membrane-spanning proteins play a vital role in 
these signalling pathways. A large number of examples of synthetic membrane channels and 
transporters have been reported in the past four decades. However, signal transduction without 
mass transfer is considerably more challenging. In this dissertation, an indirect artificial 
transmembrane signalling mechanism which operates by controlled translocation of a synthetic 
transducer across the lipid bilayer was investigated. "e fundamental concept of the 
translocation mechanism is the switching of membrane-permeability of the two head groups 
of the transducers. "e recognition head group of the transducer becomes membrane-
permeable in response to an external chemical stimulus, which leads to membrane 
translocation, exposing a catalytic head group to the interior of the vesicle. Catalytic hydrolysis 
of an internal substrate generates an amplified output signal. 
Previously reported examples showed that the transducer could respond to di!erent external 
stimuli, such as pH (hydroxide ions) or metal ions. Herein, we present e!orts towards 
generalising the concept and extending the scope of this mechanism into more biological 
systems. Firstly, a maleimide transducer was designed as a “stem transducer” to which a wide 
range of recognition groups could be attached in situ by using maleimide-thiol conjugation 
chemistry. Secondly, a carboxylic acid transducer was studied in an attempt to achieve 
controlled cargo-release in response to an acid input. "irdly, a vesicle-to-vesicle 
communication system was assembled with a desthiobiotin transducer by leveraging the 
desthiobiotin-avidin-biotin system. "is example represents a key step towards designing 
artificial cell-like compartments that communicate in a similar way to cells. Furthermore, we 
explored an analogue of the β-galactose transducer and the viability of using enzymatic cleavage 
as an input on the membrane surface. Finally, 19F NMR studies were conducted to provide 
insight into the positioning of the catalytic head groups of transducers in the membrane, and 
a fluorescence quenching assay was used to determine the ion transport ability of transducers.  
"is work provides further understanding of the proposed membrane translocation 
mechanism and extends the scope of artificial transmembrane signal transduction from purely 
synthetic assemblies into more sophisticated biological systems. "is opens up the potential for 
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Résumé de Thèse 
Les membranes cellulaires coordonnent une grande variété de processus biologiques en 
reconnaissant et en répondant sélectivement à di!érents stimuli externes. Les protéines 
transmembranaires jouent un rôle vital dans ces voies de signalisation. Un grand nombre 
d'exemples de canaux membranaires synthétiques et de transporteurs ont été rapportés au cours de 
ces quarante dernières années. Cependant, la transduction de signal sans transfert de masse est 
considérablement plus di"cile. Le mécanisme de translocation induit par la translocation contrôlée 
d’un transduceur synthétique à travers la bicouche lipidique a été étudié au cours de ce travail. Ce 
mécanisme repose sur la commutation de la perméabilité membranaire d’un groupe de 
reconnaissance et d’un groupe catalytique d’un transduceur. En réponse à un stimulus chimique 
externe, le groupe de reconnaissance du transduceur devient perméable à la membrane ce qui 
conduit à une translocation, exposant le groupe catalytique à l'intérieur de la vésicule. L'hydrolyse 
catalytique d'un substrat interne génère ainsi un signal de sortie amplifié. 
  Les exemples précédemment rapportés ont montré qu’un transduceur peut répondre à di!érents 
stimuli externes, tels qu’une modification de pH par ajout de base ou la présence d’ions métalliques. 
Nous présentons ici les e!orts déployés pour généraliser ce concept et étendre la portée de ce 
mécanisme à davantage de systèmes biologiques. Tout d'abord, un transduceur possédant un 
groupement maléimide a été conçu comme transduceur de base auquel un large éventail de groupes 
de reconnaissance pourrait être attaché in situ en utilisant une chimie de conjugaison maléimide-
thiol. Deuxièmement, un transduceur possédant un groupement acide carboxylique a été étudié 
dans le but d'obtenir une libération contrôlée de la cargaison en réponse à une modification de pH 
par ajout d'acide. Troisièmement, un système de communication de vésicule à vésicule a été 
construit avec un transduceur dérivé de desthiobiotine, en utilisant le système de desthiobiotine-
avidine-biotine. Cet exemple représente une étape clé dans la conception de compartiments 
artificiels ressemblant à des cellules et communiquant comme ces dernières. De plus, nous avons 
exploré un analogue du transduceur β-galactose ainsi que la viabilité de l’utilisation de clivages 
enzymatiques comme moyens d’entrée à la surface de la membrane. Enfin, des études de RMN 19F 
ont été conduites pour étudier le positionnement des groupes catalytiques des transduceurs dans la 
membrane. Un test d'extinction de fluorescence a aussi été utilisé pour déterminer la capacité de 
transport ionique des transduceurs. 
Ces travaux permettent de mieux comprendre le mécanisme de translocation membranaire et 
ouvre la voie au développement de vésicules capable de communiquer entre elles en construisant 
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Aib  α-Aminoisobutyric Acid  
AmB  Amphotericin B 
ATP  Adenosine Triphosphate 
Boc  tert-Butyloxycarbonyl Group 
cAMP  Cyclic Adenosine Monophosphate  
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DMF  N,N-Dimethylformamide 
DMSO Dimethyl Sulfoxide  
DNA  Deoxyribonucleic Acid 
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DOPC  1,2-Dioleoyl-sn-glycero-3-phosphocholine  
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DXR  Doxorubicin 
EA  Ethyl Acetate 
EDC  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EDTA  Ethylenediaminetetraacetic Acid 
EGF  Epidermal Growth Factor  
FRET  Förster Resonance Energy Transfer  
FT-IR  Fourier-Transform Infrared Spectroscopy 
gA  Gramicidin 
GDP  Guanosine Diphosphate  
GPCR  G-Protein Coupled Receptor 
GTP  Guanosine Triphosphate  
GUV  Giant Unilamellar Vesicle 
H-bond Hydrogen-Bond 
HABA  4-Hydroxyazobenzene-2-carboxylic Acid  
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic Acid 
HPLC  High-performance Liquid Chromatography 
HPTS  8-Hydroxypyrene-1,3,6-trisulfonic Acid  
HR-MS High Resolution Mass Spectrometry 
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Ka  Association Constant 
Kd  Dissociation Constant 
LC-MS  Liquid Chromatography–Mass Spectrometry 
LDH  Lactate Dehydrogenase  
LMV  Large Multilamellar Vesicle 
LUV  Large Unilamellar Vesicle 
m.p.  Melting Point 
MES  2-(N-morpholino)ethanesulfonic Acid 
MVV  Multivesicular Vesicle 
NAv  NeutrAvidin 
NBD  Nitrobenzoxadiazole 
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NMR  Nuclear Magnetic Resonance 
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PDB  Protein Data Bank 
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r.t.  Room Temperature 
RTK  Receptor Tyrosine Kinase 
SEC  Size Exclusion Chromatography  
SUV  Small Unilamellar Vesicles  
TFA  Trifluoroacetic Acid 
THF  Tetrahydrofuran 
UPLC  Ultra-Performance Liquid Chromatography 
UV-vis  Ultraviolet–Visible Spectroscopy 
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1.1   Transmembrane Signal Transduction in Nature 
Lipid bilayer membranes in biological systems form compartments to separate the interior of 
cells from their extracellular microenvironments. !is compartmentalisation protects the cell 
from its surroundings and allows chemical processes to be physically decoupled on both sides 
of the membrane. Cell membranes coordinate a large variety of biological processes by 
selectively recognising and responding to di"erent stimuli. !is is of great significance for many 
processes, such as development, proliferation, di"erentiation, homeostasis and immunity.  
In nature, membrane-spanning proteins play a key role in signalling processes for 
transmission of chemical or electrochemical signals across membranes.1 Cells use a wide variety 
of specifically defined signalling pathways to regulate their activities. Whilst some of the 
systems respond to internal signals, which are commonly seen as metabolism messengers, the 
majority of them are activated by external signals. All signalling pathways can be divided into 
two main forms depending on whether the process involves a direct or indirect mass transfer. 
Common examples of direct mass transfer across the membrane are ions channels2, aquaporin3, 
and carrier proteins4, which are responsible for mediating the selective passage of ions, water 
and small molecules, respectively. In 2003, the Nobel Prize in Chemistry was awarded jointly 






1.1.1   Ion Channels 
Ion channels are one of the most widely distributed membrane proteins that allow the rapid 
and selective flow of ions across the cell membrane. Among many functions they perform, they 
play a pivotal role in regulating membrane potentials and conducting nerve impulse in higher 
organisms.2 !ere are more than 300 types of ion channels in any given cell and they are usually 
classified by gating mechanisms. For example, voltage-gated ion channels are activated by 
changes in the electrical membrane potential6, whilst ligand-gated ion channels are activated 
in response to the binding of a specific ligand7, such as a neurotransmitter.  
Figure 1.1 shows a ligand-gated potassium ion channel which consists of a selectivity filter, 
shown at the top of the protein, and a gating domain with a Ca2+ binding site, shown at the 
bottom.8 !e gating domains open and close the channel depending on the local concentration 
of  Ca2+. At a high Ca2+ concentration the channel opens the gating ring and allows potassium 
ion flux. 
  
Figure 1.1   Illustration of a ligand-gated potassium ion channel in the lipid bilayer. The gating domain (in the 
membrane) opens upon calcium ion binding and allows K+ influx. PDB entry: 1LNQ (left), 1K4C (right), 
©copyright S. Dutta and D. S. Goodsell. This figure has been re-illustrated from the original representation 
under CC-BY-4.0 license. 
1.1.2    Aquaporin 
Aquaporins, also called water channels, are membrane proteins that selectively conduct water 
molecules while preventing the passage of ions and other solutes. !ey are extremely abundant 
not only in bacteria and plants but also in mammals. At least seven aquaporins are expressed 
in the kidney to facilitate essential functions such as formation of urine and regulation of 
osmolality.9 !e signalling function of aquaporin is less obvious than other membrane-
expanding proteins mentioned previously and therefore is not reviewed in this section. 
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1.1.3   Carrier Proteins 
Small molecules such as glucose, urea, and ammonia can be transported across the membrane 
with the help of relevant solute carrier proteins.10–12 An important property of solute carrier 
proteins is that they are very specific for only one or a few structurally related molecules. For 
example, the glucose transport protein family, a common protein family that is found in most 
mammalian cells, facilitates the movement of glucose into erythrocytes. It recognises only 
glucose and a few similar monosaccharides, such as galactose and mannose. Moreover, the 
transport is stereospecific, i.e. only D- but not L-isomers of these monosaccharides can be 
transported across the membrane. A human genome encoded glucose transporter is shown in 
Figure 1.2.13 Initially, the glucose transporter is in the conformation that exposes the binding 
site to the outside of the cell, which favours the binding of a D-glucose from the outside of the 
membrane (left). !e binding event causes the transport protein to undergo a conformational 
change, which opens the binding site to the inside of the cell (right). !e glucose can then be 
released in the cell and the transporter protein is free to revert to its original conformation, 
ready for the next cycle. 
  
Figure 1.2   A glucose transport mechanism in the lipid bilayer. The glucose transporter is in the conformation 
that exposes the binding site to the outside of the cell, which favours the binding of a D-glucose from the 
outside of the membrane (left). The binding event causes the transport protein to undergo a conformational 
change, which opens the binding site to the inside of the cell and release the glucose (right). PDB entry: 
4ZWC (left), 4PYP (right), ©copyright D. S. Goodsell. This figure has been re-illustrated from the original 
representation under CC-BY-4.0 license. 
  Signalling pathways that do not have direct mass transfer, i.e. where input and output signal 
are separated by the membrane, have more complex mechanism profiles. To date, up to 18 
indirect transmembrane signalling pathways have been identified. Regardless of how di"erent 
these mechanisms are, the first step of signalling is always a binding event of ligand on the 
outside of the membrane, which triggers a conformational change of the protein. Subsequently, 
information is conveyed either through protein-protein interactions (for example dimerization 
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or oligomerization of proteins, as observed in receptor tyrosine kinase (RTK)14 or tumour 
necrosis factor receptors15, respectively), or it is transmitted by generating di!usible yet 
membrane-impermeable molecules inside the cells, which are usually referred to as secondary 
messengers, as observed in G protein-coupled receptors (GPCRs). In 2012, the Nobel Prize in 
Chemistry was shared jointly to Robert J. Lefkowitz and Brian K. Kobilka for their studies of 
GPCRs.16 
1.1.4   Receptor Tyrosine Kinases (RTKs) 
In the human genome there are 58 receptor tyrosine kinase proteins (RTK) encoded and their 
principal functions involve the regulation of cell growth, di!erentiation, adhesion, motility 
and death.17 RTK proteins have also been reported to have significant roles in the development 
of diseases, including diabetes and cancer.  
  Figure 1.3 shows an epidermal growth factor (EGF) receptor18, a typical RTK located at the 
surface of cell membrane which gives cells permission to grow and divide. It consists of a large 
extracellular recognition domain, a membrane anchor section, a kinase domain and a long 
flexible tail. "e recognition domain faces outwards from the cell and can bind EGF. When 
there is no EGF present, this extracellular domain folds back on itself, as shown on the left. 
Once an EGF binding (input) event happens, the recognition domain undergoes a 
conformational change to unfold itself. Subsequently, it binds to another copy of the EGF-
bound receptor, forming a dimeric complex as shown on the right. "e extracellular 
dimerization triggers intracellular dimerization of the kinase domain (shown at the bottom 
right), which then produces a cascade reaction (output) adding phosphate groups to the 
tyrosine on the flexible tail of the receptor. "e phosphorylated tails stimulate further 
downstream signalling proteins in the cell. 
 
Figure 1.3   Transmembrane signalling of epidermal growth factor receptors. The receptor (blue) selectively 
binds EGF (input, red) and triggers a conformational change that favours dimerisation of two identical 
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receptors. Internal kinase domain is activated upon dimerization and produces a cascade reaction in the cell 
(output). PDB entry: 1EGF (EGF), 1NQL, 1IVO, 2JWA, 1M17, 2GS6 (receptor). ©copyright D. S. Goodsell. This 
figure has been re-illustrated from the original representation under CC-BY-4.0 license. 
1.1.5   G Protein-Coupled Receptors (GPCRs) 
Guanine nucleotide-binding proteins (G proteins) are a family of proteins that regulate a wide 
range of cell activities including metabolism, transcription, contractility, and secretion. !ere 
are two classes of G proteins depending on whether they are membrane-associated: monomeric 
small GTPases (not membrane-associated) and heterotrimeric G proteins (membrane-
associated). !e latter are receptor-mediated and are composed of α-, β-, and γ-subunits (Gαβγ) 
on the inner membrane surface of the cell, see Figure 1.4.19  
  When the G protein is inactive, it is attached to the GPCR and there is a guanosine 
diphosphate (GDP) bound to Gα subunit.  When a ligand, for instance a hormone, 
neurotransmitter, or glycoprotein, binds with a GPCR from the outside of the membrane 
(input), this ligand either stabilises or induces a conformational change in the receptor that 
releases the coupled G protein and activates it. !en the GDP dissociates from the Gα subunit 
and picks up a guanosine triphosphate (GTP) from the inside of the cell, and subsequently the 
G protein disassembles itself into Gα-GTP and Gβγ subunits. Both subunits can activate 
downstream e"ectors.20 For example, cyclic adenosine monophosphate(cAMP)-dependent 
signalling pathways, adenylyl cyclase is activated by Gα-GTP.21 In turn, the activated adenylyl 
converts adenosine triphosphate (ATP) to cAMP, a typical secondary messenger. Multiple 
secondary messengers can be generated by one stimulus through this enzymatic reaction inside 
the cell to achieve amplification. An increase in concentration of the cAMP can further activate 
multiple signalling events, for example activation of a cyclic nucleotide-gated ion channel.22 
  
Figure 1.4   Transmembrane signalling of G protein-coupled receptor. In the initial state, the receptor (pink) 
is bound to the G-protein (blue). Binding with an adrenaline molecule (input) triggers a conformational change 
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of the receptor and release the G-protein at the inner side of the membrane. Further conformational change 
dissociates Gα subunit (orange) and subsequently binds and activates adenylyl cyclase (purple) and generates 
multiple cAMP molecules (output, red) in the cell. PDB entry: 2RH1, 1GOT, 1CUL, 1TBG (from left to right), 
©copyright D. S. Goodsell. This figure has been re-illustrated from the original representation under CC-BY-
4.0 license. 
1.2   Vesicles and Applications 
Lipid bilayer membranes not only separate cells from the surroundings, they also provide 
compartmentalisation for sub-cellular structures, such as the nucleus, mitochondrion, Golgi 
apparatus, and vesicles. In cell biology, a vesicle is a spherical structure that consists of liquid 
or cytoplasm encapsulated by a lipid bilayer membrane. !is structure is a tool used by cells 
for organising cellular substances within or outside the cell and is involved in many essential 
cell functions such as metabolism and transport. Cell-derived extracellular vesicles also have a 
myriad of potential clinical applications, ranging from biomarkers to anticancer therapy.23 !e 
2013 Nobel Prize in Physiology or Medicine was awarded to James E. Rothman, Randy W. 
Schekman and !omas C. Südhof “for their discoveries of machinery regulating vesicle tra"c, 
a major transport system in our cells.”24 
  Artificial vesicles, commonly referred to as liposomes, have been utilised in the 
pharmaceutical industry due to their flexible structures and practical function since their 
discovery in mid-60s.25 In fact, liposomes are the first drug delivery nanotechnology that have 
been successfully translated from research to clinical trials. Research on liposomal formulation 
has progressed from conventional liposomes (1st generation liposome) to 2nd, 3rd,and 4th 
generation liposome.26  !e 1st generation liposomes were simple formulations of liposome-
containing drugs such as amphotericin B, Ambisome (Nexstar, USA), and doxorubicin, Myocet 
(Elan Pharma Int., USA). All further generations are surface, lipid composition, and charge 
modified variations for di#erent therapeutic purposes. To date, there are more than 15 
clinically used liposome-based products on the market that are used to treat fungal infections, 
inflammation, cancer, and in gene therapy.27  
Synthetic vesicles have become a highly valued model for scientists to study and understand 
diverse biophysical processes in the membranes.28–30 Apart from targeted delivery and 
controlled cargo release, artificial vesicles have also been actively pursued to engineer more 
complex functions such as recognition and signalling31–42, membrane fusion43–46, and 
construction of artificial minimal cells.47,48  
1.2.1. Classification of Vesicles  
Vesicle size can range from small (20 nm – 100 nm), large (100 nm – 400 nm), to giant (1 µm 
and larger), or they can be unilamellar (one lipid bilayer), multilamellar, and multivesicular 
(refer to multiple vesicles encapsulated in one bigger vesicle). Mixing and matching these two 
parameters (size and number of lamellar) creates the following terms that are widely used in 
the field: small unilamellar vesicles (SUVs), large unilamellar vesicles (LUVs), giant unilamellar 
 
 33 
vesicles (GUVs), large multilamellar vesicles (LMVs), and multivesicular vesicles (MVVs).49 A 
schematic illustration of the classification of vesicles is shown in Figure 1.5. 
 
Figure 1.5   Vesicle classification based on size and number of lamellae.49 
1.2.2   General Methods for Vesicle Preparation 
Depending on the desired structure of the vesicles, various techniques can be used to prepare 
them.49 Conventional methods of preparation at laboratory scale involve the following basic 
stages: a) drying down lipids from organic solvent; b) rehydration of lipids in aqueous media; 
c) mechanical dispersion such as freeze-thaw, extrusion, or sonication; d) vesicle purification. 
Most of the techniques start with preparing dried lipid films on a surface by evaporation under 
reduced pressure or blow-drying with a nitrogen or argon stream. Next, the films are 
rehydrated using an aqueous solution (usually a bu!er) with swelling and MLVs are formed.50 
To modify the structure and size of these MLVs, various methods can be used.51  
  Rapid freezing and slow thawing cycles of MLVs create unilamellar vesicles as a result of the 
fusion of vesicles throughout the process.52 It can also improve the encapsulation e"ciency of 
solutes in the vesicles.53,54 Extrusion of MLV suspensions using porous polycarbonate 
membranes is a standard method for preparing LUVs.55,56 It is a convenient and e"cient 
method for small scale vesicle preparation. Extrusion of vesicles through small pores (approx. 
100 nm in diameter) results in relatively uniform-sized vesicles, while for larger LUVs, the 
extrusion technique tends to result in a more heterogeneous population of vesicles. Large pore 
dialysis may be used to improve dispersity.57 One drawback of this method is that, for lipids 
with transition temperatures higher than room temperature, it is challenging to maintain the 
whole apparatus at a constant high temperature, resulting in di"cult extrusion. Probe or bath 
sonication is the most extensively used method for the preparation of SUVs. For probe 
sonication, the tip of a sonicator is directly submerged into the MLVs suspension. Due to high 
energy input at the tip, external cooling with a water/ice bath is usually required. Disadvantages 
of this method include noticeable lipid degradation: for a sonication up to 1 h, 5% of the lipids 
may be de-esterified. Note that only a few of these methods are capable of encapsulating large 
quantities of water-soluble agents. To entrap bioactive agents, methods such as the reverse-
phase evaporation technique58, or ether/inject technique59,60 can be used to yield higher 




Figure 1.6   A schematic illustration showing pathways for vesicle formation. ©copyright(1988) Portland Press, 
reprinted under CC-BY-4.0 license.50  
Size exclusion chromatography (SEC) is a well-established method to separate small solutes 
from vesicles or to narrow the size distribution.61–63 Vesicle retention on the polymeric gel 
depends on the pore size, material, and mobile aqueous phase. It is a dynamic and reversible 
process and extra attention needs to be given when choosing the column to minimize lipid loss 
and sample contamination during the chromatography.64  
1.3   Direct Mass Transfer: Artificial Transporters and Channels 
Taking inspiration from nature, supramolecular chemists have designed and constructed 
simple molecular structures or systems to reproduce many of the fundamental functions of 
natural signalling proteins. A large number of synthetic systems that can physically transport 
ions or small molecules across lipid membranes via pores or transporters have been developed 
throughout the past three decades. Although it is considered to be more challenging, recent 
advances and new concepts in supramolecular chemistry have made it possible for the 
development of signalling systems that are capable of transmitting a molecular signal without 
physical transport of the messenger across the membranes.  
  !ere are hundreds of examples of a wide range of mechanisms and building blocks capable 
of conducting ion transport across the membrane. In this section, we briefly summarize some 
of the most important designs with a focus on the architecture of these channels or transporters. 
Figure 1.7 illustrates four major categories of artificial transporters and channels and their 
variations: carrier, barrel, ring, and helix. !e carrier category represents systems with the 
specific ion-binding site(s) and can achieve ion transport through either a ferry-like movement 
or a binding relay mechanism. !e other three categories represent systems with channel 
structures. For the barrel category, the channels are formed by vertical components that 
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assemble horizontally in the membrane. For the ring category, the channels are formed by 
horizontal ring components that assemble vertically in the membrane. !e helix category is 
formed by helical structures, where the molecules elongate both horizontally and vertically. 
Due to the complex nature of di"erent examples reported in the literature, these four categories 
are unlikely to be completely mutually exclusive and collectively exhaustive. However, it can 
form the basis of our understanding.  
 
Figure 1.7   Four major categories (carrier, barrel, ring, and helix channel) of artificial transporters and 
channels in the lipid bilayer membrane. Carrier: (from left to right) ferry-like transporter, central relay, multiple 
relay, swing; Barrel: barrel-stave molecules, linked (linkage in gold) barrel-stave, aggregates (gold represents 
another molecule), dimer aggregates (linkage in gold); Ring: stacked rings, linked (linkage in gold) rings, 
rosette (monomer grey or gold); Helix channels: monomeric, dimeric, and oligomeric helix channels (monomer 
in grey or gold). 
  !ere are several techniques to study the ion transport mechanism. !e “U-tube” transport 
experiment is useful for identifying synthetic carriers. In this experiment, an organic solvent 
(for example chloroform) where carriers are dissolved is place at the bottom of a U-shaped tube, 
and two aqueous bu"ers are deposited on both sides of the tube. If solutes that are loaded from 
 
 36 
one side of the bu!er can be detected on the other side, one can unambiguously report the 
presence of a carrier as the channel mechanism is not possible.65 One well-established method 
is 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) assay. HPTS is a pH-sensitive dye whose 
fluorescence emission can be used to monitor ion-transport-induced changes in internal pH of 
vesicles. However, the HPTS assay only confirms the transport of ions but does not detect the 
transport mechanism. Single-channel conductance experiments in planar bilayers can be used 
to identify the channel mechanism, as this experiment can detect the opening and closing of 
single ion channels. "e lifetime of single channels also reveals their kinetic stability.65  
1.3.1   Carriers  
"e di!erence between a carrier and a channel is that the former acts as a ferry and physically 
moves to perform metal transport, whilst the latter remain still in the lipid bilayer. In addition, 
carriers also recognise and bind non-covalently to one or a few specific solutes, and then release 
them when the complex reaches the other side the membrane. In this regard, several examples 
in this carrier category have structures that consist of multiple carrier monomers that form a 
“relay” across the membrane – the ions can be passed on from one side to another via multiple 
binding sites in a sequential manner. Although the carriers themselves in these particular 
examples might not be moving a great distance in the membrane, the mechanism is still a 
bind/unbind process that transports ions. 
 
Figure 1.8   Valinomycin K+ transporter mechanism. (a) 3D model of K+–valinomycin complex determined by 
x-ray diffraction. (b) Valinomycin facilitates the transport of K+ ions across the cell membrane. At the surface 
of the membrane, valinomycin binds a K+ ion. Because the hydrophobic exterior shields the positive charge 
of the metal ion, the K+–valinomycin complex is soluble in the nonpolar lipid bilayer. The complex translocates 
to the other side of the membrane and releases the K+. Then the valinomycin is free to diffuse back to the 
other side of the membrane to repeat the cycle. ©copyright (2012) Saylor Academy66, reprinted under CC 
BY-NC-SA 3.0 license.  
Early emphasis on carrier systems focused on mimicking valinomycin, gramicidin, or 
amphotericin. Valinomycin is a naturally occurring lipid-soluble macrocyclic polypeptide that 
can carry K+ across the lipid bilayer.67 "e transport mechanism consists of interfacial binding 
of K+ from one side of the membrane, translocation of the cationic complex through the lipid 
bilayer, release of K+ at the other side of the membrane, see Figure 1.8.66 "is transport is 
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electrogenic (i.e., it modifies a membrane potential) because there is a net transfer of charge 
across the lipid bilayer. Depending on the charge transferred, ionophores can be further 
classified into cationophores (including protonophores) and anionophores.  
  
Figure 1.9   Examples of synthetic ionophores that functions as carriers. 
Synthetic cationophores have been proven to conduct similar transport activity as 
valinomycin using structures such as cyclic peptides68,69, calixarene esters70, and armed crown 
ethers71 (Figure 1.9). !ey all have a cyclic structure with an electron-rich cavity that can bind, 
sometimes selectively, cations and transport them across lipid bilayer membranes. Di"erent 
sizes of cavity favour di"erent cations. For example, compound 1-1 is a calcium-specific 
transporter that transports Ca2+ 10 times faster than Mg2+. For the calix[n]arene esters 1-2, 
each family member has a specific alkali-metal ion transport preference: Na+ (n = 3), K+ (n = 
4), Rb+ (n = 5), Cs+ (n = 6). Note that there is a possibility that dimeric calix[n]arene esters 
form a channel-like structure, but for simple calix[n]arene esters, this claim lacks evidence.70 
Crown ether 1-3 is the classic example for host-guest interactions, and its lipophilic arm acts 
as an anchor in the lipid bilayer. Calix[4]pyrrole derivatives 1-4 have been studied for anion 
binding. Calix[4]pyrrole promotes ion pair transport such as CsCl72. As for anionophores, 
biotin[6]uril ester 1-5 favours the transport of less hydrophilic anions such as Cl– and NO3– 
over hard, strongly hydrated anions such as HCO3– and SO42–.73 Cyclocholamides 1-6 have a 
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hydrophobic exterior and a strongly hydrophilic interior due to multiple NH3+ groups. !ese 
positive charges at the inner side of the ring make the carrier anion-selective.74 
Supramolecular chemists have studied a wide range of mimics of prodigiosin (1-5), a well-
known non-cyclic natural anionophore which recognises and transports anions such as Cl- and 
NO3-, examples see Figure 1.10. Functionalised prodigiosin derivatives75 and similar molecules 
with imidazole or isophthalamide moieties have been reported to conduct anion transport.76 
Dinuclear zinc complexes 1-6 is able to transport anionic molecules including phospholipids.77 
Cholapods (steroid-based anionophores, 1-7) consist of cholate sca"olds with anion binding 
sites that show remarkable Cl--selective transport. 78 Its transport activity is determined by the 
hydrogen-bond donors o"ered in the preorganized binding site. Positively charged ceragenins 
such as 1-8 showed the ability to mediate the e#ux of anionic fluorophores or cationic 
quenchers.79 Molecular umbrellas, for example 1-9, are active in transporting protons and both 
Na+ and Cl-. !ey were initially studied to determine the position in the lipid bilayer 
membrane and the results suggested that higher total charge leads to better membrane 
incorporation.80  
  
Figure 1.10   Prodogiosin (1-5) and examples of synthetic ionophores (1-6 to 1-9).  
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Attaching the carrier to a membrane anchor creates a molecular swing, as recently reported 
by Huaqiang Zeng (Figure 1.11).81 Molecule 1-10 consists of three elements: a long rod with 
two membrane anchors to allow the swing to be embedded into the hydrophobic membrane 
regions, a 15-C-5 or 18-C-6 crown as the swing seat for binding and transporting metal ions 
such as K+, and a flexible polyethylene glycol chain which acts as the swing. !e swing 
mechanism is supported by both HPTS H+/M+ transport assay as well as single-channel 
experiment. !e system is essentially a carrier system with extra elements that facilitate and 
guide the movement of the carrier.  
  
Figure 1.11   An example of a molecular swing. ©copyright 2019 Wiley‐VCH, reprint with permission.81 
!e oligocrown sca"old 1-11 is a classic example of a central relay mechanism, see Figure 
1.12. !e two crowns at the end of the molecule are located at the membrane-aqueous interface 
whilst the middle one is embedded in the lipid bilayer and perpendicular to the other two 
crowns.82 Cations such as Na+ binds in a sequence of end-middle-end crowns and get released 
at the other side of the membrane. Longer relay has also been proven possible. Compound 1-
12 contains four 18-C-6 crown binding sites with a ferrocene active centre connecting the 
middle two.83 !e ferrocene unit also performs redox-gating. When oxidized from Fe2+ to Fe3+, 
the transport of Na+ or K+ across the bilayer is inhibited. Compound 1-13 is one of a series of 
synthetic helical peptides that are oligomers of a repeating unit with five leucine residues and 
21-C-7 aligned on one side of the helix axis.84  
Normand Voyer and coworkers have further investigated how far can an ion travel through 
membranes in the relay mechanism by using a series of helical peptide with crown ether 
binding sites.85 !ese molecules have a di"erent distance between any adjacent two crown ether 
 
 40 
units and their Na+ transport ability was measured by classic HPTS assay. !e distance between 
two binding sites for which significant transport can be observed is 11 Å.  
!e relay does not necessarily have to be a crown ether system. Figure 1.13 demonstrates a 
halogen anion hopping on 1-14, a linear oligomer of p-oligophenyls  functionalised with 
tetrafluoroiodobenzyl groups.86 !is rigid-rod sca"old can span the lipid bilayer and e"ectively 
transport halogen anions. Figure 1.14 shows another membrane transporter that uses the relay 
mechanism.87 !e phosphatidylcholine derivative 1-15 is equipped with a urea group. !e 
relay mechanism requires that the transporter must reside in both leaflets of the bilayer so that 
the anion can be transferred from one leaflet to another via an intermediate 1:2 complex. !is 
hypothesis was confirmed by using two di"erent transport loading methods: pre-incorporation 
and external addition. No Cl- transport was observed when the experiment was done by 
external addition method, suggesting the transporter cannot flip flop from one leaflet to 
another.  
 




Figure 1.13   An example of halogen relay mechanism. ©copyright (2013) American Chemical Society, reprint 
with permission.86 
 
Figure 1.14   An example of dimeric relay mediated by urea-anion binding relay. ©copyright (2008) American 
Chemical Society, reprint with permission.87 
1.3.2   Barrel Channels 
In the literature, multiple terms are used in describing a channel system formed by an 
aggregation of vertical components. !e use of these terms is sometimes ambiguous and 
overlapped. However, despite the name di"erences, all systems are topologically similar to each 
other and therefore each individual system can be regarded as a barrel. Stefan Matile elaborated 
the nuances between the beta-barrels, barrel-stave, bundles in a review article88. 
  !e term “barrel-stave” was first used in 1996 by Koji Asami and co-workers, who have 
synthesized template-assembled alamethicins in which three to five 18-mer alamethicin 
fragments were arranged to form a channel 1-16 – 1-18, see Figure 1.15.89 !e alamethicin 
oligomer forms alpha helix bundles which are linked by a macrocycle. Ion transport was 
confirmed by single-channel conductance experiments and the largest cycle (n = 5) has various 






Figure 1.15   Molecular structure and schematic presentation a barrel-stave channel.  
Stefan Matile and co-workers reported systematic studies on artificial rigid-rod beta-barrels 
(1-19 – 1-20) that forms pores in the membrane.90 In these systems, short peptide strands are 
attached to a molecular rod. It is proposed that the amino acid residues on the peptide strands 
point alternatively to the barrel interior and the outer surface, see Figure 1.16, and 
programming these residues can achieve various functionalities such as enzyme sensing. 
         
Figure 1.16   Proposed self-assembly of p-octiphenyls rods into rigid-rod β-barrel channel. Residue: A = G, 
B = L, C = K, D = L/W, E = H/D, F = L/V. ©copyright (2003) The Royal Society of Chemistry, reprint with 
permission.90 
Yoshiaki Kobuke and co-workers presented the first synthetic voltage-gated ion channel 
system by introducing electrical asymmetry to the two ends of the sca!old molecule, namely 
carboxylic acid and phosphoric acid for compound 1-21, and hydroxyl and carboxylic acid for 
compound 1-22, see Figure 1.17.91 In basic pH environments, the head groups have charges 
of -1/-2 and 0/-1, respectively, resulting in a charge density asymmetry of the channel. When 
embedded in a lipid bilayer membrane, application of positive voltage induces alignment of 
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Figure 1.17   A proposed structure of voltage-gated synthetic ion channel. ©copyright (2001) American 
Chemical Society, reprint with permission.91 
  Amphotericin B (AmB), which has an amphiphilic macrocyclic structure (Figure 1.18a), 
forms membrane-spanning aggregates in the lipid bilayer, creating a hydrophilic pore. !e 
lipophilic side is a polyene and the hydrophilic side is enriched with hydroxyl groups. !e 
channel structure is believed to be maintained by an intermolecular hydrogen-bonding system, 
which is reminiscent of barrel structure in Figure 1.18b.92 On average, approx. 75% of the 
hydroxyl groups form hydrogen bonds with neighbouring AmB molecules. !e channel 
enables rapid exchange of monovalent ions such as K+, Na+, H+, Cl-, resulting in anti-fungal 
activity. 
          
Figure 1.18   a) Molecular structure of Amphotericin B amphiphilic macrocycle. b) A simulated structure of 
hydrogen-bonding system in Amphotericin B channel. ©copyright (1997) ASPET, reprint with permission.92 
  Jürgen-Hinrich Fuhrhop and co-workers have reported a 38-membered tetraether macrocycle 
compound 1-23, which can be converted into a two-headed amphiphile by oxidation or 
alkylation of the sulphur atoms, see Figure 1.19.93 When incorporated into vesicle membranes, 























the lipid bilayer, leading to Li+ and Fe2+ transport, as suggested by a fluorescein quenching 
assay. It is also possible to stop the transport by sealing these pores with “stopper” molecules 
such as ethylenediaminetetraacetic acid (EDTA) or taurine.  
 
Figure 1.19   Molecular structures of a channel-forming system.  
Simon J. Webb and co-workers have developed a system using palladium coordination to 
gate half-channel molecules 1-25, see Figure 1.20.94 !e monomer is ine"ective at transporting 
ions across the membrane. Incubating vesicles with PdCl2 gave at least a 9-fold enhancement 
in the transport rate of Na+ and a 5-fold increase of K+ in the HPTS assay. Hexathia-18-crown-
6 (18S6) can be used to switch transport o", and the addition of further PdCl2 restores ion 
transport. !is method was further developed for Pd2+-mediated assembly of porphyrin 
channels in the membrane.95  
 
Figure 1.20   Palladium gated ion channel. When embedded into lipid bilayer, adding palladium salt dimerize 
the half-channel molecule and enables ion transport. Addition of hexathia-18-crown-6 removes Pd2+ and 
therefore dissociate the channel.  
  Foldamers are synthetic oligomers that can form well-defined and stable helical structures like 
protein or peptides. Jonathan Clayden, Simon J. Webb and co-workers have demonstrated 
that 310-helical α-aminoisobutyric acid (Aib) foldamers 1-26 have ionophoric activity in the 
lipid bilayer, see Figure 1.21.96 A series of Aib oligomers have been synthesized and the 
strongest conductance was observed for foldamers that have end-to-end distances greater than 
the hydrophobic width of the bilayer. Single-channel conductance and HPTS assay confirmed 
alkali ion transport and suggested that the length of the sca"olding molecule is one of the 






















































Figure 1.21   An Aib foldamer structure and relative rate constant for Na+ transport Aib foldamers vs number 
of Aib residues for foldamers. ©copyright (2016) American Chemical Society, reprint with permission.96 
With advances in deoxyribonucleic acid (DNA) nanotechnology, Hendrik Dietz, Friedrich 
C. Simmel and coworkers created sca!olded DNA origami that can penetrate and span a lipid 
bilayer, forming membrane pores, see Figure 1.22.97 TEM image confirmed that DNA 
channels could bind to lipid bilayers as designed. Single-channel conductance experiments 
suggest that these DNA origamis can not only transport ions but also detect and discriminate 
between single-DNA strands as a single molecule biosensor.  
  
Figure 1.22   Synthetic DNA origami channel embedded in lipid bilayer membrane. Schematic illustration of 
the channel formed by 54 double-helical DNA domains packed on a honeycomb lattice. Cylinders indicate 
double-helical DNA domains. Red denotes transmembrane stem; orange strands with orange ellipsoids 
indicate cholesterol-modified oligonucleotides that hybridize to single-stranded DNA adaptor strands. 
©copyright (2016) AAAS, reprinted under CC-BY-4.0 license.97 
1.3.3   Ring Channels 
Many channel transport systems with cyclic ring structures have been reported. Hitoshi Ishida 




natural amino acids sequence with a long acryl chain (compound 1-27, Figure 1.23). 
Depending on ring size and side-chain length, the cyclic peptides showed di!erent cation 
selectivity.98 A similar strategy using cyclic peptides has been developed. M. Reza Ghadiri and 
co-workers synthesized a cyclic peptide analogue with alternating D, L- amino acids which can 
form β-sheet-like tubular structures.99,100 "ese peptides can self-assemble using a hydrogen-
bonding system that connects neighbouring layers vertically with amide groups, as confirmed 
by single-channel experiments. Amino acid side chains of the peptides are therefore in the 
equatorial positions around the macrocycle facing towards the membrane lipids. Apart from 
conducting Na+ or Cl-, one of the cyclic peptides showed high e#ciency in transporting 
glutamic acid.  
 
Figure 1.23   A channel-forming cyclic peptide in a self-assembled tubular configuration embedded in a lipid 
bilayer membrane (for clarity most side chains are omitted). ©copyright (1994) Nature Publishing Group, 
reprint with permission.98 
  Apart from cyclic peptides, other ring structure components have been used to form channel 
structures by ring stacking. Bing Gong, Zhifeng Shao and co-workers have reported a series of 
shape-persistent macrocycles with aromatic oligourea, sulfonamide, and oligohydrazide 
backbones that can form K+ channels (supported by single-channel conductance and HPTS 
assay) through a ring stacking mechanism, an example is shown in Figure 1.24.101,102 Apart 
from the intramolecular hydrogen-bonding system that sti!ens the ring structure, 






Figure 1.24   An example of shape-persistent macrocycles with aromatic oligourea.  
Pengyang Xin, Changpo Chen and coworkers reported a series of hybrid pillararene-
cyclodextrin molecules with di!erent lengths that form membrane channels, see Figure 1.25. 
According to single-channel experiments and HPTS assay, channel 1-29 which possesses the 
shortest linker showed specific transport preference for K+ over other alkali metal ions. 
Elongation of the linkers in the channels 1-30 and 1-31 increases the flexibility of the tubular 
structures and the distance between the binding sites, which might be responsible for the 
decreased ion transport selectivity.103 
 
Figure 1.25   Structures of pillararene-cyclodextrin molecules. a) molecular structure of channels 1-29 – 1-
31. b) Schematic illustration of the ion transport mechanism.  ©copyright (2019) Wiley-VCH, reprint with 
permission.103 
Another noticeable design to construct rings is metal-organic cyclic structures. Paolo Tecilla 
and co-workers designed a stable tetraporphyrin metallacycle with Re(I) corners and peripheral 
carboxylic acid residues (compound 1-32) that is capable of forming pores in the lipid bilayer, 
see Figure 1.26.104 HPTS assay confirmed alkali metal ion transport. As the corresponding 
methyl ester (compound 1-33) does not transport ions, the presence of the properly oriented 
carboxylic acid groups is essential for the transport ability. "erefore, a dimeric structure of 
channel assembled with hydrogen-bonding system was proposed. "is channel can also be 
blocked by the addition of a cystamine core polyamidoamine (PAMAM) dendrimer that 
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Figure 1.26   Schematic representation of the porphyrin metallacycle and formation of a transmembrane 
nanopore upon hydrogen-bonding driven dimerization. ©copyright (2012) American Chemical Society, reprint 
with permission.104 
Julio D. Martin and co-workers proposed a transport mechanism channel that is formed by 
self-assembly of rosette monomers joined by hydrogen-bonding networks.105,106 !e monomer 
1-34 – 1-36 has two carboxylic acid groups that can construct cyclic two-dimensional 
hydrogen bond arrays in crystal structure, see Figure 1.27. !e bicyclic backbone provides 
steric demands which orientate the angle of two carboxylic acid groups in order to form the 
supramolecular macrocycle. When incorporated into the lipid bilayer membrane, these 
molecules  showed transmembrane Na+ transport activity. No further evidence of channel 
formation was reported. Other cyclic assemblies with various functional groups have also been 
reported.107–109 
           
Figure 1.27   Rosette monomer and a hexametric association. ©copyright (2000) American Chemical Society, 
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1.3.4   Helix Channels 
Gramicidin (gA) peptides form head-to-head helical dimers in the lipid bilayer that open a 
tubular channel which allows transmembrane ion exchange (e.g. Na+). !e 3D structure is 
shown Figure 1.28.110 !e canonical mechanism of gA channels is reversible transmembrane 
dimerization of two nonconducting subunits that reside in opposite bilayer leaflets, and the 
channel can associate and dissociate. However, this mechanism was challenged by Tyson L. 
Jonas and co-workers who suggested that gA channels are internally gated.111 !e two 
mechanisms are illustrated in Figure 1.29.112  
 
Figure 1.28   Gramicidin A channel (PDB entry: 1MAG) determined by solid state NMR spectroscopy in 
uniformly aligned lamellar phase lipid bilayers. ©copyright (1999) Nature Publishing Group, reprint with 
permission.110 
 
Figure 1.29   Two mechanism proposed for gramicidin channels. (A) the canonical model in which gramicidin 
channels are formed by reversible transmembrane dimerization of two nonconducting subunits. (B) the 
switching model proposed by Jones et al., in which gramicidin channels exist as dimers that can switch 
between conducting and nonconducting states. ©copyright (2017) Elsevier, reprint with permission.112 
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  Huaqiang Zeng and co-workers have reported a helical foldamer 1-37 that could self-assemble 
into a helix superstructure for guest encapsulation and water transport.113 !e water transport 
was determined by a dynamic light scattering experiment, and the HPTS fluorescence assay 
suggested that the system does not transport Na+ or K+, providing a potential in desalination 
applications. !e structure is stabilized by a combination of di"erent factors such as aromatic 
π–π stacking, water-host or water-water binding, and intermolecular C=O···H–C type H-
bonds, as shown in Figure 1.30.113 
  
Figure 1.30  (a) Structure of a foldamer monomer. (b) H-bond in the solid state. (c)–(e) illustrate crystal 
structure with water chain in the cavity. ©copyright (2016) American Chemical Society, reprint with 
permission.113 
1.4   Signal Transduction without Direct Mass Transfer 
1.4.1   Dimerisation Mechanism 
!e earliest example using dimerization mechanism of synthetic molecules to achieve signal 
transduction was demonstrated by J. Kikuchi31, see Figure 1.31. In this system, synthetic 
receptor 1-38 was embedded in the membrane and pig heart lactate dehydrogenase (LDH) 
was bound to the vesicle surface through electrostatic interactions. Cu2+ e"ectively inhibited 
the LDH activity. When an input signal 1-hydroxy-2-naphthaldehyde 1-39 was added, it 
formed an imine bond with the receptor 1-40. !e resulting Schi" base then scavenged and 
chelated Cu2+, forming a 2:1 complex in the membrane due to enhanced binding a#nity, as 
confirmed by UV-vis spectroscopy. !e activated LDH increased the observed rate of pyruvic 
acid dehydrogenation (output). However, the input and output signal were on the same side 






Figure 1.31   Schematic illustration of switching of LDH activity mediated by an artificial cell-surface receptor 
1-38. (a) and (b) represent the off- and on-states of LDH in the absence and presence of an external signal 
1-39, respectively. ©copyright (1999) The Royal Society of Chemistry, reprint with permission.31 
  In 2002, the Hunter group demonstrated a simple synthetic system that mimics RTK 
dimerisation signal transduction.32 !e system consists of two membrane-spanning molecules 
(1-40 and 1-41, Figure 1.32). Two thiol groups (orange), or a thiol (orange) and a disulfide 
(grey) are connected by a bis-cholenic acid derivative that enables the molecules to span the 
lipid membranes of vesicles. An external oxidant input dimerised the thiols by forming a 
disulfide bond, which accelerated nucleophilic disulfide bond formation on the inside of the 
vesicles to release the thiopyridine chromophore (green). !is is the first example of a synthetic 
signalling system that enabled molecular communication across the membrane without direct 
contact between the species involved. Further examples based on this system have also been 
developed.35,37 
           1-38 
            
           1-39 




Figure 1.32   Design and function of a synthetic RTK mimic. Top: Structure of two components of the 
synthetic RTK mimic. Bottom: Extra-vesicle oxidation of thiols forms disulfide group (orange). Intra-vesicle 
intramolecular disulfide formation is subsequently triggered and a chromophore (green) is released.  
1.4.2   Conformational Change Mechanism 
Synthetic mimicry of GPCR has not yet been achieved. However, Jonathan Clayden, Simon 
Webb and co-workers have made significant progress towards it114 and have recently reported 
a synthetic membrane-bound receptor 1-42 which can be modulated by a ligand-binding event. 
!is system consists of three components: a metal-containing binding site (green), a helical 
peptide spacer (grey), which anchors the receptor into the membrane and relays 
conformational changes from the binding site to the reporter, and a fluorophore (blue) as a 
spectroscopic indicator of conformational change (Figure 1.33). !e two helical conformations 
of the peptide spacer are interchangeable. Adding di"erent chiral ligands to the vesicles changes 
the ratio of excimer-to-monomer emission, which corresponds to an increase in the proportion 




Figure 1.33   Design and function of a synthetic GPCR mimic. Top: Structure of Aib peptide with copper(II) 
cofactor binding a carboxylate ligand (red). Bottom: Change in equilibrium population distribution of right- 
and left-handed screw-sense conformers in response to reversible binding of a chiral carboxylate ligand (red). 
This figure has been re-illustrated from the original published version under CC-BY-4.0 license.114 
1.4.3   Membrane Translocation Mechanism 
!ese two previously reported systems have several limitations. !e molecules are synthetically 
challenging. Switching between two states is not all or nothing, and the input or output signals 
are not useful. Biological receptors are usually conjugated with a catalytic domain that amplifies 
the signal, but the synthetic molecules achieve no signal amplification. Recently, the Hunter 
group has developed a novel membrane translocation mechanism for signal transduction and 
amplification, which is not observed in nature. !e basic design principles of a synthetic 
transducer are illustrated in Figure 1.34. Two polarity switchable head groups (blue and green 
when polar, purple and red when apolar) are attached to a short hydrophobic spacer (grey) 
which cannot span the bilayer: one head group acts as an external input sensor and the other 




Figure 1.34   Membrane translocation mechanism. A synthetic transducer consists of two polarity switchable 
head groups is initially embedded in the outer leaflet of the lipid bilayer membrane. In the initial OFF state, 
the pro-catalyst remains inactive in the membrane (red). Switching of polar head groups (blue, green) to polar 
(red, purple) drives translocation of the transducer across the bilayer. Binding of a charged cofactor generates 
the ON state, where the activated catalyst (green) is exposed to the internal aqueous phase and turns over 
an encapsulated substrate (grey) to generate an amplified output signal (light green). 
!e polarity of head groups is essential to determine the position of the transducer as it 
changes the solubility of the head group: when the head groups are polar they tend to stay in 
the aqueous phase, and when they are apolar they can enter the membrane and are free to move. 
!is bistable transducer therefore provides a mechanism for a controlled translocation of the 
molecule across a bilayer membrane. In the initial OFF state, the sensor head group is polar 
(blue) and sits in the external aqueous solution which anchors the transducer in the outer leaflet 
of the membrane. Meanwhile, the pro-catalyst head group is apolar (red) and remains inactive 
inside the membrane. An input signal switches the external head group from polar to apolar 
(blue to purple), which allows the transducer to translocate across the lipid bilayer. !e ON 
state is generated by binding of a charged cofactor from the internal aqueous solution. !is 
switches the internal head group from apolar to polar (red to green), which simultaneously 
activates the catalyst and provides a driving force for the directional translocation, anchoring 
the system in the inner leaflet of the membrane. In this ON state, the polar catalyst is exposed 
to the internal aqueous phase and turns over encapsulated substrate molecules to generate the 
output signal. By coupling each input molecular signal to the activation of a catalyst, the output 




1.4.3.1   Transducer Design and Input 
!e di"ering solubility characteristics of polar and apolar head groups at lipid bilayer 
membrane interfaces are key features of the transducer: charged, polar moieties are 
preferentially located in the aqueous phase, while neutral, apolar moieties can enter the interior 
of the hydrophobic bilayer. Figure 6 shows two types of transducers that have been reported 
and use a membrane translocation mechanism.115,116 !ese two transducers consist of similar 
components: 1) a polarity switchable head group (Figure 1.35 blue: charged, purple: neutral) 
which is responsive to di"erent input signals, namely pH variation and metal ion binding; 2) 
a steroid core (spacer) that links the input responsive head group with a pro-catalyst and 
anchors the transducer in the bilayer membrane in a perpendicular orientation; 3) the pro-
catalyst moiety (Figure 1.35 red) that can be switched to a charged state by the coordination 
of a zinc ion cofactor (Figure 1.35 green), which pulls the catalyst into the internal aqueous 
phase. Zinc binding also lowers the pKa of the oxime from 11 to <6. If the pH on the inside 
of the vesicle is maintained at 7 by a bu"er, cofactor binding will lead to deprotonation of the 
oxime and activation of the catalyst (the ON state).117 
 
Figure 1.35   Molecular structure of two types of transducers. a) morpholine transducer 1-43-H+ (OFF state), 
the Zn2+-activated catalyst 1-43-Zn2+ (ON state); b) phenanthroline transducer 1-44 as the Cu2+ complex 1-
44-Cu2+ (OFF state), the Zn2+-activated catalyst 1-44-Zn2+ (ON state).  
  Transducer 1-43 consists of a morpholine moiety (Figure 1.35a blue), which acts as the sensor 
for the input signal. When the pH on the outside of the vesicle is below the pKa of morpholine 
(∼8), the charged head group will be held in the external aqueous phase (the OFF state). Raising 
the external pH will remove the charge and allow the neutral morpholine head group (Figure 
1.35a purple) to enter the membrane. Transducer 1-44 consists of a phenanthroline moiety 
and binds with Cu2+ ions. When copper is bound, the head group is charged (Figure 1.35b 
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blue) and held out of the membrane in the aqueous phase. Displacement of the bound cation 
by adding EDTA in the extra-vesicle solution reveals the neutral phenanthroline head group 
(Figure 1.35b purple), which can enter the membrane and generate an output. 
1.4.3.2   Substrate and Output 
!e encapsulated substrate 1-45 is non-fluorescent and can be hydrolysed by the zinc complex 
of the oxime catalyst at neutral pH to give a product 1-46, which is highly fluorescent (Figure 
1.36). Both substrate 1-45 and product 1-46 are highly charged at neutral pH and do not cross 
lipid bilayer membranes and can be encapsulated e"ciently inside vesicles. Fluorescence 
spectroscopy was used to monitor the conversion of 1-45 into 1-46 inside the vesicles. In 
addition, the fluorescence excitation spectrum of 1-46 was used to quantify internal pH 
changes independently of the total product concentration. HPTS has a pKa of ~7.3 and 
exhibits a pH-dependent absorption shift (Figure 1.36b), allowing ratiometric measurements 
using an excitation ratio of 460/405 nm.118 !e calibration curve can be obtained by plotting 
the pH of a lysed vesicle solution vs the fluorescence emission I460/I405 (excitation at 460 nm 
and 405 nm, emission at 510 nm) of that solution by using a Henderson-Hasselbach type 
equation (Equation 1.1).115 
 
Figure 1.36   Hydrolysis of substrate 1-45 and use of its product 1-46 as a pH probe. a) The non-fluorescent 
substrate 1-45 can be hydrolysed to a highly fluorescent product 1-46. b) 1-46 as a pH probe: excitation 
spectra of HPTS (emission at 510 nm). The ratio of the peaks at 460 nm and 405 nm can be used to determine 
the pH of the solution inside the vesicles. Change in relative fluorescence emission intensity at 510 nm, 
exciting at 415 nm, can be used to determine the conversion of the substrate independently of pH.  
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Equation 1.1                  
All transmembrane signalling experiments were carried out in artificial vesicles (LUV) 
prepared by a standard extrusion. !e membranes should be capable of decoupling di"erent 
chemical events that occur on both sides of the vesicles. In addition, the vesicles should be 
impermeable to the substrate 1-45, product 1-46, the bu"er, zinc (II) or copper (II) and EDTA. 
For the morpholine transducer system, maintaining a pH gradient is essential so that the pH 
on the outside and inside of the vesicles can be changed independently. A mixture with 3:2 
ratio of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) can e"ectively perform this function. 
1.4.3.3  Transmembrane Signalling Experiments 
A representative result of transmembrane signalling experiment is shown in Figure 3.38. !e 
vesicles are loaded with pH-sensitive morpholine transducer 1-43 at neutral pH. Raising 
external pH from 7 to 9 deprotonate the morpholine group and initiate the translocation of 
the transducer. Upon zinc(II)-binding, the catalytic head group of the transducer hydrolyses 
the encapsulated substrate 1-45 and generates the fluorescent product 1-46 (green data). It is 
important to note that, similar to biological signalling events, this process provides a 
mechanism for signal amplification: a single hydroxide ion, corresponding to the external input 
signal, can generate approximately five 1-46 as the internal output signal.  
 
Figure 1.37   Transmembrane signal transduction experiment with pH-sensitive transducer 1-43. Time 
dependence of the relative fluorescence emission intensity at 510 nm (exciting at 415 nm). Red data: vesicles 
with 2.5 mol% loading of 1-43 at pH 7. Green data: vesicles with 2.5 mol% loading of 1-43 initially incubated 
at an external pH of 7, and then raised to an external pH of 9 after 20 minutes (indicated by the black arrow). 




DOPC/DOPE vesicles containing 250 μM substrate 1-45, 250 μM ZnCl2 and 100 mM HEPES buffer at pH 7. 
©copyright (2017) Nature Publishing Group, reprint with permission.115 
  !e signalling process is reversible and can be switched between ON and OFF states by 
altering the external pH of the vesicles, see Figure 1.38. At pH 7, the morpholine unit is 
protonated and the system is in the OFF state. Raising the external pH to 9 deprotonates the 
morpholine recognition head group and initiates the translocation. !e catalytic head group is 
switched ON by binding to Zn2+ in the internal aqueous solution. Decreasing the external pH 
back to 7 re-protonates the morpholine recognition head group, which pulls the catalytic head 
group out of the internal compartment and switch the system to the OFF state. !e cycle can 
continue until the encapsulated substrate is fully hydrolysed. 
 
Figure 1.38   Reversible switching of transducer. Changing the external pH between 7 and 9 switches the 
system OFF and ON. The plot shows the time dependence of the relative fluorescence emission intensity at 
510 nm (exciting at 415 nm) during two strokes of a reciprocating cycle in which the external pH was changed 
by addition of aliquots of sodium hydroxide and hydrochloric acid to the vesicle suspension. Experiment 
conducted in 200 nm DOPC/DOPE vesicles with 2.5 mol% loading of 1-43 that encapsulated 250 μM 
substrate 1-45, 250 μM ZnCl2 and 100 mM HEPES buffer. ©copyright (2017) Nature Publishing Group, reprint 
with permission.115 
1.4.3.4  Controlled-Release  
!e translocation mechanism can also be used to trigger controlled release from vesicles by 
using the substrate 1-47, see Figure 1.39.115 An external input signal (hydroxide) switches the 
permeability of the recognition head group of a membrane-bound transducer and initiates the 
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transducer translocation. Upon cofactor binding from the internal aqueous solution, the 
catalytic head group is switched ON and catalyses the intra-vesicle generation of a surfactant 
(2-naphthoic acid). Permeabilization of the membrane by surfactant leads to cargo e!ux. "is 
system may provide a generic platform with which to develop triggered release applications 
such as for drug delivery. 
 
 
Figure 1.39   Triggered cargo release from vesicles using an artificial signal transduction mechanism. a) 
Transmembrane signal transduction: the input signal switches the external head group (blue) of a synthetic 
signal transducer embedded in the membrane from polar to apolar (purple), allowing it to translocate through 
the membrane. b) Catalytic surfactant generation: charged co-factor binding to the inner (catalytic) head 
group (red) activates the catalyst (green), turning on catalytic surfactant generation by catalysing the 
hydrolysis of a substrate (grey) into a surfactant (yellow). The surfactant disrupts the membrane and enhances 
the permeability of the lipid bilayers to polar solutes; c) Cargo release: cargo (pink) encapsulated in the 
vesicles are released through disordered lipid bilayers and an output is generated. d) Molecular structures of 
substrate 1-47 and hydrolysis products: HPTS and 2-naphthoic acid. ©copyright (2017) American Chemical 
Society, reprint with permission.119 
1.5   Objectives 
Vesicles in cells perform a large variety of functions, for example signalling, metabolism, cargo 
transport, temporary storage, and acting as reaction chambers. Artificial vesicles have the 
potential to mimic these functions as in the synthetic system, the compartmentalisation 
a#orded by the bilayer membrane provides a similar metastable barrier to biological systems 













!erefore, there is huge potential to develop highly responsive vesicles that can be selectively 
activated by an extra-vesicle signal to achieve a well-defined function. Our ultimate goal is to 
develop highly tuneable and user-definable synthetic analogues that can e"ectively transduce 
and amplify a wide range of di"erent external signals into various internal responses in artificial 
vesicles or living cells.  
  !e potential biological applications using this transmembrane signal transduction 
mechanism are as follows: 1) Detection and diagnostics. Responsive vesicles could be 
introduced into a living organism as a means to examine organ function or other aspects of 
health, by sensing the presence of a specific metabolite or protein and subsequently transducing 
the chemical signals into an optical output via internal chromophore/fluorophore generation. 
2) Drug delivery. !is could be achieved through the controlled-release of anti-tumour drugs 
from responsive vesicles, which can sense the molecular di"erences between normal and 
cancerous tissue microenvironments and target the delivery. 3) Cell modulation. Direct 
insertion of artificial transducers into living cell membranes would enable these cells to respond 
to an input defined by the head group of the transducer. By attaching various catalytic domains 
that can generate specific biological messengers, the transducer can act as an artificial analogue 
of signalling proteins to regulate cell activity. Modulation of cell function could thus be 
achieved by the addition of the corresponding input. 
Previous studies in the Hunter group have demonstrated the viability of the membrane 
translocation mechanism. In this dissertation, the main objective is to investigate the 
development of new external signal input modules and extend the scope of the translocation 
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Freedom is nothing but a chance to be better. 
     Albert Camus 
 
Maleimide Transducer  
2.1   Introduction 
In biology, signal transduction is a conversion process by which a stimulus is recognised and 
transmitted through a cell membrane. Membrane-spanning proteins respond to a large variety 
of input signals and give rise to well-defined biochemical cascade reactions in cells. !e 
signalling events regulate almost all functions of the cell from basic survival to specific 
biochemical response. !ere are two major categories of signalling pathways: 1) direct mass 
transfer, where molecules pass through cell membranes such as membrane channels or 
transporters1, or 2) indirect transfer, where signal input and output are separated by the 
membrane, such as observed in G protein-coupled receptor2 or receptor tyrosine kinases3. 
Although numerous examples of synthetic membrane channels and transporters have been 
reported, signal transduction without mass transfer is considerably more challenging.   
A novel transmembrane signalling mechanism was recently reported which operates by 
controlled translocation of a synthetic transducer across a vesicle lipid bilayer.4 !e external 
recognition head group of the transducer becomes membrane-permeable in response to an 
external chemical stimulus, which leads to membrane translocation, exposing a catalytic head 
group to the interior of the vesicle. Catalytic hydrolysis of an internal substrate generates an 
amplified output signal, which can also be used to trigger the release of the vesicle contents.5 
!e choice of recognition head group can be used to make this system respond to di"erent 
external stimuli, such as pH4 or metal ions6. To generalise the concept of the translocation 
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mechanism, we aimed to develop a synthetic transducer that can be conveniently 
functionalised and respond to di!erent stimuli. To achieve this goal, a “stem transducer” from 
which other specific input responsive transducers can be further derived is needed, together 
with a corresponding in-situ chemistry that allows the embedded “stem transducer” to be 
functionalised in the extra-vesicle solution.  
Maleimide-sulfhydryl coupling is commonly used in biochemistry for labelling and 
crosslinking.7 Sulfhydryl groups react specifically with maleimide units at neutral pH (6.5-7.5) 
and form a stable thioether linkage. We exploited this conjugation reaction and designed a 
maleimide transducer 2-1 as a “stem transducer”. Compared to previously reported pH-
controlled and molecular recognition-controlled transducers, the major di!erence of this 
maleimide transducer 2-1 is that the input responsive group is not directly attached to the 
transducer by organic synthesis, but can be attached via a thiol-maleimide in-situ conjugation 
on the vesicles, providing flexibility and ease of synthesis. 
"e approach to controlling membrane translocation of maleimide transducer 2-1 is 
illustrated in Figure 2.1. Similar to previous transducers, 2-1 consists of a steroid core which 
links two head groups: a pyridine-oxime pro-catalyst and a maleimide head group which is 
responsible for in-situ conjugation. However, as the maleimide moiety is soluble in the lipid 
bilayer, an extra piperazine moiety acting as a “safety catch” is included between the maleimide 
moiety and the steroid core. "e piperazine should be protonated and membrane-impermeable 
at neutral pH, keeping the maleimide in the aqueous phase and available for reaction. Initially, 
the transducer is anchored at the external membrane-water interface (OFF state). "e 
recognition group equipped with a thiol is added to the extra-vesicle solution and an in-situ 
maleimide-thiol conjugation reaction takes place. "e excess amount of thiol can be easily 
removed by size exclusion chromatography. "e recognition group should be membrane-
impermeable in order to hold the transducer at the outer leaflet of the membrane. Raising the 
external pH deprotonates the piperazine unit and releases the “safety catch”. An appropriate 
input switches the recognition group from membrane-impermeable to membrane-permeable 





Figure 2.1   Schematic representation of maleimide transducer signal transduction system. a) The piperazine 
unit acts as a “safety catch” to ensure the maleimide moiety is held in the aqueous phase. The membrane-
impermeable recognition group which bears a thiol moiety is attached to the maleimide transducer via thiol-
maleimide in-situ conjugation by adding an excess amount of thiol into the vesicle suspension. The “safety 
catch” is released by raising the external pH and the conjugated recognition group takes over the role of 
anchoring the transducer on the outside of the membrane. A relevant input signal switches the recognition 
head group from membrane-impermeable to membrane-permeable, allowing it to enter the membranes. The 
other head group is a neutral pyridine-oxime pro-catalyst which can be switched to a charged activated state 
by coordination of a zinc (II) ion cofactor. This pulls the catalyst into the internal aqueous phase and catalyses 
the hydrolysis of encapsulated substrate to generate the output signal. b) Molecular structures of initial OFF 
state of maleimide transducer (2-1-H+), thiol reagent and recognition group conjugated transducer with 
activated catalyst (RS-2-1-Zn2+, ON state). R = recognition group. 
2.2   Results and discussions 
2.2.1   Synthesis of Maleimide Transducer 
!e maleimide head group (prone to nucleophilic attack) and oxime head group (good 
nucleophile) could make the maleimide transducer intrinsically unstable. To test the stability 
of transducer 2-1, Pyridine-oxime derivative 2-4 and N-neopentyl maleimide 2-5 were 
synthesised as model compounds to assess the stability of transducer 2-1 (Scheme 2.1). 
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Scheme 2.1   Synthesis of pyridine-oxime derivative 2-4 and maleimide derivative 2-5. 
  We then put compound 2-4 and 2-5 together in various conditions which they might 
encounter during synthesis. !e 1H NMR spectrum of the mixture was recorded to examine 
whether the sp2 CH of maleimide remained intact. !e results are shown in Table 2.1. Results 
in Entry 1, 2 and 6 suggest that maleimide and oxime do not react with each other in organic 
solvents or in HEPES bu"er solution. However, when potassium carbonate or sodium acetate 
was added into the mixture (Entry 3 and 4), the sp2 CH signal of maleimide decreased and 
multiple new peaks appeared. Addition of hydroxylamine into the mixture of 1 and 6 (Entry 
5), maleimide (Entry 7) or compound 6 (Entry 8) also led to a decrease of the sp2 CH signal 
of maleimide, indicating that hydroxylamine or oxime is not compatible with maleimide in 
basic conditions. Entry 9 indicates that pyridine-oxime is stable in acidic conditions. !erefore, 
the maleimide head group should be protected in reactions that require the use of a base. 
Table 2.1   Stability assay of model compounds 2-4 and 2-5 in various conditions. 
Entry Compound Condition Solvent Result 
1 2-5+2-4a r.t., 16 h chloroformb No reaction 
2 2-5+2-4a 110 ℃, 5 h toluene No reaction 
3 2-5+2-4a, K2CO3 60 ℃, 16 h dimethylformamide Reactedc 
4 2-5+2-4a, NaOAc r.t., 48 h chloroform/ethanol/waterb,e Reactedd 
5 2-5+1a, NH2OH, NaOAc 60 ℃, 16 h chloroform/ethanol/waterb,e Reactedc 
6 maleimide+2-4a, HEPES r.t., 16 h waterb No reaction 
7 maleimide, NH2OH, NaOAc r.t., 16 h chloroform/ethanol/waterb,e Reactedc 
8 2-5, NH2OH, NaOAc r.t., 16 h chloroform/ethanol/waterb,e Reactedc 
9 2-4, HCl r.t., 16 h methanol No reaction 
*(a) 1:1 ratio mixture; (b) Reaction carried out in deuterated solvent in a sealed NMR tube; (c) Decrease of 
the integral of the signal due to the sp2 CH (maleimide) observed; (d) Slow reaction, new peaks appeared 
after 24 h; (e) 1/1/0.1 ratio. 
   
To avoid basic hydrolysis, we used furan to protect the maleimide motif by a Diels-Alder 
reaction (Scheme 2.3). Deprotection should be achieved via a retro-Diels-Alder reaction at 
















lithocholic acid. EDC coupling of 1-tert-butyloxycarbonylpiperazine with lithocholic acid gave 
compound 2-8. Reduction with boron trifluoride yielded compound 2-9. Condensation with 
chloroacetyl chloride gave compound 2-10. Functionalisation with pyridine-oxime 2-1 
a!orded compound 2-11. After Boc-deprotection, furan protected maleimide 2-7 was attached 
to yield compound 2-12. Condensation with hydroxylamine a!orded the pyridine-oxime pro-
catalyst 2-13. Unfortunately, however, the final step of deprotection of 2-13 through a retro-
Diels-Alder reaction was unsuccessful in toluene and in N,N-dimethylformamide. 1H NMR 
spectra also suggested that degradation of the transducer occurred upon heating in solution. 
"e deprotection step was then tested without solvent under high vacuum at 95ºC, monitored 
by 1H NMR and mass spectroscopy. Deprotection of the maleimide reached approximately 
90% after heating for 10 h. However, significant degradation or polymerisation was observed. 
A pure sample of maleimide transducer 2-1 was isolated by reverse-phase HPLC in 15% yield. 
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2.2.2 Transmembrane Signalling Experiments 
200 nm DOPC/DOPE (molar ratio 3:2) vesicles with 1 mol% loading of maleimide 
transducer containing 250 μM ester 2-2 and 250 μM zinc chloride in HEPES bu!er at pH 7 
were prepared. Raising the extra-vesicle pH to 10 deprotonates the piperazine group and 
therefore enables the translocation of the transducer, generating a rapid increase in the 
fluorescent emission, see Figures 2.2 red data. For the control systems lacking maleimide 
transducer 2-1, a slow increase in fluorescent emission intensity was observed over a period of 
hours, which reflects the background rate of the hydrolysis of substrate 2-2 (Figure 2.2 grey 
data). When the external pH was raised to 10, a small increase of fluorescence was observed 
due to the pH jump inside the vesicles, as indicated in Figure 2.2b. "is background rate of 
hydrolysis is comparable to that observed for vesicles with 1 mol% loading of transducer 2-1 
without adding the external base pulse. Figure 2.3 shows an example of the change in excitation 
spectra of vesicles suspension at the beginning and the end of the experiment. "ese results 
confirm the catalytic activity of maleimide transducer as well as the viability of using the 
piperazine “safety catch” to lock the transducer at the external surface. 
 
Figure 2.2   Transmembrane signal transduction using maleimide transducer 2-1 with pH sensitive “safety 
catch”. a) Time dependence of the normalised fluorescence emission intensity at 510 nm (exciting at 415 nm). 
Red data: (1) vesicles with 1 mol% loading of maleimide transducer 2-1 at pH 7; (2) vesicles with 1 mol% 
loading of transducer  2-1 and the external pH was raised to pH 10 after 30 min, indicated by the arrow; Grey 
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data: (3) control vesicles prepared without transducer incubated at an external pH of 7; (4) control vesicles 
prepared without transducer and the external pH was raised to pH 10 after 30 min, indicated by the arrow. 
All experiments were conducted in 200 nm DOPC/DOPE vesicles containing 250 μM substrate 2-2, 250 μM 
ZnCl2 and 250 mM HEPES buffer at pH 7. b) Internal pH of vesicles. 
 
Figure 2.3   Change in excitation spectra of vesicle suspension with 1 mol% loading of transducer (external 
pH raised to 10) with time during the signalling experiment. Excitation spectra of the vesicle suspension (λem 
= 510 nm) at (grey) t = 0 and (red) t = 600 min. 
  To demonstrate the viability of performing thiol-maleimide in-situ conjugation at the vesicle 
surface, we designed a “molecular ruler” system (Figure 2.4). When the desired conjugation 
occurs with a thiol that bears a sulfonate group, the transducer should remain at the outer 
leaflet of the membrane as the sulfonate group is charged and membrane-impermeable. If the 
spacer between the thiol and sulfonate is short, raising the external pH to release the “safety 
catch” does not switch the system to an ON state because translocation is not possible. On the 
contrary, if the spacer is long enough to enable the conjugated maleimide transducer span the 
lipid bilayer, the catalytic head group can cross the membrane and be exposed to the internal 






































Figure 2.4   Proposed design of the molecular ruler. The “safety-catch” locks the transducer in the outer 
leaflet of the membrane, exposing the maleimide head group. Addition of thiol (illustrated as yellow circle) 
that bears a sulphonate group (small blue circle) and a membrane-permeable spacer (purple chain) 
undergoes in-situ maleimide-thiol conjugation and anchors the transducer in the outer leaflet of membrane 
as the sulfonate group remains charged and membrane-impermeable. a) If the maleimide transducer is 
conjugated with a short thiol, when the external pH is raised, the translocation of the transducer is limited 
due to the short length of the transducer. Therefore, an ON state cannot be achieved.; b) If the spacer of the 
thiol is long enough to enable the conjugated maleimide transducer cross the lipid bilayer, the catalytic head 
group can enter the internal aqueous solution and generates an output. 
2-Mercaptoethanesulfonic acid, a short thiol reagent with sulfonate group, was selected to 
examine the above concept. !iol-maleimide in-situ conjugation was performed by adding an 
excess amount (103-fold) of thiol into the vesicles and incubating at r.t. for 2 hours. !e vesicles 
were then purified from the external solution by size exclusion chromatography and were 
suspended in a bu"ered solution at pH 7. !e preliminary results are shown in Figure 2.5. For 
the control system lacking transducer 2-1, after raising external pH from 7 to 10, an increased 
background rate for hydrolysis of the substrate 2-2 (Figure 2.5a grey data) was observed. A 
similar result was observed with the addition of thiol (Figure 2.5a yellow data), showing that 
thiol has no e"ect on the background hydrolysis rate. When the maleimide transducer 2-1 was 
included in the vesicles and subjected to thiol-maleimide in-situ conjugation, the results 
(Figure 2.5a green data)  were similar to the control experiments. !is is because when the 
thiol-maleimide reaction takes place, the sulphonate group makes the conjugate membrane-
impermeable. As the length of the conjugate is not long enough to span the lipid bilayer, the 
catalytic head group cannot cross the membrane and be exposed to the inner surface, i.e. an 
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ON state is not achieved. After raising the external pH to 10, a small jump of internal pH 
(from 7.0 to 7.3) was observed in all of these four experiments. As the internal pH is 
comparable, the pH e!ect on the hydrolysis rate can be ruled out. "ese preliminary results 
suggest that it is feasible to perform thiol-maleimide in-situ conjugation in vesicle suspensions.  
  
Figure 2.5   Transmembrane signal transduction of maleimide transducer 2-1 with in-situ thiol-maleimide 
conjugation (thiol: sodium methanethiolate). a) Time dependence of the normalised fluorescence emission 
intensity at 510 nm (exciting at 415 nm). Green data: vesicles with 1 mol% loading of 2-1 and addition of thiol. 
Yellow data: a control experiment without transducer, with addition of thiol. Red data: vesicles with 1 mol% 
loading of maleimide transducer 2-1. Grey data: a control experiment without transducer. All experiments 
were conducted in 1 mM 200 nm DOPC/DOPE vesicles containing 250 μM substrate 2-2, 250 μM ZnCl2 and 
250 mM HEPES buffer at pH 7, the pH of external solution was raised to 10 after approximately 30 min, 
indicated by an arrow. Experiments with addition of thiol (103 eq. relative to transducer 2-1) was added and 
the vesicles were incubated at r.t. for 2 h prior to the measurement.  b) internal pH of vesicles in green, yellow, 
red, and grey data, respectively. 
  However, although our preliminary results were convincing, the ON state achieved by 
removing the “safety-catch” of transducer 2-1 (Figure 2.5a red data) was not reproducible. A 
large number of repetitions, including variation in the loading of the transducer and the bu!er 
concentration, were conducted but a reliable ON state could not be achieved. In addition, the 
change in the internal pH after the base pulse was variable. Figure 2.6 shows the distribution 
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of internal pH values measured in 27 repeats of the similar experiments with an external base 
pulse to pH 10. !e internal pH increased from the initial value of 7.0 to as high as 8.0. If a 
stable internal pH cannot be maintained, the high internal pH could possibly result in a false-
positive signal. Although in theory it is possible to examine the internal pH and eliminate these 
false positive results, the randomness of the internal pH jump makes it practically di"cult to 
reproduce the result that has an internal pH of 7.3. One reason for the variability in the pH 
change is that the lipids were purchased from di#erent suppliers and di#erent batches and 
purities may maintain the pH gradient better.  
 
Figure 2.6   A statistic distribution (in percentage) of internal pH after the external base pulse to pH 10, out 
of 27 experiments. 1 mM 200 nm DOPC/DOPE vesicles containing 250 μM substrate 2-2, 250 μM ZnCl2 and 
250 mM HEPES buffer at pH 7, the pH of external solution was raised to 10 by addition of sodium hydroxide. 
2.3   Conclusion 
To conclude, we have designed and synthesised a transducer featuring a maleimide head group 
with a piperazine unit acting as a “safety catch”. In neutral pH, the piperazine unit is charged 
and membrane-impermeable, locking the transducer in the outer leaflet of the lipid bilayer. 
Preliminary results suggested the viability of the “safety catch” and demonstrated that the 
transducer could be functionalised with an in-situ thiol-maleimide conjugation reaction at the 
membrane surface. However, the ON state experiment could not be reproduced. !erefore, 
we cannot draw a conclusion on whether the in-situ thiol-maleimide reaction is a reliable 
technique for this particular system. Furthermore, the pH gradient was not maintained when 
external pH is raised to 10, which suggests that the system could generate false-positive signals 
due to high background hydrolysis rate. Having realised these challenges, we decided not to 
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2.4   Supporting Information 
2.4.1   Synthetic Procedures and Characterisation 
Materials and Methods  
1H NMR and 13C NMR spectra were recorded on a 400-MHz Bruker® spectrometer. 
Chemical shifts are reported as δ values in ppm. Microwave reactions were carried out 
on a Biotage® Initiator+ microwave reactor. Flash chromatography was carried out on 
an automated system (Combiflash® Rf+ Lumen™) using pre-packed cartridges of silica 
(25 µm PuriFlash® Column) or neutral alumina (50 µm RediSep® Rf Column). RF-HPLC 
was carried out on an Agilent 1100 Series HPLC Value System. SEC purification of the 
vesicles was carried out using GE Healthcare PD-10 desalting columns prepacked with 
Sephadex® G-25 medium. Melting point was measured on a Mettler-Toledo MP90 
Melting Point System. Fluorescence spectra were recorded using a Cary Eclipse 
fluorescence spectrophotometer (Agilent Technologies) in Hellma® Analytics Suprasil® 
quartz cuvettes. Measurements of pH were conducted using a Mettler-Toledo 
SevenCompact™ pH meter equipped with an InLab® Micro electrode. Vesicles were 
assembled in Eppendorf® polypropylene DNA LoBind® polypropylene microcentrifuge 
tube and extruded as described below using Avanti® Polar Lipids extruder kits, 
equipped with Avestin® LiposoFast Liposome Factory 200 nm polycarbonate 
membranes with GE Healthcare Whatman® 10 mm polyester filter support. Sonication 
was carried out using an Elma® Transsonic 420 sonicator. Vortexing was carried out on 
a Heidolph™ Reax Top Vortex Mixer. Solutions or vesicles suspensions were transferred 
using Eppendorf Multipette® Xstream Pippette with Combitips Advanced® or Hamilton 
Microliter™ syringes. All reagents and solvents were used without further purification. 






To a solution of maleic anhydride (2.0 g, 20.4 mmol) in chloroform (40 mL) was added the 
solution of neopentylamine (1.8 g, 20.4 mmol) in chloroform (5 mL). The mixture was stirred 
at r.t. for 90 min. The precipitate was filtrated and dissolved in glacial acetic (20 mL) acid 
with potassium acetate (400 mg, 4 mmol). The mixture was stirred under reflux for 2 h. The 
reaction mixture was then poured onto chilled sodium bicarbonate solution and extracted 
with diethyl ether, washed with brine, dried over magnesium sulphate and purified by flash 
column chromatography (silica gel, petroleum ether/ethyl acetate:9/1, Rf = 0.3) to afford a 
white crystal (267 mg, 8%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.71 (s, 2H), 3.32 (s, 2H), 0.92 (s, 9H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 171.6, 134.2, 49.3, 33.7, 28.2. 
HR-MS (ES+): calcd. for C9H14NO2: 168.1025, found: 168.1026. 
FT-IR (ATR): νmax  3105, 3091, 2957, 2910, 2872, 1697 cm-1. 








Figure S2.1   1H spectrum of compound 2-5. 
 





In a sealed bottle the solution of 3-maleimidopropionic acid N-hydroxy-succinimde ester 2-
6 (100 mg, 0.376 mmol) in furan (15 mL) and tetrahydrofuran (5 mL) was stirred at 60 °C 
under microwave radiation for 2 h. After evaporation of solvent, the product was obtained 
as a pale yellow solid (145 mg, quant. yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): Endo-exo isomers were found with a ratio of 4:6. 6.50 (s, 
0.8H), 6.41 (s, 1.2H), 5.31 (s, 1.2H), 5.27 (s, 0.8H), 3.88 (t, J = 7.1 Hz, 0.8H), 3.72 (t, J = 6.8 Hz, 
1.2H), 3.55 (dd, J = 3.6, 1.6 Hz, 1.2H), 2.99 (t, J = 7.1 Hz, 0.8H), 2.91 (s, 1.2H), 2.88 (t, J = 6.8 
Hz, 1.2H), 2.82-2.81 (m, 4H). 
13C NMR (100 MHz, CDCl3) δ (ppm): Endo-exo isomers were found. 175.90/174.54, 
168.88/168.86, 166.06/166.04, 136.67/134.71, 81.05/79.54, 47.68/46.13, 34.14/33.55, 
29.08/28.68, 25.68. 
HR-MS (ES+): calcd. for C15H15N2O7: 335.0879, found 335.0879. 













Figure S2.3   1H spectrum of compound 2-7. (Prime notation indicates an endo/exo isomer) 
 
 





Compound 2-8 has been previously characterised within the group (unpublished result). The 
solution of lithocholic acid (2.00 g, 5.32 mmol), N-ethylcarbodiimide hydrochloride (1.53 g, 
5.32 mmol), 1-boc-piperazine (1.50 g, 5.32 mmol) and 4-dimethylaminopyridine (10 mg) in 
anhydrous dimethylformamide (50 mL) was stirred at r.t. for 24 h, then diluted with ethyl 
acetate (100 mL) and washed with aqueous LiCl (5%, 10 ! 25 mL) and brine (25 mL). The 
organic phase was dried over Na2SO4 and purified by flash chromatography (SiO2, 0-15% 
gradient of methanol in dichloromethane) to afford the product as a white solid (2.37 g, 82% 
yield).  
1H NMR (400 MHz, CDCl3) δ (ppm): 3.69-3.57 (m, 3H), 3.48- 3.39 (m, 6H), 2.39 (m, 1H), 2.24 
(m, 1H), 1.97 (dt, 1H), 1.92-0.92 (m, 41H), 0.66 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 172.3, 154.6, 80.3, 71.8, 56.5, 56.0, 45.5, 42.8, 42.1, 41.3, 
40.4, 40.2, 36.5, 35.9, 35.6, 35.4, 34.6, 31.4, 30.5, 30.4, 28.4, 28.3, 27.2, 26.4, 24.2, 23.4, 
20.8, 18.5, 12.1. (This characterisation was conducted by Peter Bolgar) 
HR-MS (ES+): calcd. for C33H57N2O4: 545.4318, found: 545.4323.  













BH3-THF (1M, 50 mL) was added to compound 2-8 (2.30 g, 4.22 mmol) with external cooling, 
then refluxed for 3 h. Methanol (60 mL) was added to quench the reaction and the crude was 
purified by flash chromatography (silica, 0-50% gradient of ethyl acetate in petroleum ether) 
to afford the product as a white solid (1.88 g, 84% yield).  
1H NMR (400 MHz, CDCl3) δ (ppm): 3.68-3.56 (m, 5H), 2.97-2.81 (m, 2H), 2.76-2.58 (m, 4H), 
1.96-0.90 (m, 50H), 0.62(s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 154.44, 80.52, 71.89, 65.36, 57.37, 57.28, 56.57, 56.23, 
56.21, 42.84, 42.19, 40.52, 40.27, 36.54, 35.94, 35.68, 35.45, 34.67, 33.58, 30.64, 28.45, 
27.30, 26.52, 24.30, 23.48, 19.50, 19.44, 18.73, 12.16. 
HR-MS (ES+): calcd. for C33H59O3N2: 531.4520, found: 531.4516.  











Figure S2.5   1H spectrum of compound 2-9. 
 
 





To a solution of compound 2-9 (400 mg, 0.754 mmol), DMAP (9 mg, 0.075 mmol) and 
triethylamine (0.31 mL, 2.262 mmol) in dichloromethane (20 mL) was added a solution of 
chloroacetyl chloride (0.12 mL, 1.508 mmol) 10 mL of dichloromethane (10 mL) with external 
cooling. The reaction was then stirred at r.t. for 24 h. After quenching with methanol (2 mL), 
the solvent was evaporated and the crude was purified by flash chromatography (silica, 0-
5% gradient of methanol in dichloromethane) to afford the product as a white solid (253.2 
mg, 55% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): 4.83-4.80 (m, 1H), 4.03 (s, 1H), 3.76-3.56 (m, 4H), 3.26-
3.22 (m, 2H), 2.97-2.79 (m, 4H), 2.04-0.93 (m, 47H), 0.65 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 166.57, 154.04, 80.57, 76.45, 60.17, 58.36, 56.21, 55.87, 
53.73, 53.69, 42.52, 41.66, 41.03, 40.21, 39.88, 35.54, 35.25, 34.70, 34.34, 33.11, 31.81, 
28.10, 26.75, 26.24, 26.07, 23.94, 23.06, 20.62, 18.74, 18.41, 11.85. 
HR-MS (ES+): calcd. for C35H60N2O4Cl: 607.4260, found: 607.4242. 














Figure S2.7   1H spectrum of compound 2-10. 
 
 





The solution of compound 2-10 (100 mg, 0.165 mmol), compound 2-4 (146 mg, 0.823 mmol) 
and potassium carbonate (158 mg, 1.15 mmol) in anhydrous dimethylformamide (10 mL) was 
stirred at r.t. for 48 h. The reaction mixture was diluted with ethyl acetate (50 mL) and 
washed with lithium chloride (5% aq., 5 x 10 mL), sodium carbonate (sat. aq., 3 x 10 mL) and 
brine (10 mL). After evaporation of solvent, the crude was purified by flash chromatography 
(neutral alumina, 0-15% gradient of ethyl acetated in petroleum ether then silica, 0-30% 
gradient of ethyl acetate in petroleum ether) to afford the product as a white solid (65 mg, 
53% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm):  8.06 (d, J = 7.9 Hz, 1H), 7.97 (d, J = 7.9 Hz, 1H), 7.78 (d, J = 
7.9 Hz, 1H), 4.82 (s, 1H), 4.73 (s, 1H), 3.74-3.57 (m, 4H), 3.24-3.20 (m, 2H), 2.91-2.84 (m, 4H), 
2.40 (s, 3H), 2.45 (s, 3H), 1.96-0.91 (m, 47H), 0.62 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 200.12, 169.41, 157.11, 154.35, 153.20, 152.64, 137.04, 
124.13, 121.59, 80.88, 75.35, 71.42, 58.67, 56.55, 56.19, 54.05, 54.02, 42.82, 41.96, 40.53, 
40.22, 35.85, 35.55, 35.06, 34.66, 33.42, 32.30, 28.41, 28.39, 27.08, 26.70, 26.39, 25.76, 
24.26, 23.39, 20.92, 19.05, 18.72, 12.16, 11.26. 
HR-MS (ES+): calcd. for C44H69N4O6: 749.5200, found: 749.5217.  












Figure S2.9   1H spectrum of compound 2-11. 
 
Figure S2.10   13C spectrum of compound 2-11. 
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Compound 2-11 (deprotected) 
 
The solution of compound 2-11 (65 mg, 0.08 mmol) and trifluoroacetic acid (1 mL, 13.1 mmol) 
in dichloromethane (10 mL) was stirred at r.t. for 1 h. The reaction was quenched with 
sodium hydroxide (2 M, aq., 6 mL) then washed with sodium bicarbonate (sat., aq., 3 x 10 
mL), brine (10 mL) and dried over anhydrous sodium sulphate. After evaporation of solvent 
the product was obtained as white solid (60.2 mg, quant. yield) and used for the next step 
without further purification. 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.06 (d, J = 7.9 Hz, 1H), 7.98 (d, J = 7.9 Hz, 1H), 7.77 (t, J = 
7.9 Hz, 1H), 4.83 (m, 1H), 4.73 (s, 1H), 3.22-3.17 (m, 4H), 2.97-2.84 (m, 4H), 2.73 (s, 3H), 2.45 
(s, 3H), 1.96-0.91 (m, 37H), 0.63 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 200.00, 169.29, 157.01, 153.10, 152.55, 136.93, 124.02, 
121.49, 75.26, 71.32, 56.51, 56.45, 56.15, 42.73, 42.69, 41.87, 40.44, 40.13, 35.76, 35.56, 
34.96, 34.57, 33.33, 32.21, 28.29, 26.99, 26.61, 26.30, 25.65, 24.17, 23.29, 20.82, 18.67, 
18.62, 12.06, 12.03, 11.16. 
HR-MS (ES+): calcd. for C39H61O4N4: 649.4687, found: 649.4681. 











Figure S2.11   1H spectrum of compound 2-11 (deprotected). 
 
 





The solution of deprotected compound 2-11 (60 mg, 0.092 mmol), compound 2-7 (145 mg, 
0.433 mmol) and triethylamine (0.038 mL, 0.277 mmol) in anhydrous dimethylformamide 
(10 mL) was stirred at r.t. for 24 h. The reaction mixture was diluted with ethyl acetate (25 
mL), washed with lithium chloride (5%, aq., 5 x 10 mL), brine (10 mL) and dried over 
anhydrous sodium sulphate. After evaporation of solvent, the crude was purified by flash 
chromatography (silica, 0-10% gradient of methanol in dichloromethane) to afford the 
product as a white solid (35 mg, 44% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): Two endo-exo isomers were found with a ratio of 8:2. 
8.06 (d, J = 7.9 Hz, 1H), 7.98 (d, J = 7.9 Hz, 1H), 7.78 (t, J = 7.9 Hz, 1H), 6.50 (s, 1.6H), 6.38 (s, 
0.4H), 5.29 (s, 0.4H), 5.26 (s, 1.6H), 4.91-4.78 (m, 1H), 4.74 (s, 2H), 3.80 (t, J = 7.9 Hz, 1.6H), 
3.61-3.44 (m, 4.8H), 2.84 (s, 1.6H), 2.73 (s, 3H), 2.59 (t, J = 7.9 Hz, 1.6H), 2.46-2.31 (m, 9.4H), 
1.97-0.91 (m, 40H), 0.63 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 200.17, 176.14/174.83, 169.44, 168.15, 157.16, 153.24, 
152.69, 137.06, 136.66/134.53, 124.17, 121.63, 81.04, 75.42, 71.46, 59.10, 56.65, 56.27, 
47.57, 42.82, 42.02, 40.59, 40.28, 35.90, 35.74, 35.35, 35.11, 34.71, 32.35, 30.73, 30.50, 
29.82, 28.43, 27.14, 26.75, 26.45, 25.79, 24.32, 23.44, 22.81, 22.75, 20.96, 18.82, 12.16, 
11.30. 
HR-MS (ES+): calcd. for C50H70N5O8: 868.3236, found: 868.5224. 
















Figure S2.13   1H spectrum of compound 2-12. 
 
 





To a solution of compound 2-12 (17.5 mg, 0.0346 mmol) in chloroform/ethanol (1:1, 5 mL) 
was added a solution of hydroxylamine hydrochloride (2.8 mg, 0.0692 mmol) and sodium 
acetate (1.4 mg, 0.0346 mmol) in water (0.5 mL). The reaction mixture was sealed and stirred 
at 60 °C under microwave radiation for 5 h. After dilution with chloroform (30 mL), the 
mixture washed with water (2 x 10 mL), brine (10 mL) and dried over anhydrous sodium 
sulphate. The crude was purified by flash chromatography (neutral alumina, 0-20% gradient 
of methanol in dichloromethane) to afford the product as a white solid (12 mg, 67% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): Endo-exo isomers + Z-E isomers. 8.01-7.77 (m, 2H), 7.68-
7.52 (m, 1H), 6.50/6.39 (2s, 2H), 5.32/5.26 (2s, 2H), 4.74-4.73 (m, 3H), 3.83-3.52 (m, 7H), 
2.84 (s, 2H), 2.62-2.35 (m, 13H), 1.83-0.63 (m, 46H), 0.57 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 176.17, 170.10, 168.26, 157.81, 152.64, 136.68, 136.34, 
120.06, 119.89, 81.06, 77.48, 75.31, 71.36, 56.36, 47.60, 42.86, 42.63, 41.76, 40.43, 40.07, 
35.92, 35.78, 35.33, 35.00, 34.90, 34.73, 34.60, 32.12, 30.74, 28.20, 27.15, 27.11, 27.07, 
26.45, 26.31, 24.29, 23.44, 20.83, 19.64, 18.99, 18.79, 12.12, 11.30, 10.22. 
MS (ES-): calcd. for C50H69N6O8: 882.1, found: 882.2. 



















Figure S2.15   1H spectrum of compound 2-13. 
 
 





Compound 2-13 (12 mg, 0.136 mmol) was heated at 95 °C in vacuo for 10 h. The residue was 
purified by RF-HPLC (XBridge® BEH C8 2.5 µm Column, solvent A: water + 0.1% formic acid; 
solvent B: acetonitrile +0.1% formic acid; 47.5% isocratic gradient of solvent B in solvent A, 
retention time: 2 min) to afford the product as a white solid (0.73 mg, 6 % yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): Z-E isomers. 7.97-7.85 (m, 2H), 7.72-7.61 (m, 1H), 6.71 (s, 
2H), 4.84-4.74 (m, 3H), 3.85-3.54 (m, 6H), 2.92-2.55 (m, 7H), 2.44 (s, 3H), 2.38 (s, 3H), 2.04-
0.63 (m, 41H), 0.58 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 170.67, 170.10, 168.32, 157.82, 157.35, 153.94, 152.68, 
136.35, 134.42, 122.22, 120.09, 75.30, 71.37, 56.63, 56.38, 53.57, 42.65, 41.76, 40.44, 40.08, 
35.92, 35.78, 35.70, 35.02, 34.91, 34.60, 34.20, 33.45, 32.12, 31.56, 28.21, 27.06, 26.77, 
26.32, 24.29, 23.44, 20.83, 18.76, 12.19, 12.12, 11.30, 10.23.  
HR-MS (ES+): calcd. for C46H67N6O7: 815.5066, found: 815.5047. 






















Figure 2-18   13C spectrum of compound 2-1. 
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2.4.2   Vesicle Experiments 
General Protocol for Vesicle Preparation 
To a 1.5 mL microcentrifuge tube was added a chloroform solution of lipids (DOPC/DOPE 
in a 3:2 ratio) in order to obtain a final lipid concentration of 1 mM in 3.5 mL (final elution 
volume). The solvent was evaporated using a dry nitrogen stream and dried under high 
vacuum for at least 2 h to yield a thin lipid film. To the microcentrifuge containing the 
lipids was added 25 mM HEPES 150 mM NaCl buffer (0.5 mL) at pH 7, as well as stock 
solutions of ester substrate and zinc chloride as appropriate to reach final 
concentrations of 250 µM. After swelling for 1 min, the suspension was subjected to 5 
cycles of freeze-thaw using liquid nitrogen and 35 °C water bath. The suspension was 
extruded for 19 times through a 200 nm polycarbonate filter in an extruder apparatus, 
and then the vesicles were separated by a bulk solution using prepacked SEC columns 
eluting with the same HEPES buffer at pH 7.  
Fluorescence Measurements 
Fluorescence excitation experiments were recorded using the following parameters: 
emission wavelength = 510 nm, excitation range 380!480 nm, recorded at 2-minute 
intervals. At the end of the experiment, 5% Triton X-100 (50 µL) and 1 M NaOH (50 µL) was 
added to lyse the vesicles and hydrolyze all of the remaining substrates. The emission 
measured at this end point was used to normalise the data taking into account of the 
dilution factor. 
 
Safety-Catch (Figure 2.2) 
OFF state red data (1): To a 1 mL fluorescence cuvette was added 1 mM vesicle suspensions 
with 1 mol% loading of maleimide transducer 2-1 (800 µL); ON state red data (2): An aliquot 
of 1 mM NaOH was added to the above OFF state vesicle suspensions to raise the external 
pH to 10 at t = 40 min; OFF state grey data (3): To a 1 mL fluorescence cuvette was added 1 
mM vesicle suspensions without loading of maleimide transducer 2-1 (800 µL); OFF state 
grey data (4): An aliquot of 1 mM NaOH was added to the above OFF state vesicle 
suspensions (3) to raise the external pH to 10 at t = 40 min; 
 
In-Situ Thiol Conjugation (Figure 2.5) 
OFF state grey data: To a 1 mL fluorescence cuvette was added 1 mM vesicle suspensions 
without loading of maleimide transducer 2-1 (800 µL). An aliquot of 1 mM NaOH was added 
to the vesicle suspensions to raise the external pH to 10 at t = 40 min; ON state red data: To 
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a 1 mL fluorescence cuvette was added 1 mM vesicle suspensions with 1 mol% loading of 
maleimide transducer 2-1 (800 µL). An aliquot of 1 mM NaOH was added to the vesicle 
suspensions to raise the external pH to 10 at t = 40 min; OFF state green data: To a 1 mL 
fluorescence cuvette was added 1 mM vesicle suspensions with 1 mol% loading of maleimide 
transducer 2-1 (800 µL). 103 eq. of 2-mercaptoethanesulfonic acid (relative to 2-1) was 
added externally and the vesicle suspension was incubated at r.t. for 2 h before the start of 
the fluorescence measurement. An aliquot of 1 mM NaOH was added to the vesicle 
suspensions to raise the external pH to 10 at t = 40 min; OFF state yellow data: To a 1 mL 
fluorescence cuvette was added 1 mM vesicle suspensions with 1 mol% loading of maleimide 
transducer 2-1 (800 µL). 103 eq. of 2-mercaptoethanesulfonic acid (relative to 2-1 in green 
data) was added externally and the vesicle suspension was incubated at r.t. for 2 h before 
the start of the fluorescence measurement. An aliquot of 1 mM NaOH was added to the 









People face trade-o!s, and the cost of something is what you give up to get it.      
     Gregory Mankiw 
 
Carboxylic Acid Transducer  
3.1   Introduction 
Development of e!ective therapy for malignant tumours is one of the biggest challenges in 
research as well as in the clinic. One major di!erence between many solid tumours and the 
surrounding normal tissue is the acidic extracellular pH (range from 5.7 to 7.8), because of 
high concentration of acidic metabolites such as lactic acid.1 Moreover, changes in pH are also 
encountered in the process of endocytosis where pH can drop as low as 6.0-6.5 in early 
endosomes and 4.5-5.5 in late endosomes and lysosomes, as shown in Figure 3.1.2 "erefore, 
this acidic external vesicle pH can be exploited as a drug-release trigger. Recent therapeutic 
approaches have been designed to target the tumour pH through low-pH activation of drug 
release from micelles and nanoparticles.3  
We have recently developed a novel transmembrane signalling mechanism by controlling the 
movement of a synthetic transducer across a vesicle lipid bilayer.4,5 "e external recognition 
head group of the transducer becomes membrane-permeable in response to an external 
chemical stimulus, which leads to membrane translocation, exposing a catalytic head group to 
the interior of the vesicle. Catalytic hydrolysis of an internal substrate generates an amplified 
output signal, which can also be used to trigger the release of the vesicle contents6, see Figure 
3.2. In this case, one of the products generated by substrate hydrolysis is a surfactant, which 
disrupts the membrane and enhances the permeability of the lipid bilayers to polar solutes; "e 




We therefore designed a carboxylic acid transducer using this translocation mechanism in an 
attempt to trigger drug release from artificial vesicles.  
 




Figure 3.2   Triggered cargo release from vesicles using an artificial signal transduction mechanism. 
Transmembrane signal transduction: the input signal switches the external head group (blue) of a synthetic 
signal transducer from polar to apolar (purple), allowing the translocation of the transducer across the 
membrane. Catalytic surfactant generation: charged co-factor binding to the inner (catalytic) head group (red) 
activates the catalyst (green), leading to hydrolysis of a substrate (grey) into a surfactant (blue) and 
fluorophore (green). Membrane disruption: The surfactant disrupts the membrane and enhances the 
permeability of the lipid bilayers to polar solutes; Cargo release: cargo (pink) encapsulated in the vesicles are 
released through disordered lipid bilayers and an output is generated. 
  !e designed chemical structure of carboxylic acid transducer 3-1 and the corresponding 
signalling experiments for anti-tumour drug release is illustrated in Figure 3.2.  Transducer 3-
1 consists of a polarity switchable carboxylic acid group with pKa value of 4.8 (in aqueous 
solution) and a steroid core spacer which links to a pyridine-oxime pro-catalyst. Vesicles 
contain substrate 3-3, and water-soluble anti-tumour drug, for example doxorubicin (DXR)7. 
In the initial pH neutral state, carboxylic acid transducer is embedded on the outside leaflet of 
the lipid bilayer as the carboxylic acid group is deprotonated. Concurrence of acidic 
microenvironments in tumour tissue protonates the transducer, which gives a neutral 
carboxylic acid group and allows the transducer to translocate the membrane and turn on the 
hydrolysis reaction of substrate 3-2 inside the vesicles. !e surfactant 3-4 subsequently 
dissolves into the lipid bilayer and increases the membrane permeability to the polar contents. 
Drugs encapsulated in the vesicles are released through the disordered membrane and are 





Figure 3.3   A designed controlled release of anti-tumour drug triggered by transmembrane signal 
transduction using carboxylic acid transducer. Vesicles are loaded with water-soluble anti-tumour drug, zinc 
ions and a hydrolysable substrate. At physiological pH, the carboxylic acid group of carboxylic acid 
transducer 3-1 is deprotonated (blue) and stays in the outside leaflet of the vesicle membrane. Concurrence 
of acidic microenvironments in tumour tissue protonates the transducer, and the neutral carboxylic acid 
group (purple) allows the transducer to translocate the membrane. Binding of zinc ions to the inner catalytic 
head group (red) activates the catalyst (green), turning on surfactant generation by catalysing the hydrolysis 
of the substrate (grey) into a surfactant (light blue). The surfactant subsequently dissolves into the lipid bilayer 
and increase the membrane permeability to polar solutes. Drugs encapsulated in the vesicles are released 
through the disordered membrane and target the nearby tumour cells.  
3.2   Results and Discussions 
3.2.1   Synthesis of Carboxylic Acid Transducer 
Carboxylic acid transducer 3-1 was synthesised in five steps from lithocholic acid, see Scheme 
3.1. Condensation of chloroacetyl chloride gave 3-5. Esterification of carboxylic acid group 
with tert-butyl alcohol gave 3-6. Functionalisation with pyridine mono-oxime 3-7 gave 3-8. 
TFA deprotection of tert-butyl group gave transducer 3-9. Condensation of hydroxylamine 






























1. (COCl)2, CH2Cl2, 16h











































3.2.2   Signalling Experiments 
DOPC/DOPE vesicles (molar ratio: 3/2) with 5 mol% loading of the carboxylic acid 
transducer 3-1 were assembled at neutral pH with encapsulation of 250 μM substrate 3-10 
and 250 μM zinc chloride in HEPES bu!er saline. At pH 7 and the carboxylic acid group 
should be deprotonated and membrane-impermeable. An external acid pulse with addition of 
hydrochloric acid should protonate the carboxylate anion and initiate the translocation. 
However, no turn ON was observed after the acid pulse, see Figure 3.4.  
 
Figure 3.4   Attempted signalling experiments (HEPES buffer). Time dependence of the normalized 
fluorescence emission intensity at 510 nm (exciting at 415 nm). Experiments were conducted in 200 nm 
DOPC/DOPE vesicles (molar ratio: 3/2, 2 mM lipid concentration) with 5 mol% loading of carboxylic acid 
transducer 3-1 containing 250 μM substrates 3-10, 250 μM zinc chloride, and 250 mM HEPES buffer 150 
mM NaCl at pH 7. Black data: background hydrolysis of substrate 3-10 in vesicles at pH 7. Yellow/pink/red 
data: external addition of HCl at t = 20 min (indicated by an arrow) to reach pH 6, 5, and 4, respectively. b), 
c), d) and e): Time dependence of internal vesicle pH, calculated from fluorescence emission intensity at 510 
nm (exciting at 405 nm and 460 nm). External addition of HCl at t = 20 min to reach pH 6, 5, and 4, respectively. 
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  Previously, Dr Flore Keymeulen discovered that, at pH 5, the catalytic hydrolysis rate of 
pyridine-oxime catalytic head group for substrate 3-10 in water is approximately 500 times 
slower than the hydrolysis rate at pH 7 (unpublished results). !is indicates that the 
e"ectiveness of the catalytic head group is pH-dependent. !e product HPTS is a pH indicator. 
!e HPTS fluorescence emission ratio at 510 nm between excitation at 405 and 460 nm can 
be used for calculating the internal vesicle pH.4 After the acid pulse, the internal vesicle pH 
dropped to pH 6.5 when external vesicle pH was 5 (Figure 3.4d), and it dropped to pH 5.5 
when external vesicle pH was 4 (Figure 3.4e). !erefore, even when the transducer is in the 
ON state, i.e. the transducer has translocated across the lipid bilayer and bound to zinc(II) at 
the inner surface of the membrane, the significantly slow rate of hydrolysis makes the system 
OFF. !e lipid used in these experiments was a mixture of DOPC/DOPE in 3:2 molar ratio 
which failed to maintain the internal vesicles pH at pH 7. 
 
 
Figure 3.5   Attempted signalling experiments (MES buffer). Time dependence of the normalized fluorescence 
emission intensity at 510 nm (exciting at 415 nm). Experiments were conducted in 200 nm DOPC/DOPE 
vesicles (molar ratio: 3/2, 2 mM lipid concentration) with 5 mol% loading of carboxylic acid transducer 3-1 
containing 250 μM substrate 3-10, 250 μM zinc chloride, and 250 mM MES buffer 150 mM NaCl at pH 7. 
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Black data: background hydrolysis. Yellow/Magenta/Red data: external addition of HCl to reach pH 6, 5, and 
4, respectively. b), c), d) and e): Time dependence of internal vesicle pH, calculated from fluorescence 
emission intensity at 510 nm (exciting at 405 nm and 460 nm). External addition of HCl at t = 20 min to reach 
pH 6, 5, and 4, respectively. 
  We then made several attempts to improve the maintenance of pH gradient across the 
membrane by changing bu!er, raising bu!er concentration to increase bu!ering capacity, and 
altering lipid composition. For example, MES has pKa value of 6.15 at 20 ºC compared to pKa 
7.5 of HEPES. "us the useful pH bu!ering range of MES bu!er more suitable than HEPES 
in acidic environments. Figure 3.5 shows a vesicle experiment with 5 mol% loading of the 
carboxylic acid transducer using MES bu!er. "e external vesicle pH decreased to pH 6, 5, 
and 4 after the acid pulse. However, the internal vesicle pH dropped rapidly to pH 6 or less.    
  Several pH gradient assays were conducted to test how di!erent lipid compositions maintain 
the pH gradient. We assembled vesicles with di!erent lipids encapsulating 250 uM HPTS in 
the bu!er and followed the internal vesicle pH change after the acid pulse. For example, Figure 
3.6 - 3.8 show pH gradient assays of vesicles with lipid composition of DOPC/cholesterol:2/1, 
POPC (100%), and DOPC/DOPE/cholesterol: 50/34/16, respectively. Unfortunately, none 
of these systems was able to maintain a stable pH gradient for the duration of the signalling 
experiments when external vesicle pH is at pH 4 (pKa of the carboxylic acid group is ~4.7). 
Potentially, the carboxylic acid transducer could act as a proton carrier to shu#e the proton 
from one side to another via a flip-flop mechanism, as observed for lipid translocation in the 
lipid bilayer membrane.8  
 
Figure 3.6   pH gradient test (lipid composition: DOPC/cholesterol). Time dependence of internal vesicle pH 
calculated from fluorescence emission intensity at 510 nm (exciting at 405 nm and 460 nm). Experiments 
were conducted in 200 nm DOPC/cholesterol vesicles (molar ratio: 2/1, 1 mM lipid concentration) containing 
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250 μM HPTS, 250 μM zinc chloride, and 250 mM HEPES buffer 150 mM NaCl at pH 7.  a) without external 
addition of HCl. b), c), and d) external addition of HCl at t = 20 min to reach pH 6, 5, and 4, respectively.  
  
Figure 3.7   pH gradient test (lipid composition: DOPC). Time dependence of internal vesicle pH calculated 
from fluorescence emission intensity at 510 nm (exciting at 405 nm and 460 nm). Experiments were 
conducted in 200 nm DOPC vesicles (1 mM lipid concentration) containing 250 μM HPTS, 250 μM zinc 
chloride, and 250 mM HEPES buffer 150 mM NaCl at pH 7.  a) without external addition of HCl. b), c), and d) 
external addition of HCl at t = 20 min to reach pH 6, 5, and 4, respectively. 
 
Figure 3.8   pH gradient test (lipid composition: DOPC/DOPE/cholesterol). Time dependence of internal 
vesicle pH calculated from fluorescence emission intensity at 510 nm (exciting at 405 nm and 460 nm). 
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Experiments were conducted in 200 nm DOPC/DOPE/cholesterol vesicles (50/34/16, 1 mM lipid 
concentration) containing 250 μM HPTS, 250 μM zinc chloride, and 250 mM HEPES buffer 150 mM NaCl at 
pH 7.  a) without external addition of HCl. b), c), and d) external addition of HCl at t = 20 min to reach pH 6, 
5, and 4, respectively. 
3.2.3   In-situ EDC coupling at membrane surface 
Whereas pH gradient is challenging to maintain as well as the catalytic head group is very 
much less e!ective in acidic pH environment, we proposed a signalling system using in-situ 
carbodiimide coupling chemistry at membrane surface to avoid the change of pH as a trigger 
for translocation, see Figure 3.10. "e carboxylic acid transducer at neutral pH is deprotonated 
and exposes the carboxylate ion at the membrane surface. EDC is a water-soluble carbodiimide 
and works by activating carboxylic group for amide formation with primary amine. N-
hydroxysuccinimide (NHS) can be included in the EDC coupling protocols to improve the 
coupling e#ciency. "e resulting O-acrylisourea and sulfo-NHS ester are both charged and 
therefore membrane-impermeable, maintaining the transducer at the outer surface of the 
membrane. "ese intermediates are relatively unstable but highly reactive. Addition of a 
membrane-permeable primary amine would yield a stable amide conjugate that is overall 
neutral, initiating the membrane translocation and generate the ON state.  
 
Figure 3.9   Proposed in-situ EDC coupling of carboxylic acid transducer 3-1 with a membrane-permeable 
amine. The carboxylic acid transducer is deprotonated in neutral pH. In-situ reaction with EDC and sulfo-
NHS should generate a membrane-impermeable activated intermediate. Further reaction with a membrane-
soluble amine should lead to formation of a neutral amide bond, initiating the translocation of the transducer. 
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  For the attempted signalling experiments, we assembled POPC vesicles with 5 mol% loading 
of carboxylic acid transducer 3-1 in HEPES bu!er saline. An excess amount of EDC/NHS 
was added externally followed by addition of propylamine, and the fluorescent emission of the  
product HPTS in the vesicles was measured, see Figure 3.10. Two control experiments were 
conducted at the same time: 1) vesicles with external addition of EDC/NHS, and 2) vesicles 
with external addition of propylamine. "ese experiments were designed to rule out any e!ects 
that EDC/NHS or propylamine may cause on the hydrolysis of substrate 3-10. Unfortunately, 
no sign of switching to ON state was achieved in this attempted signalling experiment. It is 
possible that carboxylic acid transducer is not fully exposed at the membrane surface so that 
the in-situ reaction did not occur or did not occur e!ectively as designed.  
 
Figure 3.10   Attempted in-situ EDC coupling and signalling experiment. Time dependence of the normalized 
fluorescence emission intensity at 510 nm (exciting at 415 nm). Experiments were conducted in 200 nm POPC 
vesicles (1 mM lipid concentration) with 5 mol% loading of carboxylic acid transducer 3-1 containing 250 μM 
substrate 3-10, 250 μM zinc chloride, and 250 mM MES buffer 150 mM NaCl at pH 7. Black data: background 
hydrolysis of substrate 3-10 in vesicles. Red data: external addition of 2 mM EDC/NHS (40 eq. relative to 
transducer 3-1) at t = 5 min (indicated by the black arrow) and 2 mM propylamine (40 eq. relative to transducer 
3-1) at t = 15 min (indicated by the blue arrow). Yellow data: a control experiment with external addition of 2 
mM EDC/NHS (40 eq. relative to transducer 3-1) at t = 5 min. Pink data: a control experiment with external 
addition of 2 mM propylamine in DMSO (40 eq. relative to transducer 3-1) at t = 15 min.  
3.3   Conclusion 
In this chapter, a transducer with a carboxylic acid head group was designed and synthesised 
in an attempt to conduct signal transduction across the membrane in acidic pH condition. As 
the pKa of carboxylic group is approximately 4.7, external pH should decrease to 4 to protonate 
the majority of the transducers and enable the translocation. However, lowering extravesicular 
pH from neutral to pH 4 resulted in undesired rapid pH decrease inside the vesicles because 
1) transducer could act as a proton transporter through a flip-flop mechanism, and 2) even the 
membrane without the loading of transducer could not maintain a stable pH gradient.  
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Unfortunately, catalytic hydrolysis of substrate 3-10 is significantly slowed down at pH <6, 
making the ON/OFF state of the system undistinguishable. Various lipids compositions and 
bu!ers solutions were examined to try to maintain a pH gradient across the membrane but 
with little success. We then changed the signalling design from a pH-responsive system to an 
amine-responsive one using an in-situ EDC/sulpho-NHS coupling chemistry. "e highly 
active EDC/NHS intermediate should be charged and membrane-impermeable. Coupling 
with a membrane-soluble amine would form a stable amide bond and initiate the translocation 
of the transducer. However, the observed negative results suggest that carboxylic acid 
transducer might not be fully exposed to the internal aqueous solution, making the in-situ 
reaction di#cult to occur at the membrane surface. We therefore stopped further investigation 
on this carboxylic acid transducer. 
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3.4   Supporting Information 
3.4.1   Synthetic procedures and characterizations 
Materials and methods 
1H NMR and 13C NMR spectra were recorded on a 400-MHz Bruker® spectrometer. Chemical 
shifts are reported as δ values in ppm. Flash chromatography was carried out on an 
automated system (Combiflash® Rf+ Lumen™) using pre-packed cartridges of silica (25 µm 
PuriFlash® Column) or neutral alumina (50 µm RediSep® Rf Column). GPC purification of the 
vesicles was carried out using GE Healthcare PD-10 desalting columns prepacked with 
Sephadex® G-25 medium. Fluorescence spectra were recorded using a Cary Eclipse 
fluorescence spectrophotometer (Agilent Technologies) in Hellma® Analytics Suprasil® 
quartz cuvettes. Measurements of pH were conducted using a Mettler-Toledo 
SevenCompact™ pH meter equipped with an InLab® Micro electrode. Vesicles were 
assembled in Eppendorf® polypropylene Protein LoBind® polypropylene microcentrifuge 
tube and extruded as described below using Avanti® Polar Lipids extruder kits, equipped 
with Avestin® LiposoFast Liposome Factory 200 nm polycarbonate membranes with GE 
Healthcare Whatman® 10 mm polyester filter support. Solutions or vesicles suspensions 
were transferred using Eppendorf Multipette® Xstream Pippette with Combitips Advanced® 
or Hamilton Microliter™ syringes. All reagents and solvents were used without further 









To a solution of lithocholic acid (1.0 g, 2.655 mmol) in tetrahydrofuran (20 mL) was added 
chloroacetyl chloride (0.6 g, 5.311 mmol) with external cooling. The reaction mixture was 
stirred over night at room temperature. After the reaction was quenched by methanol (2 mL) 
with external cooling, the solvent was removed in vacuo. The crude was purified by flash 
chromatography (silica, methanol in dichloromethane: 0 – 20%) to yield a white solid (1.05 
g, 83%).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): 4.81 (m, 1H), 4.03 (s, 2H), 2.42 – 2.22 (m, 2H), 1.98 – 0.91 
(m, 32H), 0.65 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 180.5, 167.0, 76.9, 56.7, 56.2, 43.0, 42.1, 41.4, 40.6, 40.3, 
36.0, 35.5, 35.1, 34.8, 32.2, 31.2, 31.0, 28.4, 27.2, 26.7, 26.5, 24.4, 23.5, 21.1, 18.5, 12.3. 
HR-MS (MS+): calcd. for C26H4135ClO4: 452.2693, found: 452.2690. 











Figure S3.1   1H NMR spectrum of compound 3-2. 
 







To an anhydrous solution of compound 3-2 (100 mg, 0.22 mmol) in dichloromethane (2 mL) 
was added one drop of dimethylformamide and oxalyl chloride (130 mg, 0.88 mmol) at 0 °C. 
The mixture was stirred at r.t. for 2 h. Tert-butyl alcohol (49 mg, 0.66 mmol) and 
triethylamine (66 mg, 0.66 mmol) were added and the reaction was stirred at r.t. overnight. 
The reaction mixture was diluted with dichloromethane, washed with hydrochloric acid (1 
M), sodium bicarbonate (sat.), and brine, and the solvent was evaporated. The residue was 
purified by flash column chromatography (silica, petroleum ether/ethyl acetate:9/1, Rf = 0.5) 
to afford a white solid (43.1 mg, 38% yield). 
 
1H NMR (400 MHz, CDCl3) δ (ppm): 4.80 (m, 1H), 4.02 (s, 2H), 2.28-1.94 (m, 2H), 1.97 – 0.89 
(m, 41H), 0.65 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 173.5, 166.6, 79.7, 76.5, 56.3, 55.9, 42.5, 41.7, 41.0, 40.2, 
39.9, 35.6, 35.1, 34.7, 34.4, 32.4, 31.8, 30.9, 28.0, 27.9, 26.8, 26.3, 26.1, 24.0, 23.1, 20.7, 18.1, 
11.8. 
HR-MS (ES+): calcd. for C30H49ClO4: 508.3319, found: 508.3327. 













Figure S3.3   1H NMR spectrum of compound 3-3. 
 







To a solution of compound 3-3 (40 mg, 0.079 mmol) in dimethylformamide (1 mL) was added 
potassium carbonate (54 mg, 0.393 mmol) and stirred for 15 min before a solution of 
compound 3-4 (42 mg, 0.236 mmol) in dimethylformamide (7 mL). The mixture was stirred 
at r.t. overnight. The reaction mixture was centrifuged, and the supernatant was diluted 
with ethyl acetate (25 mL), washed with lithium chloride (15% aq.) and brine, and the solvent 
was evaporated. The residue was purified by flash column chromatography (silica, 
petroleum ether/ethyl acetate:9/1) to afford a white solid (37 mg, 71% yield). Compound 3-4 
co-eluted with the product. The product was used in the next step without further 
purification. 
 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.98 (d, J = 7.8 Hz, 1H), 7.77 (t, J = 7.8 Hz, 1H), 4.89 – 4.76 
(m, 1H), 4.74 (s, 2H), 2.78 (s, 1H), 2.73 (s, 3H), 2.46 (s, 3H), 2.34 – 2.07 (m, 2H), 1.94 – 0.91 (m, 
45H), 0.62 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 200.1, 173.8, 169.4, 157.1, 153.2, 152.7, 137.0, 124.2, 
121.6, 80.0, 75.4, 71.4, 56.6, 56.2, 42.8, 42.0, 40.6, 40.3, 35.9, 35.4, 35.1, 34.7, 32.7, 32.3, 
31.2, 28.2, 27.1, 26.7, 26.4, 25.8, 25.7, 24.3, 23.4, 21.0, 18.4, 12.2, 11.3.  
HR-MS (ES+): calcd. for C39H58N2O6: 650.4295, found: 650.4296. 
FT-IR (ATR): νmax 2973, 2956, 2925, 2866, 1750, 1723, 1468, 1449, 1421, 1407, 1372, 1230, 












Figure S3.5   1H NMR spectrum of compound 3-5. 
 







To a solution of compound 26 (37 mg, 0.062 mmol) in dichloromethane (5 mL) was added 
trifluoroacetic acid (1 mL) and stirred at r.t. for 7 h. The reaction mixture was diluted with 
ethyl acetate (30 mL), washed with sodium bicarbonate (sat.) and brine, dried over 
anhydrous sodium sulphate, and the solvent was evaporated. The residue was purified by 
flash column chromatography (silica, dichloromethane/methanol:9/1) to afford a white 
solid (30 mg, 89% yield). 
 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.06 (d, J = 7.6 Hz, 1H), 7.98 (d, J = 7.6 Hz, 1H), 7.77 (t, J = 
7.8 Hz, 1H), 4.89 – 4.76 (m, 1H), 4.74 (s, 2H), 2.78 (s, 1H), 2.73 (s, 3H), 2.46 (s, 3H), 2.34 – 2.02 
(m, 2H), 1.96 – 0.88 (m, 45H), 0.62 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 200.3, 180.0, 169.5, 157.2, 153.3, 152.7, 137.1, 124.2, 
121.7, 75.4, 71.5, 56.6, 56.1, 42.9, 42.0, 40.6, 40.3, 35.9, 35.4, 35.1, 34.7, 32.4, 31.1, 30.9, 
28.3, 27.1, 26.8, 26.4, 25.8, 24.3, 23.4, 21.0, 18.4, 12.2, 11.3. 
HR-MS (ES+): calc.d for C35H51N2O6: 595.3747, found: 595.3752. 
FT-IR (ATR): νmax 2934, 2866, 1756, 1735, 1703, 1578, 1450, 1378, 1284, 1233, 1205, 1130, 











Figure S3.7   1H NMR spectrum of compound 3-6. 
 







To a chloroform/ethanol:1/1 solution (10 mL) of compound 3-6 (30 mg, 0.050 mmol) was 
added an aqueous solution (1 mL) of hydroxylamine (3.5 mg, 0.050 mmol) and sodium 
acetate (4.1 mg, 0.050 mmol). The reaction mixture was stirred at 60 ºC overnight. The 
reaction mixture was diluted with chloroform (30 mL), washed with water (10 mL x 3) and 
brine, dried over anhydrous sodium sulphate, and the solvent was evaporated to afford a 
white solid (67 mg, 43% yield). 
 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.00 (t, J = 7.5 Hz, 1H), 7.86 – 7.63 (m, 2H), 4.87 – 4.79 
(m, 1H), 4.74 (s, 2H), 2.44 (s, 3H), 2.42 (s, 3H), 1.96 – 1.82 (m, 4H), 1.57 – 0.92 (m, 33H), 0.63 
(s, 3H) . 
13C NMR (100 MHz, CDCl3) δ (ppm): 179.7, 169.6, 157.6, 156.8, 152.8, 136.6, 120.7, 120.3, 
77.2, 75.3, 71.3, 56.5, 55.9, 42.7, 41.8, 40.4, 40.1, 35.8, 35.3, 35.0, 34.6, 32.2, 30.9, 29.7, 
28.2, 27.0, 26.6, 26.3, 24.2, 23.3, 20.8, 18.3, 12.0, 11.3, 10.9. 
HR-MS (ES+): calcd. for C35H51N3O6: 609.3778, found: 609.3779.  
FT-IR (ATR): νmax 2925, 2864, 1753, 1734, 1704, 1570, 1453, 1424, 1365, 1284, 1258, 1204, 












Figure S3.9   1H NMR spectrum of compound 3-1. 
 




3.4.2   Vesicle Experiments 
General Protocol for Vesicle Preparation 
To a 1.5 mL microcentrifuge tube was added a chloroform solution of lipids in order to 
obtain a final lipid concentration of 1 mM in 3.5 mL (final elution volume). The solvent 
was evaporated using a dry nitrogen stream and dried under high vacuum for at least 2 
h to yield a thin lipid film. To the microcentrifuge containing the lipids was added 25 
mM HEPES 150 mM NaCl buffer (0.5 mL) at pH 7, as well as stock solutions of ester 
substrate and zinc chloride as appropriate to reach final concentrations of 250 µM. 
After swelling for 1 min, the suspension was subjected to 5 cycles of freeze-thaw using 
liquid nitrogen and 35 °C water bath. The suspension was extruded for 19 times through 
a 200 nm polycarbonate filter in an extruder apparatus, and then the vesicles were 
separated by a bulk solution using prepacked SEC columns eluting with the same HEPES 
buffer at pH 7.  
Fluorescence Measurements 
Fluorescence excitation experiments were recorded using the following parameters: 
emission wavelength = 510 nm, excitation range 380!480 nm, recorded at 2-minute 
intervals. At the end of the experiment, 5% Triton X-100 (50 µL) and 1M NaOH (50 µL) was 
added to lyse the vesicles and hydrolyze all of the remaining substrates. The emission 




To a 1 mL fluorescence cuvette was added 1 mM vesicle suspensions with 1 mol% loading of 
carboxylic acid transducer 3-1 (800 µL). 
 
Attempted ON State 
An aliquot of 1 mM HCl was added to the vesicle suspensions described above to lower the 
external pH to 6, 5, or 4 at t = 20 min. 
 
Attempted In-situ EDC Coupling (Figure 3.10) 
OFF state background hydrolysis of substrate 3-10 in vesicles (black data): to a 1 mL 
fluorescence cuvette was added 1 mM vesicle suspensions with 1 mol% loading of carboxylic 
acid transducer 3-1 (800 µL). Attempted ON state (red data): to the above described vesicle 
suspension was added 40 eq. of EDC/NHS (1:1, relative to 3-1) at t = 5 min, and 40 eq. of 
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propylamine (relative to 3-1) at t = 15 min; OFF state control experiment with EDC coupling 
(yellow): to the above described vesicle suspension was added 40 eq. of EDC/NHS (1:1, 
relative to 3-1) at t = 5 min; OFF state control experiment with propylamine (pink data): to 
the above described vesicle suspension was added 40 eq. of propylamine (relative to 3-1) 
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Doubt everything. Find your own light. Pain is Certain. Su!ering is optional. 
     Gautama Buddha 
 
Desthiobiotin Transducer 
4.1   Introduction 
Cell membranes coordinate a large variety of biological processes by selectively recognizing and 
responding to di!erent external stimuli, and membrane-spanning proteins play a vital role in 
these signalling pathways. Direct mass transfer by carrier proteins or by channels allows 
exchange of molecules between the inside and outside of the cell.1 For signalling pathways that 
do not involve direct mass transfer, an external signal induces dimerization or conformational 
changes in membrane-spanning proteins that result in a cascade of reactions on the inner side 
of the membrane.2,3 Although numerous examples of synthetic membrane channels and 
transporters have been reported4–10, signal transduction without mass transfer is considerably 
more challenging11–16. 
We have recently reported a novel transmembrane signalling mechanism, which operates by 
controlled translocation of a synthetic transducer across a vesicle lipid bilayer (Figure 1).17,18 
"e external recognition head group of the transducer becomes membrane permeable in 
response to an external chemical stimulus, which leads to membrane translocation, exposing a 
catalytic head group to the interior of the vesicle. Catalytic hydrolysis of an internal substrate 
generates an amplified output signal, which can also be used to trigger the release of the vesicle 
contents.19 "e choice of recognition head group can be used to make this system respond to 
di!erent external stimuli, such pH17 or metal ions18. Here, we extend the scope of the signal 
transduction system by using ligand-protein binding as the input signal. We show that 
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multivalent interactions at lipid bilayer interfaces lead to dramatic changes in protein-ligand 
binding a!nities and exploit this phenomenon to achieve signal transduction processes 
between two di"erent populations of vesicles. 
 
Figure 4.1   Signal transduction via membrane translocation. The transducer has two switchable head groups. 
In the OFF state, the recognition head group is membrane impermeable and sits in the external aqueous 
phase (purple), and the internal pro-catalyst head group sits in the membrane (red). An external signal 
switches the recognition head group to membrane permeable (blue), allowing translocation of the transducer 
across the bilayer. Binding of a charged cofactor to the catalytic head group (green) generates the ON state, 
where the catalyst turns over an encapsulated substrate (grey) to generate an amplified output signal (yellow).  
 
 
Figure 4.2   a) An artificial signal transduction system that responds to protein-ligand binding. In the initial 
OFF state, the protein-transducer complex is anchored in the outer leaflet of the vesicle bilayer and the 
catalytic head group (red) is buried in the membrane. The input is a competing ligand (pink) that binds the 
protein (orange), displacing the transducer head group (blue) and allowing it to enter the membrane. 
Translocation followed by binding of a charged cofactor (Zn2+) from the internal aqueous solution of the 
vesicle activates the catalytic head group (green), which hydrolyses an internal substrate (grey) to generate 
an amplified output signal (yellow). b)  Molecular structure of transducer 4-1, the corresponding zinc complex, 






  !e avidin-biotin system is a well-exploited and reliable biotechnology tool used in a broad 
range of applications such as biochemical assays20, diagnosis21, and a"nity purification22. 
Avidins are water soluble proteins that have an extremely high a"nity for biotin (Kd ~ 0.01 
pM) and a somewhat lower a"nity for desthiobiotin (Kd ~ 10 pM).23 !e desthiobiotin-avidin-
biotin system is ideally suited to construction of a transducer with a recognition head group 
that responds to biotin as a molecular input signal. !e approach is illustrated in Figure 4.2a. 
Desthiobiotin is used as the recognition head group on transducer 4-1, and assembly of vesicles 
in the presence of avidin should lead to the OFF state, because the desthiobiotin-avidin 
complex is not membrane permeable. Addition of the higher a"nity ligand, biotin (pink), to 
the external solution should displace the protein from the vesicles, allowing the relatively non-
polar desthiobiotin to enter the membrane. Translocation of the transducer followed by 
binding of zinc ion cofactors to the internal catalytic head group will initiate hydrolysis of ester 
substrate 4-2 inside the vesicles. !e output signal in the ON state is the fluorescent emission 
from the hydrolysis product 4-3. 
  !e molecular structure of transducer 4-1 is shown in Figure 4.2b. !e hydrophobic steroid 
core provides the membrane anchor, and the pyridine oxime moiety is the pro-catalyst head 
group that will be activated by coordination to zinc ions.  !e desthiobiotin recognition head 
group is attached via a PEG linker to make sure it can reach the avidin binding site without 
steric clashes between the protein and the membrane (see Supporting Information). We used 
NeutrAvidin as the protein component of this system, because it has a low isoelectric point (pI 
= 6.3), which minimizes protein aggregation at neutral pH. 
4.2 Results and Discussion 
4.2.1 Synthesis 
Synthesis of ester substrate 4-2 was described previously. Transducer 4-1 was synthesized from 
lithocholic acid in four steps as shown in Scheme 1. Coupling of the alcohol with chloroacetyl 
chloride, followed by EDC coupling of the carboxylic acid with N-Boc-4,7,10-trioxa-1,13-
tridecanediamine 4-5 gave intermediate 4-6. Deprotection of the amine followed by EDC 
coupling with desthiobiotin 4-7 gave 4-8. Functionalization with pyridine dioxime 4-9 ligand 
gave transducer 4-1.  
A membrane-anchored biotin derivative was required for the signalling experiments described 
below. Compound 4-10 was therefore synthesized from lithocholic acid using the route shown 
in Scheme 4.2. !e carboxylic acid group of lithocholic acid was converted to the 
corresponding amine in two steps, and then EDC coupling was used to attach biotin. 
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Scheme 4.1   Synthesis of Desthiobiotin Transducer 4-1. 
  













































































































































4.2.2 Characterization of the Input Signal 
In order to confirm that NeutrAvidin binds transducer 4-1, a 4’-hydroxyazobenzene-2-
carboxylic acid (HABA) binding assay was first conducted in solution. HABA has a UV 
absorption maximum at 348 nm, which moves to 500 nm when it binds to NeutrAvidin.24 
Figure 3 shows the result of titrating a solution of transducer 4-1 in DMSO into a phosphate 
bu!er solution of the HABA-NeutrAvidin complex at pH 7. "e absorption at 500 nm 
decreased linearly with the amount of transducer until 4 equivalents had been added. Addition 
of just DMSO to the same solution had no e!ect on the absorption at 500 nm. "is result 
indicates that, as expected, NeutrAvidin binds four equivalents of transducer 4-1 with a high 
a#nity. Note that NeutrAvidin has four identical biotin binding sites, which will become 
important for understanding the signalling experiments below. 
 
Figure 4.3   UV/vis absorption titration of transducer 4-1 in DMSO solution (filled circles) or just DMSO (open 
circles) into a mixture of 0.3 mM HABA and 8.3 μM NeutrAvidin in 100 mM phosphate buffer with 150 mM 
NaCl at pH 7. The UV/vis absorption at 500 nm is plotted as a function of the ratio of transducer [4-1] to 
protein [NAv]. 
To confirm that NeutrAvidin also binds transducer 4-1 when it is embedded in a vesicle 
membrane, we used a Förster resonance energy transfer (FRET) assay. A NeutrAvidin-
TexasRed conjugate is commercially available, and nitrobenzoxadiazole (NBD) is a 
complementary dye suitable for FRET experiments.25 We prepared one set of 
phosphatidylcholine vesicles loaded with transducer 4-1 and a C6-Ceramide derivative of 
NBD and another set of vesicles loaded with only the dye. "e NeutrAvidin-TexasRed 
conjugate was added to both sets of vesicles, and the results are shown in Figure 4.4. For the 
vesicles that did not contain transducer 4-1, no change in the NBD fluorescence was observed, 
which indicates that the protein does not bind to the vesicles (Figure 4.4a). In contrast, when 
transducer 4-1 was also present in the vesicles, addition of NeutrAvidin-TexasRed resulted in 
[4-1]/[NAv] 
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quenching of the NBD fluorescence. !e transducer-dependent quenching indicates that the 
protein does indeed bind to the membrane-anchored transducer, and that this inter-action 
brings to the two dyes into su"ciently close proximity for FRET (Figure 4.4b).  !ese results 
suggest that the NeutrAvidin•4-1 complex should provide a usable OFF state for signal 
transduction experiments. 
NeutrAvidin makes a 1:4 complex with 4-1, so there are four membrane-anchors exposed on 
the surface of complex, and there is potential for the complex to cross-link vesicles. Careful 
control of stoichiometry was therefore required. For example, for the experiment shown in 
Figure 4.4, an excess of protein was used, and no vesicle aggregation was observed. 
 
Figure 4.4   Fluorescence spectra (excitation at 330 nm, emission at 540 nm) of 0.01 mM 200 nm POPC 
vesicles with 2.5 mol% loading of NBD C6-Ceramide containing 25 mM HEPES buffer 150 mM NaCl at pH 
7: a) without transducer 4-1, and b) with 5 mol% loading of transducer 4-1. Black: initial emission spectra, 
blue: spectra after addition of 0.5 μM NeutrAvidin-TexasRed (1 eq. relative to 1). Schematic illustrations are 
shown in c) and d), respectively. 
!e same FRET assay was used to test the e#ect of biotin on the interaction between 
NeutrAvidin and transducer 4-1. Vesicles loaded with transducer 4-1 and NBD C6-Ceramide 
were prepared, and the NeutrAvidin-TexasRed conjugate was added. !e fluorescence 
quenching described above was observed, which confirms that the protein binds to the 
membrane-anchored transducer on the surface of the vesicles. !en biotin was added, but no 
change in fluorescence was observed (Figure 4.5a). If biotin were to dissociate NeutrAvidin 
from the vesicles, then the FRET between TexasRed and NBD would be abolished, which 
suggests that membrane-anchored desthiobiotin outcompetes biotin for protein binding. In 
solution, biotin binds NeutrAvidin with a 1,000-fold higher a"nity than desthiobiotin. A 
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possible reason for the change in relative a!nity in the case of membrane-anchored ligands is 
that NeutrAvidin has four binding sites and vesicles present multiple ligands on their surface, 
so multivalent interactions are possible. "e protein has two binding sites on one face and two 
on the opposite face, so we suggest that two desthiobiotin moieties bind cooperatively to two 
protein binding sites at the vesicle surface, leading to an enhanced binding a!nity for 
membrane-anchored desthiobiotin relative to solution-phase biotin (Figure 4.5c).26,27 
 
Figure 4.5   Fluorescence spectra (excitation at 330 nm, emission at 540 nm) of 0.01 mM 200 nm POPC 
vesicles with 2.5 mol% NBD C6-Ceramide and 5 mol% transducer 4-1 containing 25 mM HEPES buffer 150 
mM NaCl at pH 7: a) initial spectrum (black), spectrum after addition of 0.42 μM NeutrAvidin-TexasRed (1 eq. 
relative to 4-1) (blue), and spectrum after subsequent addition of 1.68 μM biotin (4 eq. relative to NeutraAvidin-
TexasRed) (green), and b) initial spectrum (black), spectrum after addition of 0.42 μM NeutrAvidin-TexasRed 
(1 eq. relative to 4-1) (blue), and spectrum after subsequent addition of vesicles with 5 mol% biotin derivative 
4-10 to reach a bulk concentration of 1.68 μM 4-10 (4 eq. relative to NeutraAvidin-TexasRed) (red). Schematic 
illustrations are shown in c) and d), respectively. 
If anchoring desthiobiotin in a membrane increases the apparent binding a!nity for 
NeutrAvidin, the same should be true of biotin. To test this hypothesis, we used vesicles loaded 
with membrane-anchored biotin as the input signal to displace NeutrAvidin from the 
transducer. "e FRET experiment described above was repeated, but instead of adding biotin 
to displace the NeutrAvidin from the membrane-anchored transducer, vesicles loaded with 5 
mol% of biotin derivative 4-10 were added. "e results are shown in Figure 4.5b. In this case, 
the fluorescence of the NBD present in the transducer-loaded vesicles was restored. "is result 
shows that vesicles containing biotin derivative 4-10 remove NeutrAvidin from vesicles 
containing transducer 4-1. In other words, multivalent biotin vesicles outcompete multivalent 
desthiobiotin vesicles, as expected from the solution-phase binding a!nities. "e fact that 4-
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10 binds NeutrAvidin without the PEG linker used in 4-1 suggests that a linker is not required 
for protein binding at the membrane interface. However, Figure 4.5b shows that the 
fluorescence is not fully restored by the biotin vesicles, which could be due to a relatively small 
di!erence in the protein binding a"nities of the two vesicle-anchored ligands. 
  In these experiments, the protein was present in excess relative to 4-1 to avoid cross-linking 
of the vesicles, so the other protein binding sites were initially empty. Addition of the biotin 
vesicles could cause cross-linking due to multivalent interactions at both vesicle membrane 
interfaces, but an excess of biotin was used relative to transducer 4-1, and no aggregation was 
observed on the timescale of the measurements. #e reorganization of multivalent interactions 
that would lead to vesicle aggregation appears to be relatively slow. However, when solutions 
containing both sets of vesicles were stored overnight, visible flocculation was observed 
indicating that aggregation of this system does take place on longer timescales. 
4.2.3   Transmembrane Signalling Experiments 
Before carrying out signalling experiments, we tested the catalytic activity of the transducer in 
the ON and the OFF states. Vesicles were prepared containing 250 μM ester 2 and 250 μM 
zinc chloride in HEPES bu!er at pH 7. When transducer 4-1 was added to this solution, it 
inserted into the membrane and initiated catalysis of ester hydrolysis inside the vesicles (green 
data in Figure 4.6a). #is system corresponds to the ON state of the signal transduction system 
and shows that the desthiobiotin head group does not interfere with catalysis. When the 
NeutrAvidin•1 complex was added to the vesicle solution, no increase in the background rate 
of hydrolysis of substrate 4-2 inside the vesicles was observed (black data in Figure 4.6a). #is 
system corresponds to the OFF state of the signal transduction system and shows that protein 
binding holds the catalytic head group inside the membrane, preventing translocation. Vesicle 
cross-linking in this OFF state was avoided by adding an excess of the NeutrAvidin•4-1 
complex to ensure that the surfaces of the vesicles were saturated. 
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Figure 4.6   a) Time dependence of the normalized fluorescence emission intensity at 510 nm (exciting at 415 
nm). The ON state (green) was obtained by adding transducer 4-1 in DMSO to vesicles to reach 10 mol% 
loading in lipids and a bulk concentration of 10 µM 4-1 (addition at time point indicated by the arrow). The 
OFF state (black) was obtained by adding the NeutrAvidin•4-1 complex (16.7 μM protein, 66.8 μM 4-1, i.e. 
0.25 eq. of protein eq. relative to 4-1). All experiments were conducted in 0.1 mM 200 nm DOPC/DOPE 
vesicles containing 250 μM 4-2, 250 μM zinc chloride, and 25 mM HEPES buffer 150 mM NaCl at pH 7. b) 
Schematic illustration. 
Having demonstrated that the ON and OFF states function as anticipated, we then attempted 
to switch between these two states by using external signals to initiate signal transduction. !e 
ON state was assembled as described above, and NeutrAvidin was added to the vesicle 
suspension after two hours. Figure 4.7a shows that addition of the protein e"ciently switches 





Figure 4.7   a) Time dependence of the normalized fluorescence emission intensity at 510 nm (exciting at 415 
nm). The ON state (green) was obtained by adding transducer 4-1 in DMSO to vesicles to reach 10 mol% 
loading in lipids and a bulk concentration of 1 µM 4-1. After 100 minutes, 2 μM NeutrAvidin was added (2 eq. 
relative to 4-1) to generate the OFF state (black, addition indicated by the arrow). All experiments were 
conducted in 0.01 mM 200 nm DOPC/DOPE vesicles containing 250 μM 2, 250 μM zinc chloride, and 25 mM 
HEPES buffer 150 mM NaCl at pH 7. b) Schematic illustration. 
  Having demonstrated that the ON and OFF states function as anticipated, we then attempted 
to switch between these two states by using external signals to initiate signal transduction. !e 
ON state was assembled as described above, and NeutrAvidin was added to the vesicle 
suspension after two hours. Figure 4.7a shows that addition of the protein e"ciently switches 
the system from the ON to the OFF state. In this case, two equivalents of protein relative to 
transducer 4-1 were used to avoid vesicle cross-linking, and this stoichiometry is more e#ective 
at suppressing the reaction than the 0.25 equivalents of NeutrAvidin used for the experiments 




Figure 4.8   a) Time dependence of the normalized fluorescence emission intensity at 510 nm (exciting at 415 
nm). The OFF state (black) was obtained by adding NeutrAvidin•4-1 1:4 complex (16.7 μM protein, 66.8 μM 
4-1, i.e. 0.25 eq. of protein eq. relative to 4-1) to 0.1 mM DOPC/DOPE vesicles  containing 250 μM 4-2, 250 
μM zinc chloride, and 25 mM HEPES buffer 150 mM NaCl at pH 7. Addition to the OFF vesicle solution of 
either 67 μM biotin (4 eq. relative to NeutrAvidin, red) or 1 mM biotin (60 eq. relative to NeutrAvidin, purple) 
biotin both gave OFF states. Addition to the OFF vesicle solution of different amounts of 200 nm DOPC/DOPE 
vesicles loaded with 10 mol% of biotin derivative 4-10 (green) or 5 mol% of biotin derivative 4-10 (blue) to 
reach bulk concentrations of 67 μM 4-10 (4 eq. relative to NeutrAvidin) both gave ON states. b) Schematic 
illustration. 
  To demonstrate switching from the OFF to the ON state, the OFF state was assembled as 
described above by adding the NeutrAvidin•4-1 complex to vesicles containing substrate 4-2 
and zinc ions. Figure 4.8a shows the e!ect of adding biotin to this system. Biotin slightly 
reduced the background rate of substrate hydrolysis (red data), but did not generate an ON 
state, as expected from the FRET experiments described above. Even a saturated solution of 1 
4-1•NAv 4-2+Zn2+ 
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mM biotin produced no signs of an ON signal (purple data). However, addition of vesicles 
loaded with 10 mol% of biotin derivative 4-10 lead to a rapid increase in fluorescence emission 
characteristic of the ON state (green data in Figure 4.8a). When the loading of 4-10 in the 
biotin vesicles was lowered to 5 mol%, an ON state was also obtained, albeit with lower catalyst 
activity (blue data). !is result suggests that the a"nity of the biotin vesicles for NeutrAvidin 
can be controlled with vesicle loading by changing the e#ective molarity for the cooperative 
binding interactions at the membrane interface. !e timescale for the signalling experiments is 
significantly longer than for the FRET experiments, so flocculation was sometimes observed at 
the end of these experiments, presumably due to vesicle cross-linking. !e experiments shown 
in Figure 4.8 indicate that signalling molecules displayed on the surface of one set of vesicles 
are able to initiate catalytic substrate turnover inside a second set of di#erent vesicles. !is 
process is reminiscent of the kind of complex cell-to-cell signalling processes found in 
biological organisms. 
4.3   Conclusions 
!e system described here constitutes the first example of a synthetic construct where 
cooperative interactions at membrane interfaces have been used to trigger transmembrane 
signal transduction. A molecular signal (biotin) displayed on the external surface of one 
population of vesicles was used to trigger a catalytic process on the inside of a second 
population of vesicles. !e key recognition event is the exchange of proteins (NeutrAvidin) 
bound to vesicles displaying desthiobiotin to vesicles displaying biotin. !e 
desthiobiotin•NeutrAvidin complex was used to anchor a synthetic transducer in the outer 
leaflet of the vesicles, and when the protein was displaced, the transducer translocated across 
the bilayer to expose a catalytic head group to the internal vesicle solution. As a result, an ester 
substrate encapsulated on the inside of this second population of vesicles was hydrolysed to 
give a fluorescent product, which constitutes an amplified output signal. NeutrAvidin has four 
ligand binding sites, and multivalent interactions with the membrane-anchored ligands leads 
to very high binding a"nities. !us biotin, which has a dissociation constant three orders of 
magnitude higher than desthiobiotin, did not displace NeutrAvidin from the membrane-
anchored transducer, and membrane-anchored biotin was required to generate the input signal. 
!ese findings extend the scope of artificial signal transduction from purely synthetic 
assemblies into more sophisticated systems, which opens up the potential for future 
development of responsive vesicles in bionanotechnology.    
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4.4   Supporting Information 
4.4.1   Molecular modelling 
There is no NeutrAvidin•biotin crystal structure available in the PDB bank, so the X-ray 
crystal structure of the avidin•biotin complex (PDB entry: 2AVI) was used to assess an 
appropriate length of linker to ensure that the membrane would not interfere with binding. 
NeutrAvidin is a deglycosylated version of avidin. The structure of the transducer 4-1 was 
built and energy minimized in an extended conformation using Avogadro. The amide group 
of the linker unit of transducer 4-1 was superimposed with the carboxylate group of biotin 
in the binding pocket of avidin using VMD (Figure S4.1). The dihedral angle adjustment 
function was used to manually configurate the bond angles of the rest of the transducer so 
that the steroid core extended towards outside of the protein. The resulting structure 
suggests that the linker used in transducer 4-1 is long enough to allow protein binding to 
the dethiobiotin unit simultaneously with anchoring of the steroid in the lipid bilayer of 
vesicles (Figure S4.2). 
 
Figure S4.1   The binding pocket of the Avidin•4-1 model. The amide group of the linker of 4-1 was 
superimposed with the carboxylate group of biotin in the binding pocket of avidin. 
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Figure S4.2   Model of the Avidin•4-1 complex at a DOPC/DOPE lipid bilayer interface, which is 4 nm thick.1 
4.4.2   Synthetic Procedures and Characterizations 
Materials and methods 
1H NMR and 13C NMR spectra were recorded on a 400-MHz Bruker® spectrometer. Chemical 
shifts are reported as δ values in ppm. Flash chromatography was carried out on an 
automated system (Combiflash® Rf+ Lumen™) using pre-packed cartridges of silica (25 µm 
PuriFlash® Column) or neutral alumina (50 µm RediSep® Rf Column). GPC purification of the 
vesicles was carried out using GE Healthcare PD-10 desalting columns prepacked with 
Sephadex® G-25 medium. Fluorescence spectra were recorded using a Cary Eclipse 
fluorescence spectrophotometer (Agilent Technologies) in Hellma® Analytics Suprasil® 
quartz cuvettes. pH measurements were conducted using a Mettler-Toledo 
SevenCompact™ pH meter equipped with an InLab® Micro electrode. Vesicles were 
assembled in Eppendorf® polypropylene Protein LoBind® polypropylene microcentrifuge 
tube and extruded as described below using Avanti® Polar Lipids extruder kits, equipped 
with Avestin® LiposoFast Liposome Factory 200 nm polycarbonate membranes with GE 
Healthcare Whatman® 10 mm polyester filter support. Solutions or vesicles suspensions 
were transferred using Eppendorf Multipette® Xstream Pippette with Combitips Advanced® 
or Hamilton Microliter™ syringes. All reagents and solvents were used without further 





Scheme S4.1   Synthesis of desthiobiotin transducer 4-1. 
 
Scheme S4.2   Synthesis of ester substrate 4-2. 
 




































































































































































Compound 4-4  





A mixture of compound 4-4 (100 mg, 0.221 mmol), N-Boc-4,7,10-trioxa-1,13-
tridecanediamine 4-5 (71 mg, 0.221 mmol), EDC (52 mg, 0.265 mmol) and 4-
dimethylaminopyridine (1 mg, cat.) in dichloromethanem (3 mL) was stirred at room 
temperature overnight. The reaction mixture was diluted with 25 mL of dichloromethane, 
then washed with 1 M hydrochloric acid (10 mL ! 2), sodium bicarbonate (sat., 10 mL), brine 
(10 mL) and dried over anhydrous sodium sulfate. The solvent was removed in vacuo and 
the crude was purified by flash chromatography (neutral alumina, methanol in 
dichloromethane 0 – 5%) to afford the product as a colorless oil (140 mg, 84%).   
 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.11 (s, 1H), 4.94 (s, 1H), 4.81 (m, 1H), 4.03 (s, 2H), 3.66 – 
3.53 (m, 13H), 3.38 – 3.23 (m, 2H), 3.21 – 3.20 (m, 2H), 2.25 – 2.17 (m, 2H), 1.77 – 0.90 (m, 43H), 
0.62 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 173.4, 166.8, 156.0, 77.2, 70.5, 70.5, 70.2, 70.1, 69.6, 56.4, 
56.1, 42.7, 41.9, 41.2, 40.4, 40.1, 37.9, 37.5, 35.7, 35.5, 34.9, 34.5, 33.7, 32.0, 31.9, 31.8, 29.7, 
29.0, 28.4, 28.2, 26.9, 26.9, 26.4, 26.3, 24.1, 23.2, 22.8, 22.5, 20.8, 18.4, 12.0. 
HR-MS (ES+): calcd. for C41H71N2O835Cl23Na: 777.4785, found: 777.4791.  















Figure S4.3   1H NMR spectrum of compound 4-6. 
 
 







A solution of compound 4-6 (100 mg, 0.132 mmol) and 1 mL of trifluoroacetic acid in 
dichloromethane (10 mL) was stirred at room temperature for 2 h. The reaction mixture was 
evaporated and re-dissolved in dichloromethane (50 mL) before washed with sodium 
bicarbonate (sat., 20 mL ! 3), brine (20 mL) and dried over anhydrous sodium sulfate. The 
solvent was evaporated, and the product was used directly in the next step. A solution of 
deprotected 4-6 (71 mg, 0.108 mmol), D-desthiobiotin 4-7 (26 mg, 0.119 mmol), EDC (18.5 
mg, 0.119 mmol) and 4-dimethylaminopyridine (1 mg, cat.) in 5 mL of dichloromethane was 
stirred at room temperature overnight. The reaction mixture was diluted with 50 mL of 
dichloromethane, then washed with 1 M hydrochloric acid (20 mL ! 3), sodium bicarbonate 
(sat., 20 mL), brine (20 mL) and dried over anhydrous sodium sulfate. The solvent was 
removed in vacuo and the crude was purified by flash chromatography (silica, methanol in 
dichloromethane 0 – 5%) to afford the product as a colorless oil (75 mg, 82%).   
 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.48 (s, 1H), 6.27 (s, 1H), 5.33 (s, 1H), 4.83 – 4.77 (m, 1H), 
4.68 (s, 1H), 4.02 (s, 1H), 3.84 – 3.81 (m, 1H), 3.68 – 3.55 (m, 13H), 3.35 – 3.32 (m, 4H), 2.24 – 
0.89 (m, 52H), 0.62 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 173.7, 172.9, 166.8, 163.4, 76.7, 70.5, 70.4, 70.4, 70.1, 70.0, 
69.9, 56.4, 56.1, 56.0, 51.4, 42.7, 41.9, 41.3, 40.4, 40.1, 37.8, 37.6, 36.3, 35.7, 35.6, 34.9, 34.6, 
33.7, 32.0, 31.9, 29.5, 29.1, 29.0, 28.9, 28.3, 27.0, 26.5, 26.3, 26.0, 25.4, 24.2, 23.3, 20.8, 18.4, 
15.8, 12.1. 
HR-MS (ES+): calcd. for C46H80N4O835Cl: 851.5639, found: 851.5641.  
FT-IR (ATR): νmax 3302, 2931, 2864, 1702, 1646, 1545, 1447, 1377, 1351, 1323, 1284, 1253, 1194, 



















Figure S4.5   1H NMR spectrum of compound 4-8. 
 
 







Compound 4-9 has been previously described.2,3 A solution of  2,6-diacetylpyridine (100 mg, 
0.613 mmol), hydroxylamine (104 mg, 1.53 mmol) and sodium hydroxide (61.2 mg, 1.533 
mmol) in water/methanol:1/1 was refluxed overnight. The crude was filtered and 
recrystallized in methanol to afford a white solid as product (60 mg, 50%).  
 
1H NMR (400 MHz, DMSO-d6) δ (ppm): 11.77 (s, 2H), 8.08-8.01 (m, 3H), 2.50 (s, 6H).  
13C NMR (100 MHz, DMSO-d6) δ (ppm): 154.3, 153.5, 136.9, 119.2, 10.2. MS (ES+): 194.2 (M-H+).  











A solution of compound 4-9 (19 mg, 0.099 mmol) and potassium carbonate (2 mg, 0.164 
mmol) in dimethylformamide (1 mL) was stirred at room temperature for 15 min and was 
added a solution of compound 4-8 (28 mg, 0.033 mmol) in dimethylformamide (1 mL). The 
reaction mixture was stirred at room temperature overnight. The reaction mixture was 
diluted with 50 mL of ethyl acetate and washed with hydrochloric acid (1M, 5 mL), lithium 
chloride (5% aq., 5 mL ! 5), sodium bicarbonate (sat., 5 mL), brine (5 mL) and dried over 
anhydrous sodium sulfate. The solvent was removed and the product as a colorless oil (19 
mg, 63%).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.48 (s, 1H), 6.27 (s, 1H), 5.33 (s, 1H), 4.83 – 4.77 (m, 1H), 
4.68 (s, 1H), 4.02 (s, 1H), 3.84 – 3.81 (m, 1H), 3.68 – 3.55 (m, 13H), 3.35 – 3.32 (m, 4H), 2.24 – 
0.89 (m, 52H), 0.62 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 174.4, 174.4, 172.9, 169.8, 157.7, 153.8, 152.7, 152.6, 136.1, 
120.1, 119.9, 75.1, 71.3, 70.5, 70.4, 70.2, 70.0, 70.0, 69.9, 56.4, 56.1, 55.7, 51.4, 42.6, 41.6, 40.4, 
40.1, 37.9, 37.7, 36.3, 35.6, 35.4, 34.8, 34.6, 34.4, 33.2, 32.0, 31.8, 29.5, 29.1, 28.9, 28.2, 26.9, 
26.4, 26.2, 26.1, 25.4, 24.1, 23.3, 20.7, 18.3, 15.8, 12.0, 11.2, 10.3. 
HR-MS (ES-) calcd. for C55H89N7O10: 1007.6671, found: 1007.6661.  
FT-IR (ATR): νmax 3302, 2931, 2864, 1702, 1646, 1545, 1447, 1377, 1351, 1323, 1284, 1253, 1194, 






















Figure S4.7   1H NMR spectrum of desthiobiotin transducer 4-1. 
 
 
Figure S4.8   13C NMR spectrum of desthiobiotin transducer 4-1. 
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Biotin derivative 4-10 
 
 
A reaction mixture of compound 4-12 (50.0 mg, 0.138 mmol), D-biotin (30.5 mg, 0.124 mmol), 
EDC (39.7 mg, 0.207 mmol), 4-dimethylaminopyridine (1 mg, cat.) in dimethylformamide (2 
mL) was stirred at room temperature overnight. The reaction mixture was diluted with 50 
mL of ethyl acetate, washed with hydrochloric acid (1 M, 5 mL), lithium chloride (5% aq., 5 
mL ! 5), sodium bicarbonate (sat., 5 mL), brine (5 mL), and dried over anhydrous sodium 
sulfate. After evaporation of solvent, the crude was purified by flash chromatography (basic 
alumina, methanol in dichloromethane: 0 – 10%) to afford the product as a colorless gel (39 
mg, 54%).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.30 (s, 1H), 6.00 (t, 3J = 5.8 Hz, 1H), 5.52 (s, 1H), 4.50 (dd, 
3J = 7.4, 4.9 Hz, 1H), 4.30 (dd, 3J = 7.4, 4.9 Hz, 2H), 3.64 – 3.58 (m, 1H), 3.25 – 3.12 (m, 2 H), 
2.91 (dd, 3J = 12.8, 4.9 Hz, 1H), 2.74 (d, 3J = 12.8 Hz, 1H), 2.19 (t, 3J = 7.4 Hz, 2H), 1.96 – 0.89 (m, 
41H), 0.63 (s, 3H).  
13C NMR (100 MHz, CDCl3) δ 173.0, 163.7, 71.7, 61.8, 60.1, 56.5, 56.0, 55.5, 42.6, 42.0, 40.6, 
40.4, 40.2, 40.0, 36.4, 36.1, 35.8, 35.4, 35.3, 34.5, 33.1, 30.5, 28.3, 28.2, 28.1, 27.1, 26.4, 26.1, 
25.7, 24.2, 23.3, 20.8, 18.6, 12.0.  
HR-MS (MS+): calcd. for C34H57N3O3S: 587.4121, found: 587.4112.  
FT-IR (ATR): νmax 3271, 2925, 2860, 1696, 1643, 1551, 1449, 1375, 1365, 1330, 1306, 1262, 1214, 

















Figure S4.9   1H NMR spectrum of biotin derivative 4-10. 
 







Compound 4-11 has been previously described.4 To a solution of lithocholic acid (3.0 g, 7.97 
mmol) and triethylamine (1.6 mL, 11.5 mmol) in tetrahydrofuran was added ethyl 
chloroformate (2 mL, 21.0 mmol) with external cooling. The reaction was further stirred at 
room temperature for 15 min. Cold concentrated ammonium hydroxide was added with 
external cooling until pH is basic. The precipitate was filtered, washed with cold water, and 
dried in vacuo to afford the product as a white solid (3.0 g, quant.).  
 
1H NMR (400 MHz, DMSO-d6) δ (ppm): 7.22 (br, 2H), 6.64 (br, 1H), 3.40 – 3.33 (m, 1H), 2.09-
0.87 (m, 34H), 0.61 (s, 3H).  
HR-MS (MS-): calcd. for C24H41NO2: 375.3137, found: 375.3142.  
FT-IR (ATR): νmax 3379, 3214, 2930, 2863, 1665, 1626, 1446, 1407, 1377, 1334, 1303, 1252, 1189, 
1167, 1088, 1069, 1044 cm-1.  
















Compound 4-12 has been previously described.4 To a solution of lithium aluminum hydride 
in tetrahydrofuran (1M, 20 mL) was added a solution of compound 4-11(2.5 g, 6.65 mmol) in 
tetrahydrofuran (100 mL), and the reaction mixture was refluxed overnight. The reaction 
mixture was diluted with 80 mL of ethyl acetate, and was added water (0.76 mL), sodium 
hydroxide (15% aq., 0.76 mL), water (2.28 mL), in this order respectively and stirred for 15 
min. Anhydrous magnesium sulfate was added and the reaction mixture was stirred for 
further 15 min. The product was filtered, washed with cold water, dried in vacuo to afford 
the product as a pale yellow solid (2.0 g, 83%).  
 
1H NMR (400 MHz, DMSO-d6) δ (ppm): 3.65 – 3.60 (m, 1H), 2.04 – 0.92 (m, 37H), 0.64 (s, 3H). 
HR-MS (MS+): calcd. for C24H43NO: 361.3345, found: 361.3341.  
FT-IR (ATR): νmax 2935, 2860, 1579, 1564, 1548, 1461, 1446, 1375, 1365, 1067, 1057, 1013 cm-1.  
All characterization data match with literature. 
 
4.4.3   Vesicle Experiments 
General protocol for vesicle preparation 
To a 1.5 mL microcentrifuge tube was added a chloroform solution of lipids (DOPC/DOPE in 
a 3:2 ratio) in order to obtain a final lipid concentration of 1 mM in 3.5 mL (final elution 
volume). The solvent was evaporated using a dry nitrogen stream and dried under high 
vacuum for at least 2 h to yield a thin lipid film. To the microcentrifuge containing the lipids 
was added 0.5 mL of 25 mM HEPES 150 mM NaCl buffer at pH 7, as well as stock solutions of 
ester substrate and zinc chloride as appropriate to reach final concentrations of 250 µM. 
After swelling for 1 min, the suspension was subjected to 5 cycles of freeze-thaw using 
liquid nitrogen and 35 °C water bath. The suspension was extruded for 19 times through a 
200 nm polycarbonate filter in an extruder apparatus, and then the vesicles were separated 
by a bulk solution using prepacked SEC columns eluting with the same HEPES buffer at pH 












Substrate 4-2 hydrolyses slowly in water, and there is some batch to batch variation in the 
background rate of hydrolysis inside vesicles, so a separate control experiment was carried 
out for each kinetic run. For each fluorescence experiment, a sample of the same batch of 
vesicles containing 4-2 was monitored to measure the background hydrolysis rate in the 
absence of any catalysis. These data were subtracted from the fluorescence data recorded 
in the catalysis experiment to remove the effects of background hydrolysis. At the end of 
the experiment, 5% Triton X-100 (50 µL) and 1M NaOH (50 µL) was added to lyse the vesicles 
and hydrolyze all of the remaining substrate 4-2. The emission measured at this end point 
was used to normalize the data taking into account of the dilution factor. 
 
ON State 
To a 1 mL fluorescence cuvette was added 800 µL of 0.1 mM vesicles described above. 1 mM 
4-1 solution in DMSO was added to the vesicles suspension to reach 10 mol% loading of 4-1 
relative to lipids. 
 
OFF State 
NeutrAvidin•4-1 1:4 complex solution was prepared by adding 4 eq. of 4-1 (1 mM DMSO 
solution) to 16.7 µM protein solution in HEPES buffer. To a 1 mL fluorescence cuvette was 
added 800 µL of 16.7 µM NeutrAvidin•4-1 1:4 complex solution in HEPES buffer. 1 mM 200 
nm DOPC/DOPE:3/2 vesicles containing 250 µM substrate 4-2 and 250 µM zinc chloride in 




To a 1 mL fluorescence cuvette was added 800 µL of 0.01 mM 200 nm DOPC/DOPE:3/2 
vesicles containing 250 µM substrate 4-2 and 250 µM zinc chloride in 25 mM HEPES 150 mM 
NaCl. 0.1 mM Transducer 4-1 solution in DMSO was added to the vesicle suspension using 
Hamilton syringes to reach 10 mol% loading of 4-1 relative to lipids. After 100 minutes, 83.3 
µM NeutrAvidin solution in HEPES buffer was added to reach a final protein concentration 
of 2 µM (2 eq. relative to 4-1). 
 
Attempted OFF-ON Switching with Biotin 
To the OFF State vesicles described above was added 1 mM biotin solution in HEPES buffer 




OFF-ON Switching with Biotinylated Vesicles 
To the OFF State vesicles described above was added 1 mM (lipid concentration) of 
biotinylated vesicles to reach 66.8 µM of 10 in final bulk concentration, 4 eq. relative to 
NeutrAvidin. Biotinylated vesicles were prepared in the same manner with 10 mol% of biotin 
derivate 4-10 in the chloroform solution of lipids. Flocculation occurs in this experiment, 
but the timescale is hours and is variable. The results presented are for at least three 
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!e truth is rarely pure and never simple. 
Oscar Wilde 
 
Galactose Transducer  
  
 
5.1   Introduction 
Cell signalling is a fundamental process by which cells communicate with other cells via their 
microenvironments. !e majority of enzymes are involved with cell signalling pathways and 
enzyme-linked receptors response to extracellular signal proteins that promote the growth, 
proliferation, di"erentiation, and many other functions of cells.1 !e catalytic activity of 
enzymes also amplifies the signal detected by a single receptor. For example, upon activation, 
one adenylyl cyclase can produce a large quantity of cyclic adenosine monophosphate (cAMP) 
molecules. !ese so-called secondary messengers can further activate downstream signalling 
proteins (such as glycogen phosphorylase) and, after multiple enzymatic reactions with 
intermediate protein kinases, lead to catalytic production of as many as tens of thousands of 
glucose molecules in the cell.2 
  β-Galactosidase is an important enzyme for human and many other animals as it hydrolyses 
the β-galactosidic bond of lactose to galactose and glucose, providing energy to cells. !e 
enzymatic cleavage reaction catalysed by β-galactosidase is highly e#cient – one individual 
protein can hydrolyse several thousand substrate molecules per minute.3 Although lactose 
would probably be the natural substrate of β-galactosidase, the enzyme is promiscuous for the 
non-galactose part of the substrate.4  In general, any structure that has β-D-galactopyranosides 





We have recently reported a novel transmembrane signalling mechanism, which operates by 
controlled translocation of a synthetic transducer across a vesicle lipid bilayer.5,6 !e external 
recognition head group of the transducer becomes membrane-permeable in response to an 
external chemical stimulus, which leads to membrane translocation, exposing a catalytic head 
group to the interior of the vesicle. Catalytic hydrolysis of an internal substrate generates an 
amplified output signal. In this chapter, we report the studies of an artificial transmembrane 
signalling system that responds to β-galactosidase as the input signal, which operates by using 
transducers which consist of β-galactose unit as recognition head group, see Figure 5.1. !e 
galactose head group is hydrophilic and membrane-impermeable, locking the transducer at the 
external surface of the vesicles. In the presence of the enzyme, the O-glycosidic bond of the 
transducer should be cleaved at the membrane surface and reveal a neutral phenol head group. 
!e new head group is considerably less hydrophilic, leading to translocation of the transducer 
across the membrane and exposing a catalytic head group to the interior of the vesicle. Upon 
cofactor (zinc ion) binding, the catalytic head group is activated and hydrolyses an internal 
substrate, generating an amplified output signal.  
 
Figure 5.1   Concept of β-galactose transducer transmembrane signalling. Galactose unit is hydrophilic and 




galactose yields membrane-permeable transducer with a phenol unit and initiate the translocation. Cofactor 
binding from the internal solution turns ON the catalytic hydrolysis of the encapsulated substrates (grey, non-
fluorescent, substrate 5-10) and generates an amplified output (green, fluorescent, HPTS). 
5.2   Results and Discussion 
5.2.1   Synthesis of Short/Long Galactose, Phenol, and Hydrazide Transducers 
Hydrazides are aldehyde-reactive chemical groups commonly used in biomolecular probes for 
labelling and crosslinking carbonyls on biomacromolecules such as glycoproteins and 
polysaccharides.7 Hydrazide reacts with aldehydes in acidic conditions to form a su!ciently 
stable conjugate for most biological applications. Dr Istvan Kocsis successfully synthesised two 
hydrazide transducers: a short hydrazide transducer 5-1, and a long transducer 5-4 with a 
polyethylene glycol linker (unpublished results). Both transducers have a hydrazide head group 
on one end, opposite to the catalytic head group. "e synthesis of these two transducers is 
shown in the Supporting Information. We then used these transducers as precursors for β-
galactose transducers.  
  To use the hydrazide-aldehyde reaction to attach a galactose unit onto the hydrazide 
transducers, we synthesised β-galactose-O-benzaldehyde 5-9 in two steps from 4-
hydroxybenzaldehyde, see Scheme 5.2. Condensation with acetobromo-α-D-galactose gave 
acetyl protected intermediate 5-8. Hydrolysis with sodium methoxide gave the desired 
compound 5-9. Reaction between β-galactose-O-benzaldehyde 5-9 and hydrazide transducers 
5-1 and 5-4 was done in ethanolic solutions with catalytic amount of acetic acid. Similarly, 4-
hydroxybenzaldehyde was used to obtain phenol transducers which are the equivalent of the 
enzymatic hydrolysis products. "e reactions were monitored by LC-MS to ensure that all 
hydrazide starting materials were consumed (see Supporting Information). As galactose-
aldehyde derivative 5-9 is highly water-soluble and does not become involved in the hydrolysis 
reaction, the excess amount of 5-9 was not separated from the product.  
 











































Scheme 5.2   Illustration of the conjugation reaction of short β-galactose transducer 5-2 and short phenol 
(ON state galactose) transducer 5-3. 
 
Scheme 5.3   Illustration of the conjugation reaction of long β-galactose transducer 5-5 and long phenol (ON 































5-2   R = 
























































5-5   R = 













5.2.2   Transmembrane Signalling experiments 
5.2.2.1   Signalling experiments with short transducers 
!ere are two ways to load transducer onto vesicle membranes: pre-incorporation and external 
addition. For the pre-incorporation method, the transducer was mixed with lipids in organic 
solvents before rehydration and extrusion. !is should give a statistical 50/50 distribution of 
transducer at both leaflets of the membrane. As for external addition method, the transducer 
was dissolved in water-miscible organic solvents such as methanol or dimethyl sulfoxide 
(DMSO) and this solution was added externally to the vesicle suspensions after extrusion and 
purification. We discovered that membrane-embedded transducer might act as a cation 
transporter to carry Zn2+ across the membrane. In order to distinguish the catalytic activity 
from the metal transport ability of transducers, we have designed experiments to decouple the 
two process and examine each of them individually. 
  
Figure 5.2   Schematic illustration of vesicles signalling experiments. Transducer loading techniques: pre-
incorporation or external addition. Zinc chloride: no zinc inside (added at rehydration of lipids), zinc outside 
(added after vesicles were purified), or zinc both sides. 
!ere are six possible ways to assemble the signalling systems, see Figure 5.2. !e ways of 
loading of Zn2+ in the system could be one of the following: 
1) Zn2+ only encapsulated inside the vesicles. !is can be achieved by adding zinc chloride at 
the lipid rehydration stage; or 
2) Zn2+ only in the extravesicular solution. !is can be achieved by external addition of zinc 
chloride to a vesicle suspension; or 




!ere are two ways of loading transducer into lipid bilayers:  
1) Pre-incorporating transducer. It is important to note that this pre-incorporation method 
should give a statistical 50/50 distribution of transducer at both leaflets of the membrane; or 
2) External addition of transducers in DMSO to vesicle suspensions. !is would result in an 
initial loading of transducers at only the outer leaflet of the membrane.
 
Figure 5.3   Transducer loading test. UPLC traces of short β-galactose transducer 5-2 (retention time: 1.81 
min). a) Pre-incorporation of 5 mol% transducer in 1 mM 200 nM POPC vesicles in HEPES buffer. b) external 
addition of 5 mol% of transducer in DMSO to 1 mM 200 nM POPC vesicles suspension. c) vesicles with 
external addition of 5 mol% of transducer after size exclusion chromatography. This figure is scaled up to 
reflect on the dilution factor (dilution factor = 2, for 0.5 mL loading volume and 1 mL elusion volume of SEC). 
d) A control experiment with the same amount of transducer added to HEPES buffer (without vesicles) and 
after size exclusion chromatography. Column: ACQUITY UPLC® CSH C18, 2.1x 50 mm, 1.7 μm, 130 Å. 
Solvent A: 2 mM ammonium acetate in water/acetonitrile (95:5); Solvent B: acetonitrile. Gradient: 5-95% B 
over 1 min. Flow rate: 0.6 mL/min. This experiment was done in collaboration with Dr Istvan Kocsis. 
  Together with Dr Istvan Kocsis, we proved that transducer could be incorporated into 
membrane with both loading techniques, see Figure 5.3. 1 mM 1-palmitoyl-2-oleoyl-glycero-
3-phosphocholine (POPC) vesicles were prepared with pre-incorporation and external loading 
(5 mol% relative to lipid) of galactose transducer 5-2 and the vesicles were directly injected 
into UPLC with C18 column, traces see Figure 5.3a and 5.3b, respectively. !e signal at t = 
1.81 (blue) is the UV absorption of transducer 5-2. !e sample using external addition method 
was further purified by size exclusion chromatography, and the resulting vesicles suspension 
Pre-incorporation of transducer: System A (zinc inside), System B (zinc outside), System C (zinc both sides); 
External addition of transducer: System D (zinc inside), System E (zinc outside), System F (zinc both sides). 
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was re-injected into UPLC (Figure 5.3c). No significant loss of transducer was observed as the 
absorption level is the same before and after the size exclusion chromatography (SEC). 
Addition of transducer 5-2 to HEPES bu!er led to precipitation and after SEC the transducer 
is eliminated from the solution, therefore no signal was seen in Figure 5.3d. 
Before conducting any experiments, we can predict possible outcomes of the above-
mentioned systems based on several general assumptions: 
Premise 1. Substrate 5-10 and Zn2+ are charged and do not cross the lipid bilayer 
membrane; 
Premise 2. Catalytic hydrolysis of substrate 5-10 must arise from the zinc-bound pyridine-
oxime head group of transducers, provided that there is no pH change in the 
system); 
Premise 3. "e zinc(II)-binding of the pyridine-oxime head group should follow a 
standard binding isotherm, and a higher Zn2+ concentration results in higher 
molar fraction of zinc-bound pyridine-oxime compared to unbound pyridine-
oxime, leading to higher catalytic hydrolysis activity.  
"erefore, based on these premises we can infer that:  
Inference 1. To catalytically hydrolyse the Substrate 5-10 (achieving an ON state), the 
pyridine-oxime head group must be present at the inner surface of the 
membrane; 
Inference 2. To catalytically hydrolyse the Substrate 5-10 (achieving an ON state), the Zn2+ 
concentration inside the vesicles must be high enough to allow some of 
pyridine-oxime head group of the transducer to be active.  
  According to literature8, the binding constant for Zn2+ and pyridine-dioxime K = 4.1 # 104 
M-1 at pH 7. Assuming the same binding constant is the same in vesicles, at 250 μM ZnCl2, 
90% of the pyridine-oxime head group should bind to Zn2+. If Zn2+ transport across the takes 
place, this would dilute the internal Zn2+ concentration ~ 500 times (for 0.1 mM POPC 200 
nm vesicles), resulting only 2% zinc(II)-bound pyridine-oxime head group being active in the 
system. "erefore, Zn2+ transport would switch the system to the OFF state if there is no Zn2+ 
outside the vesicles, even when translocation of transducer takes place.  
For six system setups described in Figure 5.2, each of the system could be either ON or OFF. 
"is leads to 26 = 64 total combinations of results on a particular transducer. For better clarity, 
we assigned each set of results with a binary code where “0” represents the signalling system is 
OFF compared to the background whilst “1” represents ON, see table 5.1. For example, code 
011000 represent the following set of results: System A – OFF, System B – ON, System C – 
ON, System D – OFF, System E – OFF, System F – OFF. However, not all of the outcomes 
are logical and actually the vast majority are not possible. We can quickly rule out systems that 
are not logical by examining the following contradictions:  
Pre-incorporation of transducer: System A (zinc inside), System B (zinc outside), System C (zinc both sides); 
External addition of transducer: System D (zinc inside), System E (zinc outside), System F (zinc both sides). 
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Contradiction 1. E1F0: According to Premise 3, if external addition of zinc chloride to 
vesicles suspension generates an ON state (E1), having zinc chloride on both 
sides of the membranes must generate an ON state (F1). !is is because, for 
the same loading of the transducer, the internal Zn2+ concentration in 
System E must be less than or equal to that in System F. !erefore, E1F0 is 
not a logical outcome; 
Contradiction 2. D1F0: For the same reasons in Contradiction 1, if external addition of 
transducer to vesicles encapsulating zinc chloride generates an ON state 
(D1), adding transducer to a system with zinc chloride on both sides of the 
membranes must generate an ON state (F1); 
Contradiction 3. C0F1: If external addition of transducer to vesicles generates an ON state 
(F1), the same system must be ON if the transducer is pre-incorporated 
(C1). !is is because, according to Inference 1, the transducer must cross 
the membrane to the inner surface of vesicles to achieve an ON state in 
System F. As pre-incorporation of vesicles gives 50/50 distribution of 
transducer directly in both leaflets of membranes, System C must be ON. 
!erefore, C0F1 is not a logical outcome; 
Contradiction 4. B0E1: For the same reasons in Contradiction 3, if external addition of 
transducer and zinc chloride to vesicles generates an ON state (E1), external 
addition of zinc chloride to vesicles with pre-incorporated transducer must 
be ON (B1).  
Contradiction 5. A1B1: If external addition of zinc chloride to vesicles with pre-incorporated 
transducer generates an ON state (B1), transport of Zn2+ must take place in 
System A, B and C. !us internally loaded Zn2+ in System A must be able 
to be transported to the outside of the vesicles, resulting a 500 times dilution 
in Zn2+ concentration as discussed before. !is will turn the system to OFF 
state (A0). !erefore, A1B1 is not a logical outcome; 
Contradiction 6. D1E1: If external addition of transducer and zinc chloride to vesicles 
generates an ON state (E1), transducer can cross the membrane as well as 
transport Zn2+. As discussed above, internal Zn2+ concentration in System 
D must be diluted that the system is OFF (D0). !erefore, D1E1 is not a 
logical outcome; 
Contradiction 7. A0B0C1: For the same reasons in Contradiction 5, A0C1 means the system 
can transport Zn2+. !erefore, System B must be ON (B1) as externally 
added Zn2+ should be transported into the vesicles.   
Contradiction 8. B1E0F1: As discussed above, F1 means transducer can cross the membrane, 
B1 means transducer can transport Zn2+, therefore System E must be ON 
(E1). 
Pre-incorporation of transducer: System A (zinc inside), System B (zinc outside), System C (zinc both sides); 
External addition of transducer: System D (zinc inside), System E (zinc outside), System F (zinc both sides). 
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  Taking into account of these contradictions, a summary of these predictions is shown in Table 
5.1. Apart from Entry 0 (000000) where the transducer is inactive in all systems, there are in 
total four possible outcomes: 
Entry 24 (011000): Membrane pre-incorporated transducer can transport Zn2+ but transducer 
cannot cross the membrane. Whether externally loaded transducer can transport Zn2+ cannot 
be determined; 
Entry 27 (011011): Transducer can cross the membrane as well as transport Zn2+; 
Entry 40 (101000): Membrane pre-incorporated transducer cannot transport Zn2+, neither can 
it cross the membrane. Whether externally loaded transducer can transport Zn2+ cannot be 
determined; 
Entry 45 (101101): Membrane pre-incorporated transducer cannot transport Zn2+ but 
transducer can cross the membrane. 
We then conducted signalling experiments with three short transducers in hand, namely short 
galactose transducer 5-2, short hydrazide transducer 5-1, and short phenol (ON state galactose) 
transducer 5-3. !e results are shown in Figure 5.4.  
We observed that the hydrolysis rate in ON states might vary. For short galactose transducer 
5-2, it seems counter-intuitive that System B (membrane pre-incorporated transducer with 
external addition of zinc chloride) achieved higher hydrolysis rate than System C (membrane 
pre-incorporated transducer with zinc chloride on both sides of the vesicles) as internal Zn2+ in 
System B should be less than or equal to System C. However, we need to acknowledge that, 
compared to System B and D where vesicles are of the same batch, vesicles in System B and C 
cannot be prepared in the same batch. Although we followed the same protocol for all vesicle 
preparations, it is practically impossible to obtain two identical sets of vesicles. !erefore, we 
can assign both System B and C in ON state and the rest of the systems in OFF state. !is is 
in line with above predicted outcome Entry 24. !ese results suggest that the short galactose 
transducer 5-2 is able to transport Zn2+ when pre-incorporated in the membrane but cannot 
cross the lipid bilayer when externally added to the membrane. A possible transport mechanism 
is discussed further in following sections. 
As for short hydrazide transducer 5-1, it is straightforward to distinguish the ON/OFF states 
(Figure 5.3b). We immediately recognise this system follows the outcome Entry 24, the same 
as short galactose transducer 5-2. !ese results suggest that the short hydrazide transducer 
cannot cross the membrane either, despite the hydrazide group being neutral at pH 7 (as a 
reference, pKa of acyl hydrazides is <4)9. One possible explanation is that hydrazide functional 
group may be very well solvated in aqueous phase with in total 3 hydrogen bond donors and 
3 hydrogen bond acceptors.  
Surprisingly, the short phenol transducer 5-3 generates similar results as the other two 
transducers, see Figure 5.3c, indicating that the transducer cannot cross the lipid bilayer. It is 
possible that the pKa of the hydroxyl group is reduced by the electron-withdrawing group (as 
a reference, pKa of 4-hydroxybenzaldehyde is 7.61 in water at 25ºC)10, and therefore the 
hydroxyl group could be deprotonated, making the transducer membrane-impermeable.  
Pre-incorporation of transducer: System A (zinc inside), System B (zinc outside), System C (zinc both sides); 
External addition of transducer: System D (zinc inside), System E (zinc outside), System F (zinc both sides). 
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Table 5.1   A binary code table for theoretical outcomes of system A-F. “0” represents the signalling system 
is OFF compared to background whilst “1” represents ON. 






0 0 0 0 0 0 0 Possible Cannot determine Cannot determine Cannot determine 
1 0 0 0 0 0 1 Not Possible C/F    
2 0 0 0 0 1 0 Not possible E/F    
3 0 0 0 0 1 1 Not possible C/F    
4 0 0 0 1 0 0 Not possible D/F    
5 0 0 0 1 0 1 Not possible C/F    
6 0 0 0 1 1 0 Not possible E/F    
7 0 0 0 1 1 1 Not possible C/F    
8 0 0 1 0 0 0 Not possible A/B/C    
9 0 0 1 0 0 1 Not possible A/B/C    
10 0 0 1 0 1 0 Not possible E/F    
11 0 0 1 0 1 1 Not possible B/E    
12 0 0 1 1 0 0 Not possible D/F    
13 0 0 1 1 0 1 Not possible A/B/C    
14 0 0 1 1 1 0 Not possible E/F    
15 0 0 1 1 1 1 Not possible A/B/C    
16 0 1 0 0 0 0 Not possible B/C    
17 0 1 0 0 0 1 Not possible C/F    
18 0 1 0 0 1 0 Not possible E/F    
19 0 1 0 0 1 1 Not possible C/F    
20 0 1 0 1 0 0 Not possible D/F    
21 0 1 0 1 0 1 Not possible C/F    
22 0 1 0 1 1 0 Not possible E/F    
23 0 1 0 1 1 1 Not possible C/F    
24 0 1 1 0 0 0 Possible Yes Cannot determine No 
25 0 1 1 0 0 1 Not possible D/F    
26 0 1 1 0 1 0 Not possible E/F    
27 0 1 1 0 1 1 Possible Yes Yes Yes 
28 0 1 1 1 0 0 Not possible D/F    
29 0 1 1 1 0 1 Not possible B/E/F    
30 0 1 1 1 1 0 Not possible E/F    
31 0 1 1 1 1 1 Not possible D/E    
32 1 0 0 0 0 0 Not possible A/C    
33 1 0 0 0 0 1 Not possible C/F     
34 1 0 0 0 1 0 Not possible E/F    
35 1 0 0 0 1 1 Not possible C/F    
36 1 0 0 1 0 0 Not possible D/F    
37 1 0 0 1 0 1 Not possible C/F    
38 1 0 0 1 1 0 Not possible E/F    
39 1 0 0 1 1 1 Not possible C/F    
40 1 0 1 0 0 0 Possible No Cannot determine No 
41 1 0 1 0 0 1 Not possible D/F    
42 1 0 1 0 1 0 Not possible E/F    
43 1 0 1 0 1 1 Not possible D/F    
44 1 0 1 1 0 0 Not possible C/F    
45 1 0 1 1 0 1 Possible No No Yes 
46 1 0 1 1 1 0 Not possible E/F    
47 1 0 1 1 1 1 Not possible D/E    
48 1 1 0 0 0 0 Not possible A/C    
49 1 1 0 0 0 1 Not possible C/F    
50 1 1 0 0 1 0 Not possible E/F    
51 1 1 0 0 1 1 Not possible C/F    
52 1 1 0 1 0 0 Not possible D/F    
53 1 1 0 1 0 1 Not possible C/F    
54 1 1 0 1 1 0 Not possible E/F    
55 1 1 0 1 1 1 Not possible C/F    
56 1 1 1 0 0 0 Not possible A/B    
57 1 1 1 0 0 1 Not possible B/E/F    
58 1 1 1 0 1 0 Not possible E/F    
59 1 1 1 0 1 1 Not possible D/F    
60 1 1 1 1 0 0 Not possible A/B    
61 1 1 1 1 0 1 Not possible A/B    
62 1 1 1 1 1 0 Not possible E/F    
63 1 1 1 1 1 1 Not possible D/E    
Pre-incorporation of transducer: System A (zinc inside), System B (zinc outside), System C (zinc both sides); 




Figure 5.4   Signalling experiment of a) short galactose transducer 5-2, b) short hydrazide transducer 5-1, 
and c) short phenol transducer 5-3. Time dependence of the normalized fluorescence emission intensity at 
510 nm (exciting at 415 nm) of 0.1 mM 200 nm POPC vesicles containing 250 μM substrate 5-10 substrate 
in 25 mM HEPES buffer 150 mM NaCl at pH 7. Grey data: background hydrolysis of substrate 5-10 in POPC 
vesicles. For all systems: transducer loading is 5 mol%, ZnCl2 concentration is 250 μM. d) Schematic 
illustration. 
5.2.2.2   Signalling experiments with long transducers  
Due to the small quantity of long hydrazide transducer 5-4 isolated (by Dr Istvan Kocsis), we 
did not have enough material to conduct signalling experiments with long transducers using 
the pre-incorporation methods (System A, B, and C) as they require significantly larger amount 
of materials than the external addition methods. However, for long galactose transducer 5-5, 
System E with externally loaded transducer and zinc chloride generates an ON state. As 
galactose head group is hydrophilic and membrane-impermeable, according to Inference 1, the 
ON state can be only achieved if the pyridine-oxime catalytic head group crosses the membrane 
and reaches the inner surface of a vesicle. !e fact that System E is in an ON state means that 
transducer can transport Zn2+ across the lipid bilayer. As discussed before, Zn2+ transport leads 
to 500 times dilution of Zn2+ concentration inside the vesicles in System D, e"ectively shutting 
down the catalytic activity of transducer and generating an OFF state.  
 
Pre-incorporation of transducer: System A (zinc inside), System B (zinc outside), System C (zinc both sides); 




Figure 5.5   Signalling experiment of a) long galactose transducer 5-5, b) long hydrazide transducer 5-4, and 
c) long phenol transducer 5-6. Time dependence of the normalized fluorescence emission intensity at 510 
nm (exciting at 415 nm) of 200 nm POPC vesicles (0.1 mM lipid concentration) containing 250 μM substrate 
5-10 in 25 mM HEPES buffer 150 mM NaCl at pH 7. Grey data: background hydrolysis of substrate 5-10 in 
POPC vesicles. For all systems: transducer loading is 5 mol%, ZnCl2 concentration is 250 μM. d) Schematic 
illustration. 
  Similar to long galactose transducer 5-5, long hydrazide transducer 5-4 and long phenol 
transducer 5-6 also generate an ON state in System E but remained in OFF state in System D, 
indicating both transducers can transport Zn2+ as well as span the lipid bilayer. According to a 







Figure 5.6   A Chemdraw model depicting the length of short hydrazide transducer 5-1, short galactose 
transducer 5-2, long hydrazide transducer 5-4, and long galactose transducer 5-5 in comparison with POPC 
lipids. The hydrophilic region is shown in blue, catalytic head group of 5-4 and 5-5 that are outside the 
hydrocarbon region is shown in orange. 
5.2.3   Fluorescence Quenching Assay 
Ms Lucia Trevisan’s work suggested that HPTS fluorescence emission can be quenched by 
transducer-Cu2+ complex (unpublished results). To further investigate the metal transport 
ability of six transducers, we designed an HPTS-transducer-Cu2+ fluorescence quenching assay.  
0.1 mM POPC vesicles encapsulating 250 µM HPTS in HEPES bu!er saline at neutral pH 
were assembled and suspended in the same bu!er solution. 10 μM CuCl2 was added from the 
outside of the vesicles. Transducers were then added to the vesicle suspensions and the 
fluorescence emission intensity of HPTS was monitored, see Figure 5.7. When long 
transducers were added to the vesicle suspension, we immediately observed a decrease of 
fluorescence emission to less than 20% of initial emission, indicating that long transducers can 

































































































































solution. However, for the system with short transducers, the fluorescence emission intensity 
of HPTS slowly decreased over time. !is means that externally loaded short transducers have 
limited ability to carry Cu2+ across the lipid bilayer compared to long transducers. Based on 
these observations, we can conclude that the long transducers are able to span the membrane 
and conduct Cu2+ transport, whilst the short transducers cannot span or cross the membrane, 
see Figure 5.8. 
 
Figure 5.7   Copper transport assay. (Green: short galactose transducer; Purple: short hydrazide transducer; 
Dark green: short phenol transducer; Blue: long galactose transducer; Brown: long hydrazide transducer; 
Black: long phenol transducer). Time dependence of the normalized fluorescence emission intensity at 510 
nm (exciting at 415 nm) of 0.1 mM POPC 200 nm vesicles encapsulating 250 μM HPTS in 25 mM HEPES 150 
NaCl buffer at pH 7. 10 μM CuCl2 is added externally at t = 0 min. An aliquot of transducer (1mM in DMSO) 
was added at t = 10 min (indicated by an arrow) to reach 5 μM bulk concentration (5 mol% loading relative 
to POPC lipids).  
We then examined Cu2+ transport of the system with pre-incorporated short galactose 
transducer, see Figure 5.9. !is system showed rapid transport of Cu2+. As galactose head group 
is hydrophilic and membrane-impermeable, external loading of transducer locks the transducer 
at the outer leaflet of the membrane, whilst pre-incorporation of transducer gives a 50/50 
distribution of transducer in both leaflets. We hypothesised that the rapid Cu2+ transport is 
due to a transducer relay mechanism that is only achievable when the transducer is present in 
both leaflets of the lipid bilayer, see Figure 5.10.11 !e pyridine oxime catalytic head group of 
the transducer is amphiphilic and can partition between aqueous-membrane interface and 
membrane hydrocarbon environment. When there is a concentration gradient of Cu2+ across 
the membrane, the pyridine-oxime head group binds Cu2+ and brings it into the membrane. 
Sequentially, another transducer in the other side of the membrane with opposite orientation 
takes the ion and releases it at the inner side of the vesicle. !is procedure is reversible and 







Figure 5.8   Illustration of ion transport mechanism in the lipid bilayer mediated  by a) long transducers can 
span the membrane, and b) short transducer that cannot span or cross the lipid bilayer. The blue head group 
(for example a galactose unit) is hydrophilic and therefore is locked at the outer leaflet of the lipid bilayer. The 
green catalytic head group is amphiphilic and can partition between aqueous-membrane interface and 
hydrocarbon environment. When there is a concentration gradient of metal ion (orange) across the membrane, 
the catalytic head group binds the metal, brings it across the lipid bilayer, and releases it at the inner side of 
the membrane.  
!ese findings are further pieces of evidence that transducer might be U-shaped in the lipid 
bilayer and have the ability to transport ions across the membranes, which help us better 
understand the transmembrane signalling experiment in the previous section.  
 
Figure 5.9   Copper transport assay of short galactose transducer 5-2 with different transducer loading 
techniques. Time dependence of the normalized fluorescence emission intensity at 510 nm (exciting at 415 





7. Pink data: 5 mol% transducer pre-incorporated in the membrane, 10 μM CuCl2 externally at t = 10 min. 
Purple data: 10 μM CuCl2 externally at t = 0 min. An aliquot of transducer (1 mM in DMSO) was added at t = 
10 min (indicated by the arrow) to reach 5 μM bulk concentration (5 mol% loading relative to POPC lipids). 
 
Figure 5.10   Illustration of a proposed ion transport mechanism in the lipid bilayer with pre-incorporated 
short transducers that cannot span the membrane. The blue head group (for example a monosaccharide unit) 
is lipophobic and therefore is locked at the outer leaflet of the lipid bilayer. The green catalytic head group is 
amphiphilic and can partition between aqueous-membrane interface and hydrocarbon environment. When 
there is a concentration gradient of metal ion (orange) across the membrane, the catalytic head group binds 
the metal, brings it into the membrane. Another transducer in the other side of the membrane with opposite 
orientation takes the ion and releases it at the inner side of the membrane.  
5.2.4   Enzymatic Cleavage of Galactose Transducers  
5.2.4.1    In POPC Vesicles. 
We used UPLC to monitor the enzymatic cleavage of membrane-embedded short galactose 
transducer 5-2, see Figure 5.11.  β-Galactosidase (0.2% relative to the transducer) was added 
into POPC vesicle suspension with 1 mol% loading of transducer. After 15 h of incubation, 
no change was observed in the UPLC chromatogram, indicating that the enzyme cannot 






Figure 5.11   UPLC traces of attempted β-galactosidase enzymatic cleavage of short galactose transducer 
5-2 (retention time: 1.81 min) and long galactose transducer 5-5 (retention time: 1.60 min). 1 mM 200 nm 
POPC vesicles with 1 mol% external loading of transducer (10 μM bulk concentration of the transducer). a), 
b), and c): 0 h, 5 h, and 15 h after addition of 1 mg/L (0.02 μM) of β-galactosidase to vesicles with transducer 
5-2. d), e), and f): 0 h, 5 h, and 20 h after addition of 1 mg/L (0.02 μM) of β-galactosidase to vesicles with 
transducer 5-5. Column: ACQUITY UPLC® CSH C18, 2.1x 50 mm, 1.7 μm, 130 Å. Solvent A: 2 mM ammonium 
acetate in water/acetonitrile (95:5); Solvent B: acetonitrile. Gradient: 5-95% B over 1 min. Flow rate: 0.6 
mL/min. 
We then assembled vesicles with 1 mol% loading of long galactose transducer 5-5 in the 
membrane for the same experiment, see Figure 5.11b. Addition of 0.2% of β-galactosidase 
(relative to the transducer) to the vesicle suspension led to hydrolysis of glycosidic bond, as 
indicated by the decreased UV signal at t = 1.60 min in the chromatogram as well as the 
appearance of a new signal at t = 1.81 min. !e new signal has a mass corresponding to long 
phenol transducer 5-6. Considering the usual signalling experiments time scale is 10 h in our 
studies, the cleavage rate is relatively slow as only 12% of the transducer was cleaved by the 
enzyme in 5 h or 78% in 20 h. Nonetheless, these finding suggests that the addition of 
polyethylene glycol linker enables the galactose head group to be hydrolysed by β-galactosidase 
on the membrane surface.  
5.2.4.2    In DNPC Vesicles. 
!e original design (Figure 5.1) of the transmembrane signalling system was to use β-
galactosidase as an input signal to cleave the galactose unit of transducer and trigger 
translocation. However, as short galactose transducer 5-2 is inert to enzymatic cleavage when 
embedded in POPC vesicles and long galactose transducer can span the POPC lipid bilayer 





dinervonoylphosphocholine (DNPC), a considerably longer phospholipid compared to POPC, 
would avoid the membrane-spanning but still enable the enzymatic cleavage, see Chemdraw 
model shown in Figure 5.14. 
  
Figure 5.12      A Chemdraw model for length comparison. The hydrophilic region of POPC and DNPC is 
coloured blue. Catalytic region of long galactose transducer is coloured orange. 
  We first examined the enzymatic cleavage of long galactose transducer 5-5 in DNPC vesicles 
by UPLC, see Figure 5.15. β-Galactosidase is able to hydrolyse the glycosidic bond of the 
membrane-embedded transducer as expected. !e observed hydrolysis rate from UPLC UV 
traces (68% conversion in 15 h) of the transducer at DNPC vesicles surface is slightly faster 












































































Figure 5.13   UPLC traces of β-galactosidase enzymatic cleavage of long galactose transducer 5-5 in DNPC 
vesicles. 0 h (a) and 15 h (b) after addition of 1 mg/L (0.02 μM) of β-galactosidase to 1 mM 200 nm DNPC 
vesicles with 1 mol% external loading of long galactose transducer 5-5 (10 μM bulk concentration of 
transducer, 500 eq. to β-galactosidase, retention time: 1.60 min, blue signal). Pink signal at retention time 
1.80 min corresponds to long phenol (ON state galactose) transducer 5-6. Column: ACQUITY UPLC® CSH 
C18, 2.1x 50 mm, 1.7 μm, 130 Å. Solvent A: 2 mM ammonium acetate in water/acetonitrile (95:5); Solvent B: 
acetonitrile. Gradient: 5-95% B over 1 min. Flow rate: 0.6 mL/min. 
We then tested the transmembrane signalling ability of transducer 5-5 in DNPC vesicles. 0.1 
mM 200 nM DNPC vesicles were prepared and suspended in HEPES bu!er saline with ZnCl2 
on both sides at pH 7 and 5 mol% of transducer 5-5 were loaded externally. As DNPC has a 
phase transition temperature of 27ºC (multilamellar vesicles) or 26ºC (large unilamellar 
vesicles)12, this experiment was conducted at 10ºC above the transition temperature (36ºC) to 
ensure that the lipid bilayer membrane remained fluid. "e results are shown in Figure 5.15. 
As expected, the galactose transducer is in an OFF state (pink data) without the addition of β-
galactosidase, indicating that the long transducer can no longer span the lipid bilayer. Although 
galactose transducer was cleaved in the membrane as confirmed by UPLC traces, the system 
cannot be switched ON with addition of β-galactosidase (blue data). "e resulting phenol 
transducer appears to be membrane-impermeable in the DNPC lipid bilayer. A separate 
control experiment with external addition of long phenol transducer 5-6 (black data) also gave 
an OFF state. "ese results are consistent with previous experiments with POPC vesicles that 











Figure 5.14   Signalling experiment of long galactose transducer 5-5. Time dependence of the normalised 
fluorescence emission intensity at 510 nm (exciting at 415 nm) of 200 nm DNPC vesicles (0.1 mM final lipid 
concentration) containing 250 μM substrate 5-10 in 25 mM HEPES buffer 150 mM NaCl at pH 7 at 37ºC. Grey 
data: background hydrolysis. Pink data: 5 mol% long galactose transducer 5-5 (in DMSO) and 250 μM ZnCl2 
added externally at t = 0 min to vesicles containing 250 μM ZnCl2. Blue data: 5 mol% long galactose 
transducer 5-5 (in DMSO) and 250 μM ZnCl2 added externally at t = 0 min, 10 ug/mL β-galactosidase added 
externally at t = 10 min. Black data: 5 mol% long phenol transducer 5-6 (in DMSO) and 250 μM ZnCl2 added 
externally at t = 0 min to vesicles containing 250 μM ZnCl2. b) Schematic illustration. 
5.3   Conclusion 
To conclude, we have synthesised transducers of di!erent lengths with a hydrazide head group 
and used hydrazide-aldehyde chemistry to attach β-galactose unit as well as corresponding 
phenol moiety on them, obtaining four transducers (short and long). First, the catalytic activity 
and metal transport ability of each transducer were examined in an array of six signalling 
systems. "e combined results of these signalling systems suggest that the short galactose 
transducer cannot cross the membrane but is able to transport metal ions when pre-
incorporated in the lipid bilayer. We hypothesised that the pyridine oxime head group of a 
transducer could partition between membrane-water interface (U-shaped) and lipid 
hydrocarbon environment, enabling a possible metal-binding relay for transport mechanism. 
HPTS fluorescence quenching assay results are consistent with this hypothesis. Second, it is 
demonstrated that a polyethylene glycol linker is required for the glycosidic bond of the 
transducer to be cleaved by the enzyme at the membrane-water interface. However, the linker 





assembled DNPC vesicles with long transducers. As expected, the transducer can no longer 
cross the membrane due to relatively short length compared to DNPC lipid. Unfortunately, 
the resulting hydrolysis product – a phenol transducer – did not cross the membrane. !is is 
potentially due to the low pKa value of the phenol group of the transducer, which could 
deprotonate at neutral pH environment. !e deprotonated transducer is membrane-
impermeable and therefore no ON state could be achieved. !ese findings revealed the metal 
transport ability of transducers  and provided further understanding of the previously proposed 
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5.4   Supporting Information 
5.4.1   Synthetic Procedures and Characterisation 
Materials and Methods  
1H NMR and 13C NMR spectra were recorded on a 400-MHz Bruker® spectrometer. 
Chemical shifts are reported as δ values in ppm. Microwave reaction was carried out on 
a Biotage® Initiator+ microwave reactor. Flash chromatography was carried out on an 
automated system (Combiflash® Rf+ Lumen™) using pre-packed cartridges of silica (25 
µm PuriFlash® Column) or neutral alumina (50 µm RediSep® Rf Column). SEC 
purification of the vesicles was carried out using GE Healthcare PD-10 desalting 
columns prepacked with Sephadex® G-25 medium. Ions exchange of the substrate was 
carried out using GE Healthcare disposable PD-10 gravity columns packed with CM 
Sephadex® C-25 medium. Fluorescence spectra were recorded using a Cary Eclipse 
fluorescence spectrophotometer (Agilent Technologies) in Hellma® Analytics Suprasil® 
quartz cuvettes. Measurements of pH were conducted using a Mettler-Toledo 
SevenCompact™ pH meter equipped with an InLab® Micro electrode. Vesicles were 
assembled in Eppendorf® polypropylene DNA LoBind® polypropylene microcentrifuge 
tube and extruded as described below using Avanti® Polar Lipids extruder kits, 
equipped with Avestin® LiposoFast Liposome Factory 200 nm polycarbonate 
membranes with GE Healthcare Whatman® 10 mm polyester filter support. Sonication 
was carried out using a Elma® Transsonic 420 sonicator. Vortexing was carried out on a 
Heidolph™ Reax Top Vortex Mixer. Solutions or vesicles suspensions were transferred 
using Eppendorf Multipette® Xstream Pippette with Combitips Advanced® or Hamilton 
Microliter™ syringes. All reagents and solvents were used without further purification. 
Lipids were purchased from Sigma-Aldrich® and used without further purification.  
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Synthesis and Characterisations 
Synthesis of Short Hydrazide Transducer 5-1 
 
Scheme S5.1   Synthetic route for short hydrazide transducer 5-1. (Synthesised and characterised by Dr 





























































Synthesis of Long Hydrazide Transducer 5-3 
 
Scheme S5.2   Synthetic route for long hydrazide transducer 5-3. (Synthesised and characterised by Dr 















































































































































Synthesis of Galactose Derivative 5-9 
 





To a solution of acetobromo-α-D-galactose (400 mg, 0.972 mmol), 4-hydroxybenzaldehyde 
(118 mg, 0.972 mmol) in anhydrous chloroform (2 mL) was added silver oxide (224 mg, 1.94 
mmol) with external cooling and the reaction mixture was stirred at room temperature 
overnight. The reaction mixture was diluted with ethyl acetate (20 mL), washed with 
hydrochloric acid (1 M), sodium bicarbonate (sat. aq.), brine, and dried over magnesium 
sulfate. The crude was purified by flash chromatography (silica, 0 – 40% ethyl acetate in 
petroleum ether) to yield the product as a colourless oil (396 mg, 72%).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): 9.93 (s, 1H), 7.87 – 7.84 (m, 2H), 7.12 -7.10 (m, 2H), 5.55 – 
5.47 (m, 2H), 5.18 – 5.12 (m, 2H), 4.26 – 4.10 (m, 3H), 2.19 (s, 3H), 2.07 (s, 3H), 2.02 (s,3H).  
13C NMR (100 MHz, CDCl3) δ (ppm): 190.6, 170.3, 170.1, 170.0, 169.3, 161.3, 131.8, 131.8, 116.7, 
98.6, 71.3, 70.6, 68.4, 66.7, 61.3, 20.7, 20.6, 20.6, 20.6. 
HR-MS (MS+): calcd. for C21H24O11: 452.1319, found: 452.1313.  



















































Figure S5.1   1H NMR spectra of compound 5-8. 
 






A solution of compound 5-8 (70 mg, 0.22 mmol) and sodium methoxide (12 mg, 0.22 mmol) 
in methanol (1 mL) was stirred at room temperature for 1.5 h. The reaction mixture was 
diluted with methanol (5 mL) and neutralized with Amberlyst-15 resin. The solution was 
poured into diethyl ether (50 mL), and the precipitate was filtered and dried to give the 
product as a white amorphous solid (34 mg, 77%).  
 
1H NMR (400 MHz, D2O) δ (ppm): 9.83 (s, 1H), 7.97 (d, J = 8.6 Hz, 2H), δ 7.97 (d, J = 8.8 Hz, 1H), 
7.29 (d, J = 8.8 Hz, 1H), 5.23 (d, J = 7.7 Hz, 1H), 4.04 (d, J = 3.3 Hz, 1H), 3.95 (t, J = 6.2 Hz, 1H), 
3.89 – 3.86 (m, 1H), 3.82 (m, 1H). 
13C NMR (100 MHz, D2O) δ (ppm): 195.0, 162.0, 132.6, 130.7, 116.5, 99.8, 75.6, 72.4, 70.3, 68.4, 
60.6. 
HR-MS (MS+): calcd. for C13H16O7: 284.0896, found: 284.0897.  
FT-IR (ATR): νmax 3353, 1683, 1600, 1512, 1427, 1394, 1316, 1251, 1218, 1164, 1139, 1090, 1059, 















Figure S5.3   1H NMR spectra of compound 5-9. 
 
Figure S5.4   13C NMR spectra of compound 5-9. 
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General protocol for hydrazide-aldehyde reaction 
To a methanolic solution of 1 mM hydrazide transducer (1 eq.) and aldehyde (1.5 eq.) was 
added catalytic amount of acetic acid. The reaction was stirred at room temperature 
overnight and followed by LC-MS. Once the reaction was finished, the solvent was 
evaporated under a nitrogen beam for three times (re-dissolved in methanol). The product 
was used without further purification.  
 
Compound 5-2 (short galactose transducer) 
 
Figure S5.5   UPLC trace of a) starting material short hydrazide transducer 5-1 (retention time: 1.95 min) and 
b) a reaction mixture of compound 5-1 and compound 5-9. c) The mass spectrum (ES+) of the single peak 





















Compound 5-5 (long galactose transducer) 
 
Figure S5.6   UPLC trace of a) starting material long hydrazide transducer 5-4 (red, retention time: 1.77 min) 
and b) a reaction mixture of compound 5-4 and compound 5-9. c) The mass spectrum (ES+) of the single 






















Compound 5-3 (short phenol transducer) 
 
Figure S5.7   UPLC trace of a) starting material short hydrazide transducer 5-1 (red, retention time: 1.95 min) 
and b) a reaction mixture of compound 5-1 and 4-hydroxyl benzaldehyde (black, retention time: 0.59 min). c) 
The mass spectrum (ES+) of the peak (blue, retention time: 2.10 min) which corresponds to product short 




















Compound 5-6 (long phenol transducer) 
 
Figure S5.8   UPLC trace of a) starting material long hydrazide transducer 5-4 (red, retention time: 1.77 min) 
and b) a reaction mixture of compound 5-4 and 4-hydroxyl benzaldehyde (black, retention time: 0.59 min). c) 
The mass spectrum (ES-) of the peak (blue, retention time: 1.79 min) which corresponds to product long 
phenol transducer 5-6 (MW = 758.2; [M-H+]).  
5.4.2   Vesicle Experiments 
General Protocol for Vesicle Preparation 
To a 1.5 mL microcentrifuge tube was added a chloroform solution of lipids (POPC 100%) 
(and 5 mol% loading of transducer in System A, B, and C) in order to obtain a final lipid 
concentration of 1 mM in 3.5 mL (final elution volume). The solvent was evaporated using a 
dry nitrogen stream and dried under high vacuum for at least 2 h to yield a thin lipid film. To 
the microcentrifuge containing the lipids was added 25 mM HEPES 150 mM NaCl buffer (0.5 





















D, and F) as appropriate to reach final concentrations of 250 µM. After swelling for 1 min, 
the suspension was subjected to 5 cycles of freeze-thaw using liquid nitrogen and 35°C 
water bath. The suspension was extruded for 19 times through a 200 nm polycarbonate 
filter in an extruder apparatus, and then the vesicles were separated by a bulk solution using 
prepacked SEC columns eluting with the same HEPES buffer at pH 7. Vesicle suspensions 
can be further diluted using HEPES buffer to 0.1 mM lipid concentration. Finally, 250 µM zinc 
chloride is added externally in System B, C, E and F. 
Fluorescence Measurements 
Fluorescence excitation experiments were recorded using the following parameters: 
emission wavelength = 510 nm, excitation range 380!480 nm, recorded at 2-minute 
intervals. At the end of the experiment, 5% Triton X-100 (50 µL) and 1M NaOH (50 µL) was 
added to lyse the vesicles and hydrolyse all of the remaining substrate. The emission 
measured at this end point (Iend) and at the starting point (I0) were used to normalize the data 







System A and D: To a 1 mL fluorescence cuvette was added 0.1 mM vesicle suspensions 
(800 µL) described above at t = 0 min; System B, C, D, and E: 250 µM zinc chloride was added 
to the 0.1 mM vesicle suspensions (800 µL) described above at t = 0 min. 
 
Fluorescence Quenching Experiments 
External addition method: 0.1 mM POPC 200 nm vesicles encapsulating 250 µM HPTS in 25 
mM HEPES 150 mM NaCl were assembled at pH 7 by following the same protocol described 
above. 10 µM CuCl2 was added to the vesicle suspensions at t = 0 min, followed by an 
addition of transducer (1 mM in DMSO) at t = 10 min; Pre-incorporation method: vesicles 
with 5 mol% loading of transducer were assembled by following the same protocol 
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19F NMR Studies  
6.1   Introduction 
Membrane translocation is a recent artificial approach for transmembrane signal transduction 
developed in our group1–3. !e key concept is based on the controlled translocation of a 
synthetic molecular transducer from the outside to the inside of a vesicle, which subsequently 
leads to catalytic hydrolysis of an encapsulated substrate. We rely exclusively on the fluorescent 
emission of the hydrolysed products in the vesicles to determine whether the system is ON or 
OFF: when the internal hydrolysis rate of substrate is low, we classify the system as OFF; when 
a relatively rapid increase in the product fluorescent emission is observed, the system is 
classified as ON. !e proposed translocation mechanism is therefore inferred from collective 
observations of relative reaction rates of hundreds if not thousands of vesicle signalling 
experiments. However, apart from fluorescence measurements, there are few techniques that 
provide a more detailed understanding of how the transducers behave in the membrane as it is 
highly challenging to directly observe molecular movement within the lipid bilayer.  
!e transmembrane signalling as well as ion transport experiments in Chapter 5 suggest that 
the translocation mechanism may be much more complex than a simple translational 
movement. It is possible that the pyridine-oxime catalytic head group partitions between the 
membrane-aqueous interface and membrane hydrocarbon environment, and we hypothesised 
in Chapter 5 that the membrane-embedded transducer may be U-shaped so that both head 
groups can be exposed to the same aqueous phase.  
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19F NMR spectroscopy is a powerful tool in the study of biological systems such as protein 
structure and dynamics.4,5 19F nucleus is relatively easy to be incorporated in biomolecules 
through conventional protein-labelling techniques. Because of its small size, 19F nucleus 
provides a rather non-perturbing probe compared to other probes such as fluorescent dyes 
which usually consist of large conjugated systems. More importantly, the chemical shift of 19F 
has large dispersion and is sensitive to changes in the local environment, including Van der 
Waals interactions and local electrostatic fields.6 19F chemical shift is determined primarily by 
the five 2p electrons of fluorine, which have a large paramagnetic term in the shielding formula. 
!erefore, water solvated and membrane-embedded fluorine-labelled molecules should have 
di"erent chemical shifts, providing direct evidence on the local environment. In order to probe 
the positioning of the catalytic head group, we have designed and synthesised a series of fluorine 
labelled molecules that have the same pyridine-oxime catalytic head group as previously studied 
transducers, and used 19F NMR spectroscopy to investigate the chemical environment in the 
lipid bilayer. 
6.2   Results and discussion 
6.2.1   Synthesis of 19F-Labelled Molecules 
Fluorine atom(s) should ideally be placed as close as possible to the catalytic centre so that they 
report directly on the position of the pyridine-oxime head group in the lipid bilayer. Two 
possible labelling positions are: 1) the alpha-position of the oxime, and 2) 3-, 4-, or 5-position 
of the pyridine ring. From the synthesis point of view, as the transducer is not symmetric, 
introducing a fluorine nucleus on the 3- or 5-position of pyridine dioxime precursor would 
result in a 50/50 mixture of two products, as shown in Scheme 6.1. !is would complicate the 
synthesis as well as the interpretation of subsequent experiments. !erefore, 4-position of the 
pyridine would be the appropriate choice because a substitution on this position does not 
change the overall C2v symmetry of pyridine dioxime. Trifluoromethyl group was selected as 
the signal is three times stronger than one single fluorine substitution, and as 4-trifluoromethyl 
pyridine, the corresponding starting material, is commercially available. 
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Scheme 6.1   Substitution of transducer precursor with pyridine-oxime via SN2 mechanism 
Figure 6.1 shows the structure of a series of 19F-labelled molecules designed and studied in 
this chapter. 6-1 is the precursor of water soluble trifluoropyridine dioxime 6-2. O-Monohexyl 
substituted pyridine dioxime 6-3 is a simplified version of an ON state transducer. !e hexyl 
group represents the membrane anchor as well as the membrane-permeable recognition head 
group that would presumably allow pyridine unit to sit at the membrane-water interface. O,O-
Dihexyl substituted pyridine dioxime 6-4 di"ers from the transducer mono-oxime structure. 
!e two hexyl chains make the molecule highly hydrophobic and should allow the whole 
molecule to be embedded deep in the lipid bilayer. Compound 6-5 was designed as a closer 
mimic of the ON state transducer with another trifluoromethyl group attached to the other 
end of the lithocholic acid core. !is trifluoromethyl group should always reside inside the 
membrane regardless of zinc(II) binding on the other end of the molecule. 19F-labelled 










































Figure 6.1   Structures of 19F-labelled molecules.  
!e synthesis of each molecule is shown in Scheme 6.2 – 6.5. Compound 6-1 was synthesised 
from 4-trifluoropyridine with pyruvic acid by Minisci reaction.7 Condensation of 2 equivalents 
of hydroxylamine with 6-1 gave pyridine dioxime 6-2. O-Hexylhydroxylamine was synthesised 
in two steps from N-hydroxyphthalimide: substitution of 1-bromohexane under basic 
conditions followed by hydrolysis with hydrazine. Treating one equivalent of O-
hexylhydroxylamine with compound 6-1 and subsequent condensation with hydroxylamine 
yielded O-monohexyl substituted pyridine dioxime 6-3, whilst treating two equivalents of O-



























































Scheme 6.2   Synthesis of compounds 6-1 - 6-4. 
  Model transducer 6-5 was synthesised in four steps from lithocholic acid as shown in Scheme 
6.3. EDC coupling of the carboxylic acid with 1,1,1-trifluoroethylamine gave intermediate 
amide 6-11. Condensation of 1 equivalent of chloroacetyl chloride gave compound 6-12. 






































































Scheme 6.3   Synthesis of 6-5. 
  Synthesis of 19F-labelled hydrazide transducer 6-6 and galactose transducer 6-7 is shown in 
Scheme 6.3. Starting material 6-13 was a generous gift from Dr Istvan Kocsis (unpublished 
results, for synthesis route see the Supporting Information). Functionalisation with 4-
trifluoromethyl pyridine dioxime 6-2 ligand gave Boc-protected compound 6-14. 
Deprotection using hydrochloric acid gave transducer 6-6. Condensation of hydrazide 6-6 























































Scheme 6.4   Synthesis of 19F-labelled transducer 6-6 and 6-7. 
6.2.2   19F NMR Studies in Chloroform 
19F NMR studies were conducted on a 400 MHz NMR spectrometer with Neo Prodigy BBO 
Cryoprobe. !e results were highly reproducible with no or negligible batch-to-batch chemical 














































































Figure 6.2   400 MHz 19F NMR spectra of compound 6-1— 6-6 (10 mM) and after addition of 20 mM of zinc 
trifluoroacetate in chloroform-d at room temperature.  
 
!e 19F NMR spectra of all samples in deuterated chloroform are shown in Figure 6.2. In 
general, addition of zinc trifluoroacetate moves the fluorine signal upfield by 0.1 – 0.6 ppm.  
!e chemical shift of the 19F signal observed for the diketone 6-1, the dioxime 6-2 and the 
mono-O-hexyl substituted pyridine dioxime 6-3 are very similar in chloroform. For O,O-
dihexyl substituted pyridine dioxime 6-4, two signals were observed in the 19F NMR spectrum 
with a ratio of approximately 3:1. Two signals with close retention times were also observed in 
the UPLC trace and these two signals have the same molecular mass which corresponds to 
pyridine oxime 6-4, see Supporting Information. !is evidence suggests that pyridine dioxime 
6-4 has two isomers in slow exchange on the NMR and LC-MS time scale. One possible 
explanation for the existence of isomers is that compared to 6-2 and 6-3, 6-4 cannot form an 
intramolecular hydrogen bond (see Figure 6.3 and 6.4) which would favour the E,Z- isomer. 
Upon binding with zinc(II), the two signals observed for 6-4 changed to one signal at -65.08 
ppm. !is suggests that E/Z isomers of 6-4 were able to convert to E,E-isomer at room 
temperature as zinc complexation requires specific E,E- configuration (see Figure 6.4).  
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19F chemical shifts observed for transducer 6-5 were -64.67 ppm (a singlet) -72.54 ppm (a 
triplet), corresponding to the trifluoromethyl group on the pyridine and the trifluoromethyl 
group on the amide. Zinc(II) complexation shifted the singlet upfield -0.36 ppm and the triplet 
remained unchanged as zinc binding has no e!ect on the amide bond at the other end of the 
molecule. 19F chemical shift observed for hydrazide transducer 6-6 was -64.63 ppm. Binding 
with zinc(II) shifted the signal upfield 0.38 ppm to -65.01 ppm. "e galactose transducer 6-7 
had very poor solubility in chloroform and therefore the 19F NMR spectrum could not be 
recorded.  
 














































Figure 6.4   Possible E/Z and cis-/trans- isomers of O,O-dihexyl oxime 6-4 and zinc(II) complex 6-4•Zn(II). 
6.2.3   19F NMR Studies in Water and Lipid Bilayer Membrane 
We then pre-incorporated the compounds into 20 mM 200 nm POPC vesicles to achieve a 5 
mol% loading (relative to lipids) in HEPES bu!er saline with 10 v/v% deuterated water at pH 
7. "is HEPES bu!er solution with deuterated water was prepared in one batch for all NMR 
studies to avoid any solvent isotope e!ect.9 "e 19F NMR spectra were recorded, and another 
set of data for each compound was recorded after addition of 25 mM ZnCl2 in the bu!er 
solution. "e relative concentration of Zn2+ is similar to that used in the signalling experiments 
in the previous chapters and the published results. All spectra are shown in Figure 6.5. 
Compared to 19F NMR spectra in chloroform, the spectra recorded in the POPC membrane 
are significantly broader. As T2 relaxation is caused by transient magnetic fields and usually due 
to molecular tumbling, when movement is more restricted, for example in a lipid bilayer in 
this case, the molecular motion becomes slower, thus the elongated autocorrelation time tc 
drives T2 relaxation faster and resulting in line broadening (T2 is in inverse proportion to the 
signal width at half-height). Anisotropic molecular motion due to packing into lipid bilayer 
might contribute to further line broadening as well. 
Compound 6-1 is not soluble in water. When incorporated into POPC membrane, the 19F 
chemical shift observed for 6-1 is -64.57 ppm. Pyridine dioxime 6-2 is an amphiphile with 
good water solubility, for which 19F chemical shift observed is -64.65 ppm in a HEPES bu!er. 
Upon addition of ZnCl2, the signal did not move. Incorporating pyridine dioxime 6-2 into 
POPC membranes results a 0.35 ppm chemical shift downfield to -64.30 ppm compared to 












































ppm. !ese results suggested zinc(II) binds compound 6-2 in water and at the membrane 
surface. 
  O-Hexyl mono-oxime 6-3 is not water soluble, however, it can be dissolved in the lipid bilayer 
and the 19F chemical shift observed is -64.46 ppm. Zinc(II) binding did not change either the 
shape or the chemical shift of the signal. Similar to the spectrum in deuterated chloroform, 
when incorporated into lipid bilayer membranes, there are two 19F chemical shifts observed for 
O,O-dihexyl substituted pyridine dioxime 6-4, which possibly correspond to E/Z-isomers. 
However, whilst the two signals did merge into one upon zinc binding in chloroform, adding 
zinc chloride to the system has no e"ect on the 19F NMR spectrum when the compound is in 
the membrane environment.  
 
Figure 6.5   400 mM 19F NMR spectra at room temperature of a) 1 mM pyridine dioxime 6-2 in 25 mM HEPES 
buffer 150 mM NaCl with and without 5 mM ZnCl2; b) compound 6-1 — 6-7 embedded in 20 mM 200 nm 
POPC vesicles (5 mol% loading) in 25 mM HEPES 150 mM NaCl buffer at pH 7. Samples with ZnCl2 were 
prepared with additional 5 mM ZnCl2.  
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  !ere are two possible ways to interpret these two observations: 1) Zn2+ does not bind to 
membrane embedded O-hexyl mono-oxime 6-3 and O,O-dihexyl-substituted pyridine 
dioxime 6-4, or 2) binding Zn2+ does not change the chemical environment of trifluoromethyl 
pyridine in this particular experiment. However, without further experimental evidence we 
cannot draw a definite conclusion. 
  As expected, the trifluoromethyl group at the alpha position of amide bond of transducer 6-
5 remains unchanged when zinc(II) is introduced into the system, because this part of the 
transducer is hydrophobic and therefore embedded inside the lipid bilayer. !e fact that two 
19F signals were observed for 6-5, 6-6, and 6-7 when embedded into POPC membranes 
suggests that for each of the transducers, the pyridine-oxime head group is in two di"erent 
chemical environments in slow exchange. !ese two signals could correspond to the pyridine 
unit of the transducer partitioning in between lipid bilayer and the membrane-water interface. 
Adding ZnCl2 merged the two signals into one, indicating that all transducers were able to 
bind zinc(II) regardless of the attached recognition head group. For galactose transducer 6-7, 
the saccharide head group is polar, therefore should preferably locate in the aqueous phase. In 
the presence of Zn2+, the pyridine-oxime head group should also be at the membrane-water 
interface for a couple of reasons: First, this metal ion-ligand complex is charged, hydrophilic 
and therefore prefers aqueous environment over hydrocarbon chains; Second, this compound 
catalyzes the hydrolysis reaction in the presence of zinc (see Supporting Information). As the 
substrate is highly charged and not membrane-permeable, the catalytic head group can only 
participate in the reaction in the aqueous environment. !ese results suggest that transducers 
could be in equilibrium between the two states at the membrane-water interface, see Figure 
6.8.  
 
Figure 6.6  Schematic illustration of a) transducer in lipid bilayer membrane without the presence of Zn2+ 
(yellow), where the catalytic head group (green) partitions at membrane-water interface and membrane 
environment, and b) upon Zn2+ binding, the catalytic head group resides solely at the membrane-water 
interface. 19F label is shown in red. 
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6.3   Conclusion 
To conclude, we have synthesised a series of model molecules and transducers with 
trifluoromethyl group at the 4-position on pyridine mono-oxime and used 19F NMR to 
determine the positioning of the catalytic head group in the lipid bilayer membrane. Zinc(II)-
binding is confirmed in chloroform-d for all molecules. !ese molecules can be incorporated 
into POPC lipid bilayers. !ere are two signals of fluorine signals observed for transducers 
without zinc(II) binding in the membrane, indicating the catalytic head group is at two 
di"erent local chemical environments in slow exchange. Adding zinc chloride into the system 
merges two signals into one, which confirms zinc binding to transducers at membrane-water 
interface. Based on these observations, it is suggested that in the OFF state, transducers could 
be U-shaped as the catalytic head group may partition between membrane-water interface and 
membrane environment. !is study provides further understanding of the previously proposed 
translocation mechanism. For the first time the system has been studied by using NMR 
spectroscopy techniques to examine the transducer movement on a molecular level, benefiting 
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6.4   Supporting Information 
6.4.1   Synthetic procedures and characterizations 
Materials and methods 
1H NMR and 13C NMR spectra were recorded on a 400-MHz Bruker® spectrometer. Chemical 
shifts are reported as δ values in ppm. Flash chromatography was carried out on an 
automated system (Combiflash® Rf+ Lumen™) using pre-packed cartridges of silica (25 µm 
PuriFlash® Column) or neutral alumina (50 µm RediSep® Rf Column). GPC purification of the 
vesicles was carried out using GE Healthcare PD-10 desalting columns prepacked with 
Sephadex® G-25 medium. Fluorescence spectra were recorded using a Cary Eclipse 
fluorescence spectrophotometer (Agilent Technologies) in Hellma® Analytics Suprasil® 
quartz cuvettes. Measurements of pH were conducted using a Mettler-Toledo 
SevenCompact™ pH meter equipped with an InLab® Micro electrode. Vesicles were 
assembled in Eppendorf® polypropylene Protein LoBind® polypropylene microcentrifuge 
tube and extruded as described below using Avanti® Polar Lipids extruder kits, equipped 
with Avestin® LiposoFast Liposome Factory 200 nm polycarbonate membranes with GE 
Healthcare Whatman® 10 mm polyester filter support. Solutions or vesicles suspensions 
were transferred using Eppendorf Multipette® Xstream Pippette with Combitips Advanced® 
or Hamilton Microliter™ syringes. All reagents and solvents were used without further 









Synthesis of compound 6-1 has been previously reported.1 Briefly, 4-(trifluoromethyl) 
pyridine (0.76 g, 6.8 mmol, 1 eq.) was dissolved in 0.5 M sulfuric acid (40 mL). Pyruvic acid 
(1.8 g, 20.4 mmol, 3.0 eq.) and silver nitrate (0.12 g, 0.68 mmol, 0.1 eq., 10 mol% dissolved in 
1 mL of deionized water) were added. Finally, sodium persulfate (4.9 g, 20.4 mmol, 3 eq.) was 
added with vigorous stirring. The reaction mixture was stirred at 70ºC overnight. The 
reaction was basified to pH 10 using concentrated sodium hydroxide. The reaction mixture 
was extracted with dichloromethane (3 x 20 mL) and the extracts were combined and 
filtered through a short silica pad. After evaporation of solvent, the crude was purified by 
flash chromatography to give the product as colorless needle-like crystals (750 mg, 48% 
yield).  
 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.43 (2H), 2.82 (6H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 197.8, 154.0, 141.0 (q, J = 35 Hz), 121.6 (q, J = 280 Hz), 
120.5 (q, J = 12 Hz), 25.6. 
19F NMR (400 MHz, CDCl3) δ (ppm): -64.76 (s, 3F). 
HR-MS (ES+) calcd. for. C10H9NO2F3: 232.0585, found: 232.0589 










To a solution of compound 6-1 (200 mg, 0.86 mmol, 1 eq.) and hydroxylamine hydrochloride 
(180 mg, 2.60 mmol, 3 eq.) in 1:1 (v/v) chloroform and methanol mixture was added sodium 
hydroxide (72.4 mg, 1.81, 2.1 eq.). The reaction mixture was microwaved at 90 ºC for 2 h. 10 
mL of cooled and deionized water was added to the mixture. The precipitate was filtrated 
and air dried to result the product as white solid (210 mg, 93% yield). 
1H NMR (400 MHz, DMSO-d6) δ (ppm): 11.94 (2H), 7.96 (2H), 2.24 (6H). 
13C NMR (100 MHz, DMSO-d6) δ (ppm): 157.9, 156.2, 140.0 (q, J = 34 Hz), 125.5 (q, J = 220Hz), 
122.2, 116.6, 12.7. 
19F NMR (400 MHz, DMSO-d6) δ (ppm): -63.74 (s, 3F). 
HR-MS (ES+) calcd. for. C10H11N3O2F3: 262.0803, found: 262.0813. 
FT-IR (ATR): νmax 3241, 3081, 2929, 1569, 1411,1278, 1174, 1134, 1015 cm-1. 
 
 







Figure S5.2   13C NMR spectrum of compound 6-2. 
 





The synthesis of compound 6-8 was adapted from literature.2 To a solution of N-
hydroxyphtalimide (1 g, 6.1 mmol, 1 eq.), 1-bromohexane (2.2 g, 12.2 mmol, 2 eq.) in 8 mL of 
dimethylformamide was added N,N-diisopropylethylamine (0.95 g, 7.2 mmol, 1.2 eq.). The 
reaction mixture was stirred at 70 ºC for 4 h. After the solvent was evaporated, the residue 
was re-dissolved in 20 mL of chloroform, washed with lithium chloride (5% aq.), sodium 
bicarbonate (sat. aq.), brine, and dried over anhydrous magnesium sulfate. The product was 
purified by flash chromatography on silica (petroleum ether/ethyl acetate:8/2) to yield the 
product as white solid (1.45 g, 96% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.86 – 7.81 (m, 2H), 7.76 – 7.72 (m, 2H), 4.20 (t, J = 6.8 Hz, 
2H), 1.82 – 1.75 (m, 2H), 1.52 – 1.45 (m, 2H), 1.36 – 1.31 (m, 4H), 0.90 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 163.7, 134.4, 129.0, 123.4, 78.6, 31.5, 28.1, 25.2, 22.5, 14.0. 
HR-MS (ES+) calcd. for C14H18NO3: 248.1287, found: 248.1293.  











Compound 6-9 is prepared by mixing 2 eq. of hydrazine with compound 6-8, followed by 
filtration and evaporation and use without further purification. To an ethanolic solution of 
compound 6-1 (60 mg, 0.26 mmol, 1 eq.) was added compound 6-9 (31 mg, 0.26 mmol, 1 eq.). 
The reaction mixture was microwaved at 60ºC for 4 h. After evaporation of the solvent, the 
residue was purified by flash chromatography (silica, 1%-5% ethyl acetate in petroleum 
ether) to yield the product as a white solid (21 mg, 35% yield).  
1H NMR (400 MHz, CDCl3) δ (ppm): 8.35 (s, 1H), 8.17 (s, 1H), 4.28 (t, J = 6.8 Hz, 2H), 2.77 (s, 3H), 
2.38 (s, 3H), 1.79 – 1.72 (m, 2H), 1.46 – 1.28 (m, 7H), 0.92 – 0.87 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 198.7, 155.5, 153.8, 153.5, 139.6 (q, J = 35 Hz), 122.6 (q, J 
= 280 Hz), 119.3 (q, J = 4 Hz), 116.6 (q, J = 4 Hz), 75.3, 31.6, 29.2, 25.7, 25.6, 22.6, 14.0, 10.6.  
19F NMR (400 MHz, CDCl3) δ (ppm): -64.72 (s, 3F). 
HR-MS (ES+) calcd. for. C16H22N2O2F3: 331.1633, found: 331.1632. 








Figure S6.4   1H NMR spectrum of compound 6-10. 
 
Figure S6.5  13C NMR spectrum of compound 6-10. 
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To a solution of compound 6-10 (20 mg, 0.06 mmol, 1 eq.), hydroxylamine hydrochloride 
(4.6 mg, 0.07 mmol, 1.2 eq.) in 3 mL of ethanol/water:9/1 mixture was added sodium 
hydroxide (2.7 mg, 0.07 mmol, 1.1 eq.). The reaction mixture was microwaved at 60ºC for 5 
h. After evaporation of the solvent, the residue was purified by flash chromatography (silica, 
1%-5% ethyl acetate in petroleum ether) to yield the product as a white solid (15 mg, 72% 
yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.12 (s, 1H), 8.02 (s, 1H), 4.26 (t, J = 6.8 Hz, 2H), 2.41 (s, 3H), 
2.36 (s, 3H), 1.78 – 1.71 (m, 2H), 1.45 – 1.33 (m, 6H), 0.92 – 0.87 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 157.1, 155.4, 154.9, 154.8, 139.3 (q, J = 35 Hz), 123.3 (q, J = 
280 Hz), 116.3 (q, J = 4 Hz), 115.9 (q, J = 4 Hz), 75.6, 32.1, 29.7, 26.1, 23.1, 14.5, 11.3, 10.8.  
19F NMR (400 MHz, CDCl3) δ (ppm): -64.70 (s, 3F). 
HR-MS (ES+) calcd. for C16H23N3O2F3: 346.1742, found: 346.1737. 








Figure S6.7   1H NMR spectrum of compound 6-3. 
 
Figure S6.8   13C NMR spectrum of compound 6-3. 
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Compound 6-9 is prepared by mixing 2 eq. of hydrazine with compound 6-8, followed by 
filtration and evaporation and used without further purification. To a methanolic solution 
of compound 6-1 (100 mg, 0.43 mmol, 1 eq.) was added compound 6-9 (390 mg, 1.08 mmol, 
7 eq.). The reaction mixture was microwaved at 100ºC for 20 h. After evaporation of the 
solvent, the residue was purified by flash chromatography on silica (1%-5% ethyl acetate in 
petroleum ether) to yield the product as a white solid (170 mg, 91% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.08 (s, 2H), 4.25 (t, J = 6.8 Hz, 4H) (E/Z isomer) , 2.35 (s, 
6H), 1.78 – 1.71 (m, 4H), 1.44 – 1.34 (m, 12H), 0.92 – 0.87 (m, 6H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 154.9, 154.5, 138.8 (q, J = 35 Hz), 123.2 (q, J = 280 Hz), 
115.5 (q, J = 4 Hz), 75.2, 31.8, 29.4, 25.8, 22.8, 14.2, 11.0. 
19F NMR (400 MHz, CDCl3) δ (ppm): -64.60 (s), -64.70 (s) (E/Z isomers). 
HR-MS (ES+) calcd. for C22H35N3O2F3: 430.2681, found: 430.2678. 
FT-IR (ATR): νmax 2956, 2936, 2875, 2857, 1568, 1497, 1467, 1431, 1364, 1277, 1132, 1045 cm-1. 
 
 







Figure S6.11   13C NMR spectrum of compound 6-4 (with E/Z isomer). 
 
Figure S6.12   19F NMR spectrum of compound 6-4 (with E/Z isomer). 
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Figure S6.13   LC-MS traces of compound 6-4 isomers and the corresponding mass chromatograms (MW 





































A solution of lithocholic acid (1 g, 2.66 mmol, 1 eq.), 2,2,2-trifluoroethylamine (525 mg, 5.3 
mmol, 2 eq.), EDC•HCl (560 mg, 2.92 mmol, 1.1 eq.), DMAP (24 mg, 0.2 mmol, 0.1 eq.), and 
DIPEA (377 mg, 2.92 mmol, 1.1 eq.) in 20 mL of tetrahydrofuran was stirred at r.t. overnight. 
The reaction mixture was diluted with 50 mL of ethyl acetate, washed with hydrochloric acid 
(1 M, aq.), water, sodium bicarbonate (sat. aq.), brine, and dried over anhydrous magnesium 
sulfate. Evaporation of solvent gave the product as a white solid (888 mg, 74% yield).  
1H NMR (400 MHz, MeOD-d4) δ (ppm): 3.89 (q, J = 9.4 Hz, 2H), 3.59 – 3.51 (m, 1H), 2.34 – 2.15 
(m, 2H), 2.04 – 0.96 (m, 33H), 0.70 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 173.5, 121.6 (q, J = 220 Hz, 1C), 71.9, 56.5, 55.9, 42.7, 42.1, 
40.4, 40.2, 36.4, 35.8, 35.3, 35.2 34.6, 33.3, 31.4, 30.5, 28.2, 27.2, 27.1, 26.4, 24.2, 23.4, 20.8, 
18.3, 12.0. 
19F NMR (400 MHz, MeOD-d4) δ (ppm): -74.02 (t, J = 85 Hz, 3F). 
HR-MS (ES+) calcd. for C26H42O2N1F323Na: 480.3060, found: 480.3046. 












Figure S6.14   1H NMR spectrum of compound 6-11. 
 
Figure S6.15   13C NMR spectrum of compound 6-11. 
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To a solution of compound 6-11 (200 mg, 0.44 mmol, 1 eq.), DMAP (5 mg, 0.04 mmol, 0.1 eq.), 
DIPEA (0.5 mL) in 5 mL of tetrahydrofuran was added chloroacetyl chloride (108 mg, 0.87 
mmol, 2 eq.) with external cooling at -78 ºC. The reaction mixture was stirred at r.t. overnight. 
The reaction was quenched with 2 mL of methanol and the solvent was evaporated. The 
residue was re-dissolved in 50 mL of ethyl acetate, washed with hydrochloric acid (1 M, aq.), 
water, sodium bicarbonate (sat. aq.), brine, and dried over anhydrous magnesium sulfate. 
After evaporation, the crude was purified by flash chromatography (silica, 0 – 10% methanol 
in dichloromethane) to give the product as white solid (100 mg, 41%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 5.64 (t, J = 5.6 Hz, 1H), 4.86 – 4.78 (m, 1H), 4.03 (s, 2H), 
3.97 – 3.88 (m, 2H), 2.35 – 2.11 (m, 2H), 1.98 – 0.92 (m, 32H), 0.64 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 173.5, 166.8, 124.1 (q, J = 220 Hz, 1C), 76.8, 56.4, 56.0, 42.7, 
41.9, 41.2, 40.5 (q, J = 30 Hz, 1C), 40.4, 40.1, 35.8, 35.4, 34.9, 34.6, 33.3, 32.0, 31.4, 28.2, 27.0, 
26.4, 26.3, 24.2, 23.3, 20.8, 18.3, 12.0. 
19F NMR (400 MHz, CDCl3) δ (ppm): -74.02 (t, J = 85 Hz, 3F). 
HR-MS (ES+) calcd. for C26H42O2N1F323Na: 480.3060, found: 480.3046. 












Figure S6.17   1H NMR spectrum of compound 6-12. 
 
Figure S6.18   13C NMR spectrum of compound 6-12. 
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To a solution of compound 6-12 (50 mg, 0.094 mmol, 1 eq.) and compound 6-2 (74 mg, 0.28 
mmol, 3 eq.) in DMF (1 mL) was added potassium carbonate (65 mg, 0.47 mmol, 5 eq.). The 
reaction mixture was stirred at 60 ºC for 1 h and then diluted with ethyl acetate (10 mL). The 
organic phase was washed with lithium chloride (5%, aq.), hydrochloric acid (1 M, aq.), water, 
sodium bicarbonate (sat. aq.), brine, and dried over anhydrous magnesium sulfate. After the 
solvent was evaporated, the crude was purified by flash chromatography (silica, 10% - 40% 
ethyl acetate in petroleum ether) to give the product as white solid (60 mg ,84%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 8.73 (s, 1H), 8.08 (s, 1H), 8.09 (s, 1H), 5.73 (t, J = 6.5 Hz, 1H), 
4.85 – 4.77 (m, 3H), 2.45 (s, 3H), 2,40 (s, 3H), 2.40 – 2.13 (m, 2H), 1.91 – 0.74 (m, 34H), 0.60 
(m, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 174.4, 169.5, 156.7, 155.9, 154.8, 154.0, 138.8 (q, J = 4 Hz, 
1C) , 123.4 (q, J = 220 Hz, 1C), 120.4 (q, J = 220 Hz, 1C), 115.7(q, J = 4 Hz, 1C), 115.6(q, J = 4 Hz, 
1C), 75.3, 71.4, 56.6, 55.8, 42.6, 41.7, 40.6 (q, J = 30 Hz, 1C), 40.4, 40.1, 35.6, 35.4, 34.8, 34.4, 
33.1, 32.0, 31.4, 28.2, 26.9, 26.4, 26.2, 24.1, 23.2, 20.7, 18.1, 11.9, 11.1, 10.0. 
19F NMR (400 MHz, CDCl3) δ (ppm): -64.67 (s, 3F), -74.02 (t, J = 85 Hz, 3F). 
HR-MS (ES+) calcd. for C38H52O5N4F623Na: 781.3734, found: 781.3720. 
















Figure S6.20   1H NMR spectrum of compound 6-5. 
 









To a solution of compound 6-13 (30 mg, 0.053 mmol, 1 eq.) and compound 6-2 (21 mg, 0.079 
mmol, 1.5 eq.) in 1 mL of DMF was added potassium carbonate (22 mg, 0.16 mmol, 3 eq.). The 
reaction mixture was stirred at 60 ºC for 5 h and then diluted with 20 mL of ethyl acetate. 
The organic phase was washed with lithium chloride (5%, aq.), hydrochloride acid (1 M, aq.), 
water, sodium bicarbonate (sat. aq.), brine, and dried over anhydrous magnesium sulfate. 
After the solvent was evaporated, the crude was purified by flash chromatography on silica 
(10% - 40% ethyl acetate in petroleum ether) to give the product as white solid. Compound 
6-2 coeluted with the product and the product was used in the next step without further 
purification. 
To a solution of crude compound 6-14 (20 mg, 0.053 mmol, 1 eq.) in 1 mL dichloromethane 
was added 0.1 mL of trifluoroacetic acid and the reaction mixture was stirred at r.t. 
overnight. The solvent was evaporated under a nitrogen beam and the crude was purified 
by flash chromatography on silica (methanol in dichloromethane) to give the product as 
white solid (3 mg, 17% yield). 
1H NMR (400 MHz, CDCl3) δ (ppm): 9.36 (br, 1H), 8.10 (s, 2H), 6.87 (br, 1H), 4.83 – 4.73 (m, 3H), 
3.98 (br, 2H), 2.46 (s, 3H), 2.41 (s, 3H), 2.32 – 2.03 (m, 2H), 1.89 – 0.63 (m, 33H), 0.59 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ (ppm): 169.5, 156.5, 155.8, 154.9, 154.0, 138.8 (q, J = 34 Hz, 1C) 
122.8 (q, J = 220 Hz, 1C), 115.6 (q, J = 4 Hz, 1C), 115.40 (q, J = 4 Hz, 1C), 75.2, 71.4, 56.7, 55.5, 
50.9, 42.5, 41.6, 40.5, 40.1, 35.5, 35.3, 34.8, 34.4, 31.9, 31.3, 30.8, 29.7, 28.2, 26.8, 26.3, 26.1, 
24.0, 23.2, 20.6, 18.0, 11.9, 11.1, 10.1. 
19F NMR (400 MHz, CDCl3) δ (ppm): -64.62 (s, 3F) 
HR-MS (ES+) calcd. for C36H53N5O5F3: 692.3987, found: 692.3999. 

















Figure S6.23   1H NMR spectrum of compound 6-15. 
 
 
Figure S6.24   13C NMR spectrum of compound 6-15. 
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Figure S6.25   19F NMR spectrum of compound 6-15. 
 
Synthetic route of compound 6-13  
Compound 6-13 was synthesized and characterized by Dr Istvan Kocsis from lithocholic 
acid in two steps: EDC coupling with Boc-protected hydrazine followed by condensation 
with chloroacetyl chloride. The compound was used as received without further purification. 
 
 










































General protocol for hydrazide-aldehyde reaction 
To a methanolic solution of 1 mM hydrazide transducer (1 eq.) and aldehyde (1.5 eq.) was 
added catalytic amount of acetic acid. The reaction was stirred at room temperature 
overnight and followed by LC-MS. Once the reaction was finished, the solvent was 
evaporated under a nitrogen beam for three times (re-dissolved in methanol). The product 
was used without further purification.  
 
Figure S6.26   UPLC trace of a) starting material hydrazide transducer 6-6 (retention time: 2.34 min) and b) a 
reaction mixture of compound 6-6 and compound 6-15. c) The mass spectrum of the single peak (retention 
time: 1.99 min) which corresponds to product galactose transducer 6-7. 



















6.4.2 Vesicle Experiments    
General protocol for vesicle preparation 
To a 1.5 mL microcentrifuge tube was added a chloroform solution of POPC and transducer 
or other molecules (5 mol% loading) in order to obtain a final lipid concentration of 20 mM 
in 1 mL (final elution volume). The solvent was evaporated using a dry nitrogen stream and 
dried under high vacuum for at least 2 h to yield a thin lipid film. To the microcentrifuge 
containing the lipids was added 25 mM HEPES 150 mM NaCl buffer (0.5 mL) at pH 7 (for 
measurements with zinc(II), a stock solutions of zinc chloride as appropriate was also added 
to reach final concentrations of 5 mM). After swelling for 1 min, the suspension was 
subjected to 5 cycles of freeze-thaw using liquid nitrogen and 35 °C water bath. The 
suspension was extruded for 19 times through a 200 nm polycarbonate filter in an extruder 
apparatus, and then the vesicles were separated by a bulk solution using prepacked SEC 
columns eluting with the same HEPES buffer at pH 7.  
6.4.3   Catalytic Activity of Compound 6-2 
4-Trifluoropyridine dioxime 6-2 catalytically hydrolyses substrate 6-9 in aqueous solution 
with the presence of Zn2+. This suggests that the trifluoromethyl group does not affect the 
catalytic activity of the pyridine oxime head group.
         
Figure S6.27   Time dependence of fluorescence emission of normalized fluorescence emission intensity at 
510 nm (exciting at 415 nm). The catalytic hydrolysis (pink) was obtained by adding 1 uM pyridine dioxime 6-
2 to a solution of 25 uM substrate 6-9, 250 μM zinc chloride, and 25 mM HEPES buffer 150 mM NaCl at pH 
7. Control experiment without zinc chloride (black) and background hydrolysis of substrate in buffer (grey) 
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Appendix – Comparison of Substrates 
Introduction 
We studied three substrates for the translocation signalling system: substrate 7-1, 7-2, and 7-
3, structures are shown in Figure 7.1. Substrate 7-3 was synthesised in one step from HPTS 
by condensation with benzoyl chloride (Scheme 7.1). Vesicle experiments are monitored by 
following the fluorescent emission of the hydrolysed product (HPTS) in vesicles. !ese three 
substrates have di"erent background hydrolysis and ON state hydrolysis rate. Besides, the 
corresponding hydrolysis products (acetic acid, 2-naphthoic acid, and benzoic acid for 7-1, the 
7-2, and 7-3, respectively) may cause di"erent e"ects on the bilayer membrane. For example, 
7-2 could be used to trigger controlled release of the vesicle cargo as 2-naphtoic acid is a known 
surfactant that can disrupt the membrane integrity.1 !e membrane permeability (Pmembrane/water) 
of benzoic acid is approximately 10 times lower than 2-naphthoic acid2, which suggests that 
benzoic acid should be less disruptive for the lipid bilayer than 2-naphthoic acid.  
 
Figure 7.1   Molecular structures of substrates 7-1 – 7-3. 
 






7-1   R = methyl
7-2   R = 2-naphthoyl














To benchmark the hydrolysis rate of three substrates, we assembled vesicles with 2.5 mol% 
morpholine transducer 7-43 (synthesised and reported by Dr Langton) in DOPC/DOPE 
vesicles with substrate encapsulated at neutral pH. !e system was turned ON by raising 
external pH from 7 to 9, results are shown in Figure 7.2. !e background hydrolysis rate of 
the substrate 7-2 and 7-3 are both significantly slower than that of 7-1 (~ 12 h timescale).  
 
Figure 7.2   Hydrolysis rate comparison of substrates. Time dependence of the normalized fluorescence 
emission intensity at 510 nm (exciting at 415 nm) of vesicles composed of lipids with 2.5 mol% 7-4 
encapsulating (a) 250 μM 7-1, (b) 250 μM 7-2 and (c) 250 μM 7-3.  Grey data: vesicles incubated at pH 7.  
Red data: vesicles incubated at pH 7 initially, then raised to external pH of 9 after 20 min (indicated by an 
arrow). All experiments were conducted in 200 nm DOPC/DOPE vesicles (3/2 molar ratio, 2 mM lipid 
concentration) containing 250 μM ZnCl2 and 250 mM HEPES buffer and suspended in 250 mM NaCl at pH 
7. Data shown in b) was conducted by Dr M. J. Langton and L. M. Scriven. 
Calcein Release Assay 
Calcein is a water soluble fluorescent dye that self-quenches at concentrations above 70 mM. 
It is commonly used as an indicator of vesicle leakage. To examine whether the substrates can 
cause vesicle membranes to become permeable, a calcein release assay was conducted (Figure 
2.3). DOPC/DOPE vesicles with 2.5 mol% loading of transducer 7-4 containing calcein 
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solution (70 mM) and substrate (25 μM) were prepared at pH 7. Raising the external pH to 9 
initiated the transduction and turned on the catalytic hydrolysis reaction of the substrate 
encapsulated in the vesicles. Release of calcein molecules from the vesicles results in a significant 
fluorophore dilution which increases the fluorescence emission. Total release of calcein was 
achieved by lysis of the vesicles upon adding excess detergent (Triton X-100). !e results using 
substrates 7-2 and 7-3 are shown in Figure 2.12. 
 
Figure 7.3   Schematic representation of calcein release assay. 200 nm DOPC/DOPE vesicles containing 70 
mM calcein, 25 μM substrate 7-2 or 7-3, 250 μM ZnCl2 and 250 mM HEPES buffer at pH 7. An external input 
signal (base pulse) initiates the translocation of the transducer from the outer to the inner leaflet of a lipid 
bilayer membrane and catalyses the turnover of substrate to generate its corresponding products. If the 
product is dissolved in the lipids, it will enhance the membrane permeability and facilitate the calcein cargo 
release. At high concentration, fluorescence emission of calcein is self-quenched. Releasing from internal 
vesicle solution to the extracellular solution will significantly reduce the calcein concentration, which activates 
the fluorescence emission. 
!e results suggest that raising the external pH to 9 has no e"ect on DOPC/DOPE 
membrane permeability to calcein over a period of 10 hours. Similarly, vesicles containing 
substrates 7-2 or 7-3 in the OFF state did not release their contents (Figure 7.4, red data), 
demonstrating that the substrates do not a"ect the permeability of the bilayer. For vesicles 
containing substrate 7-2, raising the external pH to 9 initiates the translocation and generates 
2-naphthoic acid inside the vesicles. !is leads to a rapid release of calcein (Figure 7.4, ON 
state). On the contrary, using  7-3 as substrate has little e"ect on calcein release in this 
signalling experiment. Less than 5% of calcein leaked out during a period of 10 hours, which 
indicates that benzoic acid does not interfere with membrane permeability. 
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Figure 7.4   Time dependence of calcein release initiated by signal transduction. 200 nm DOPC/DOPE 
vesicles (lipid concentration 0.5 mM) with 2.5 mol% transducer 7-4 containing 70 mM calcein, 250 μM ZnCl2, 
250 mM HEPES at pH 7 suspended in 400 mM NaCl. a) Without substrate encapsulation. b) With 25 μM 
substrate 7-2, c) with 25 μM substrate 7-3. Addition of NaOH to raise the external pH to 9 (black or red data, 
addition indicated by an arrow). Grey data: control experiments at pH 7 (without addition of NaOH). Calcein 
emission at 540 nm (exciting at 470 nm) was calibrated to 100% release by lysis with Triton X-100. Data 
shown in b) was conducted by Dr M. J. Langton and L. M. Scriven, graphics have been re-illustrated. 
To further confirm that leakage of the cargo is the e!ect of 2-naphthoic acid, external addition 
of 2-naphthoic acid and benzoic acid to calcein-containing (70 mM) vesicles was investigated. 
Addition of 2-naphthoic acid in methanol (<0.5% v/v, concentration of 2-naphthoic acid at 
50 μM) lead to a rapid release of calcein from the vesicles (Figure 2.13a, red data). In the 
absence of benzoic acid (Figure 7.5a, grey data) or upon addition of an aliquot of the same 
volume of neat methanol, the calcein remains encapsulated and the vesicles over the course of 
the experiment. When benzoic acid was added, minimal release of calcein (less than 3%) was 
observed (Figure 7.5b). "ese results are in line with the calcein release assay initiated by the 
transmembrane signal transduction experiments. 
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Figure 7.5   Calcein release assay initiated by external addition of P3 and P5. 200 nm DOPC/DOPE vesicles 
(lipid concentration 0.5 mM) containing 70 mM calcein and 250 mM HEPES at pH 7 suspended in 400 mM 
NaCl. Grey data: background release. Red data: release triggered by addition of (a) 2-naphthoic acid in 
methanol or (b) benzoic acid in water (50 µM). Calcein emission at (a) 540 nm (exciting at 470 nm) or (b) 534 
nm (exciting at 470 nm) was calibrated to 100% release by lysis with Triton X-100. Data shown in a) was 
conducted by Dr M. J. Langton and L. M. Scriven. 
Conclusion 
Substrate 7-2 and substrate 7-3 were synthesised and the signalling experiments show that both 
substrates have significantly slower background rates compared to substrate 7-1. Due to the 
di!erence of membrane partition coe"cient between 2-naphthic acid and benzoic acid, using 
substrate 7-2 in the vesicle experiments lead to controlled release of the content in the vesicles 
by disrupting the lipid bilayer, whilst substrate 7-3 does not cause such e!ect.  
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To a solution of pyranine (200 mg, 0.381 mmol) in anhydrous N,N’-dimethylformamide 
(10 mL) was slowly added the solution of  benzoyl chloride (267 mg, 1.90 mmol) using 
same solvent at 0 ºC. The reaction was stirred at r.t. for 48 h. The reaction mixture was 
then poured in a mixture of acetone (300 mL) and diethyl ether (100 mL). The precipitate 
was washed with cold acetone (3 x 10 mL) and diethyl ether (10 mL). The resulting solid 
was redissolved in water and purified by passing through an ion exchange column 
(Sephadex C-25, sodium form). The solvent was removed to yield the product as an 
orange solid (137 mg, 57%). 
1H NMR (400 MHz, D2O) δ (ppm): 9.25-9.12 (m, 4H), 8.71 (s, 1H), 8.49 (d, J = 9.6 Hz, 1H), 
7.40 (d, J = 7.6 Hz, 2H), 6.91 (t, J = 7.6 Hz, 1H), 6.62 (d, J = 7.6 Hz, 1H). 
 13C NMR (100 MHz, D2O) δ (ppm): 166.22, 144.12, 138.08, 136.03, 136.01, 133.34, 129.48, 
128.88, 128.70, 127.39, 126.97, 126.39, 126.19, 125.32, 125.30, 125.07, 124.51, 124.41, 
123.22, 120.00. 
HR-MS (ES+): calcd. for C23H11O11Na4S3: 650.9049, found: 650.9045. 







Figure 7.6   1H NMR spectrum of compound 7-3. 
 
Figure 7.7   13C NMR spectrum of compound 7-3. 
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